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ABSTRACT 
 
 
 
Leukaemia is defined as a group of haematological diseases (related to blood and blood-forming 
tissue) characterized by malignant proliferation of myeloblasts or lymphoblasts that replace 
normal bone marrow elements and infiltrate normal tissues. The study of leukaemia has been 
hindered by the lack of appropriate in vitro models, which can mimic this microenvironment. It 
is hypothesized that the fabrication of porous 3-D scaffolds for the biomimetic growth of 
leukaemic cells in vitro could facilitate the study of the disease in its simulated native 3-D 
niche. In this study, polyhydroxyalkanoate (PHA), in particular poly(hydroxybutyrate) (PHB) 
and poly(hydroxybutyrate-co-valerate) (PHBV) porous 3-D scaffolds with an improved 
thickness (in relative to the conventionally made PHA matrices) are utilized and investigated to 
model the abnormal 3-D leukaemic cellular growth system in the absence of exogenous 
cytokines. The polymeric porous 3-D scaffolds were fabricated using an ideal polymer 
concentration of 4% (w/v). The salt-leaching efficacy and the effect of salt residual on the cell 
growth media were carried out to validate the significant amount of salt remnant inside the 
porous materials. The physico-chemical characteristics of the porous 3-D scaffolds such as 
surface wetting, porosity, BET surface area and pore size distribution were studied by means of 
drop sessile analyzer (DSA), helium gas pycnometry, mercury intrusion porosimetry (MIP) and 
scanning electron microscopy (SEM). To increase probability of cellular attachment and 
proliferation, the polymeric scaffold surfaces were treated with O2-rf-plasma (100 W at 10 min) 
and NaOH (0.6M). Next, in order to improve the in vitro 3-D leukaemic cell culture, two main 
bone marrow extracellular matrix (ECM) proteins which are collagen type I or fibronectin were 
immobilized via physical adsorption on the treated surfaces of the polymeric porous 3-D 
scaffolds. Meanwhile, the in vitro degradation studies were conducted on both polymeric 
scaffolds with the hydrolytic degradation media of phosphate buffered saline (PBS) and cell 
growth media. The scaffolds were analyzed and compared for mass loss, morphology and pH 
changed of the PBS and cell growth media throughout 45 weeks and 9 weeks of the study 
respectively. Overall, PHB and PHBV displayed a good seeding efficiency (24 h) and excellent 
leukaemic cellular growth for up to 6 weeks (protein-coated scaffolds), assessed by MTS assay 
and SEM. Once the abnormal hematopoietic 3-D model (cell lines) was established, a new 
model to culture human primary acute myeloid leukaemia mononuclear cells (AML MNCs) was 
studied, compared and validated. All leukaemic cells grew better in PHBV scaffolds coated with 
62.5 µg/ml collagen type I and sustained cell growth in the absence of exogenous cytokines. As 
a result, it was concluded that PHBV-collagen scaffolds may provide and could be used, as a 
practical model with which to study the biology and treatment of primary AML in an in vitro 
mimicry without the use of 2-D culture system and animal models. 
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CHAPTER 1 Introduction 
 
 Tissue engineering can be defined as a process that (1) combines living cells with 
biomaterials, (2) utilizes living cells as cell therapy or diagnostic reagents, (3) generates tissues 
in vitro for therapeutic implantation and (4) provides materials or technology to enable any of 
these approaches [1]. Tissue engineering has emerged as a multi-disciplinary field combining 
biology, materials science and surgical reconstruction in order to provide living tissue products 
that restore, maintain or improve tissue functionality [2, 3]. The need for this approach has been 
a primary option because of a lack of donor organs and tissues, painful procedures of secondary 
surgery and highly invasive procedures. This option is undeniably offered a dramatic ability to 
facilitate, repair, regenerate and replace damaged or diseased tissues. To be more specific, 
biomaterials (any matter, surface or construct that interacts with biological systems) have gained 
significant importance in the field of tissue engineering. Often these biomaterials (derived either 
from nature or chemically synthesized) are used for tissue regeneration when the surrounding 
defective tissue exhibits the natural potential for tissue regeneration. However, in situations 
where the tissue lacks this ability of regeneration, relevant cells as well as growth factors have 
been used to accelerate tissue regeneration. In addition, these biomaterials have also been 
combined with drugs and used as drug delivery systems, thereby reducing the microbial 
infections while maximizing tissue regeneration [4]. In general, there are three distinct 
approaches currently being used in the tissue engineering and regenerative medicine 
applications. These are (1) infusion of isolated autologous cells or cell substitutes, (2) 
implantation of tissue-inducing acellular (no containing cells) scaffold materials in vivo (e.g., 
natural polymers and inorganic materials) by allowing the patient’s cells to repair the tissue 
guided by the scaffold and (3) implantation of expanded in vitro autologous cells seeded in 
scaffolds [3]. 
 In this thesis the investigation has focussed on the study of developing three-dimensional 
porous scaffolds from biopolymers (mainly from PHAs, particularly PHB and PHBV). The 
rationale of choosing this material is to promote the usage of palm oil mill effluent (POME) in 
producing poly(β-hydroxyalkanoates) via microbial fermentation process as an added value 
material for tissue engineering applications. Malaysia is one of the main exporters of palm oil in 
the world after Indonesia, Thailand, Nigeria and Colombia [5]. The up-stream processing of 
fresh palm fruit bunches to extract palm oil has generated an enormous amount of organic 
carbon content of liquid effluent (POME). In fact, this concentrated POME can be used as main 
carbon sources of microbial fermentation to produce PHA. In this study, two commercial PHAs 
from Sigma-AldrichTM which is PHB and PHBV were used to fabricate 3-D porous scaffolds 
with an improved thickness greater than 1 mm (in relative to the conventionally made PHA 
matrices) by using solvent-casting particulate-leaching (SCPL) method. Then, this fabricated   
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3-D porous scaffold were coated with extracellular matrix (ECM) proteins to produce a 3-D 
bone marrow biomimicry by providing an ideal microenvironment for the growth of leukaemia 
cell lines and primary sources (e.g., leukaemic cells taken from patient and normal stem cells). 
The 3-D model generated from this study will be used to explain the molecular determinants of 
leukaemogenesis, the cellular and microenvironmental elements that enhance leukaemia growth 
and protect the leukaemic stem cells from chemotherapy. Moreover, this 3-D bone marrow 
biomimicry scaffold has the potential to be used in the tissue engineering application by 
replacing the abnormal bone marrow consisting of leukaemic stem cells with normal stem cells 
via in vivo implantation. For that reason one particular class of the stem cells which are the 
hematopoietic stem cells (HSCs) were studied. Hematopoiesis is regulated in the bone marrow, 
a complex 3-D tissue composed by a heterogeneous population of haematopoietic and non-
haematopoietic stromal cells. The hematopoietic stem cells and their microenvironment (HM) 
are unique and perform several tasks that no other cells can accomplish. They are indefinitely 
housed in the bone marrow in spaces called niches which control their properties, support HSCs 
self-renewal and prevent them from differentiating. Therefore the dysregulation of the niches, 
either in structure or function, results in the pathogenesis of disease states of the bone marrow, 
such as leukaemia which was studied in detail in this thesis. The different types of leukaemia 
are grouped by the cell affected, myeloid or lymphoid and by the rate of the cell growth, acute 
or chronic. 
 
1. Acute leukaemia involves an overgrowth of very immature blood cells. This condition is 
life-threatening because there are not enough mature blood cells to prevent anaemia, 
infection and bleeding. A diagnosis of acute leukaemia is made when there are 20 percent or 
more blasts or immature cells in the bone marrow. 
2. Myelodysplastic Syndrome (MDS) or preleukaemia is a condition in which the bone 
marrow does not function normally and therefore does not produce enough normal blood 
cells. The blood cells affected are white blood cells, red blood cells and platelets. Some cases 
of MDS may, over time, progress to acute leukaemia. 
3. Chronic leukaemia involves an overgrowth of mature blood cells. Usually, people with 
chronic leukaemia have enough mature blood cells to prevent serious bleeding and infection. 
 
The necessity of identifying the pathways and stimuli involved in the self-renewal and 
differentiation processes of both normal and leukaemic stem cells is required in order to 
understand the events that lead to the leukaemogenesis but at the moment it is unknown which 
are the abnormalities required for leukaemic transformation. It was decided to study the 
indicated problem and the results obtained from this study would perhaps elucidate a definite 
22 
 
answer in future. The results are presented here in this thesis. The specific scientific objectives 
for this thesis are explained thoroughly in Chapters 5, 6, 7 and 8. 
 The leukaemic cells are non-anchorage dependent cells which mean that they need to be 
immobilized onto a specialized 3-D structure for cell culturing or the production of cell 
products. The reasons why these type of cells need to be immobilized on 3-D porous structure is 
as follows: (1) to mimic a 3-D microenvironment of native bone marrow niches that produces 
leukaemic stem cells, (2) the conventional 2-D cultures cannot support long-term primary 
leukaemic cell growth without the support of stromal cells and the used of high concentration 
(µg/ml) of exogenous cytokines. These cytokine concentrations do not correspond to those 
found naturally in the BM, in the range of pg/ml [6, 7] and (3) to increase and stabilize the 
growth of leukaemic cells for a long period of time (up to 4 weeks) by providing biosignalling 
recognition template on the material surface and to give a mechanical support between the cell 
and material. To do so, the receptor-ligand interaction through the physical adsorption of certain 
ECM proteins onto the biomaterial surface is essential. For that reason, an ideal environment of 
protein-coated 3-D scaffold is needed to mimic the microenvironment of bone marrow niches in 
vitro. The scaffolds were coated with two main bone marrow extracellular matrix proteins (e.g., 
collagen type I or fibronectin) to support all the cell functionalities (e.g., attachment, 
proliferation and differentiation).  
 In Chapter 2, a review of current research and background information is presented and 
separated into several main sections: biopolymers, properties of PHB and PHBV, sustainable 
production/economic feasibility, scaffolds for tissue engineering and leukaemias (acute myeloid 
leukaemia and chronic lymphocytic leukaemia). Chapter 3 introduces the aims and objectives 
together with the hypothesis generated at the beginning of the study. Materials and 
methodologies used in the investigation are presented in Chapter 4, which includes the 
technique of protein coating on the 3-D scaffolds for making an ideal environment for cellular 
growth. In Chapter 5, the two main polymers initially selected are introduced and fabrication 
and material/structural characterisation methods to produce and analyze them are detailed. 
Polymers selected in this study are microbial PHB and PHBV copolymers with hydroxyvaleric 
acid (HV) contents of 12% which are herein described as PHB and PHBV (12%). PHB and 
PHBV are the most widely used of the poly(β-hydroxyalkanoates) (PHA) family of 
thermoplastic aliphatic polyester. Initially, the preliminary cell-biomaterial affinity study on the 
porous 3-D scaffolds with an improved thickness greater than 1 mm (in relative to the 
conventionally made PHA matrices) is tested with AML cell line (HL-60) for 2 weeks culture 
period. Chapter 6 describes on the physico-chemical modifications (surface treatment) using the 
alkaline and rf-O2 plasma treatment to increase the surface hydrophilicity. The selection of 
suitable treatment to affect on the cell-biomaterial affinity study of the chronic lymphocytic 
leukaemia (CLL) cell line (RL) for 2 weeks culture period is presented. Chapter 7 offers the 
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comparison between the 2 treated polymeric scaffolds coated with 2 main bone marrow ECM 
proteins (collagen type I or fibronectin), untreated and unmodified scaffolds seeded with CLL 
cell lines (RL and JeKo-1) for 6 weeks culture period. The results of the most suitable protein-
coated scaffolds are presented. Chapter 8 includes the generation of a valid 3-D culture system 
using human primary leukaemia cells and the expansion of acute myeloid leukaemia blood 
mononuclear cells (MNCs) without the addition of exogenous cytokines. Finally, the main 
conclusions of the thesis are drawn in Chapter 9 and future work is identified. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
24 
 
CHAPTER 2 Background 
 
2.1 Biomaterials for Tissue Engineering Applications 
 
 A biomaterial is a “material intended to interface with biological systems to evaluate, treat, 
augment or replace any tissue, organ or function of the body” [8]. Over the past fifty years, 
biocompatible materials have been used widespread in biomedical and tissue engineering 
applications and can now be considered “third-generation biomaterials” as it helps the body heal 
itself [9]. Initially, biomaterials were chosen because of their biological inertness, the goal was 
to minimize the body’s immune response to the foreign material (i.e., metallic implants were 
used for skeletal injuries) [10]. Though this goal is still valid today, scientists have come to 
understand that complete biological inertness is a synonym to non-recognition by the body. This 
lack of biological recognition is often accompanied by fibrous tissue encapsulation and chronic 
inflammation which in turn compromise the mechanical performance and long-term 
biocompatibility of the prosthesis. Thus, second-generation biomaterials were developed 
seeking to tailor or enhance biological recognition in an attempt to improve the biomaterial-
body interface.  
 Second generation biomaterials used bioactive components that were specifically designed 
for use within the human body and promoted specific beneficial responses by the surrounding 
tissues. Two very typical examples of these components are synthetic hydroxyapatite and 
Bioglass®. They were used as porous scaffolds (synthetic hydroxyapatite), coatings or powders, 
and by the mid-1990s these new bioactive materials had attained clinical use for various dental 
and orthopaedic applications. The biomaterial-body interface problem was also addressed by 
exploiting resorbable materials and thus could eliminate such problem. For that reason, another 
class of second-generation biomaterials was introduced which is resorbable polymers. 
Resorbable polymers are the main example of these resorbable materials, namely polylactic, 
polyglycolic acid and polyhydroxyalkanoates which decompose hydrolytically into biological 
accepted molecules, H2O and CO2. They are used as sutures, screws in orthopaedics and in 
controlled-release drug-delivery systems. In these devices, cytostatic agents, cytotoxic agents, 
antithrombotic agents and/or anti-inflammatory agents are incorporated within resorbable 
polymeric matrices [10]. Therefore, the creation of third-generation biomaterials is to promote 
or inhibit specific cell activities through the combination properties of bioactive and 
bioresorbable [11]. Currently, biomaterial research efforts involve the development of materials 
that promote an ‘appropriate host response for a given application’ [12]. For example, artificial 
tissues being fabricated by placing cells within scaffold materials which help guide cell 
proliferation and differentiation. Typically, biomaterials can be divided into: polymers, metals 
and ceramics. Polymers classify as the largest class of biomaterials. The polymers used in 
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biomedical and tissue engineering scaffold fabrication can be divided into broad categories of 
synthetic, biodegradable synthetic and naturally derived polymers (biopolymers) [13], with a 
middle ground of semi-synthetic materials rapidly emerging [14]. Most of the biocompatible 
materials commonly in use in tissue engineering are adapted from other surgical 
implantation/uses, such as sutures, haemostatic agents and wound dressings [15]. Meanwhile, 
naturally derived polymers (biopolymers) can be of both plant and animal origin. Some 
examples of natural polymers derived from plants are lignocellulosic (biofibres), sodium 
alginate or natural rubber. Examples of those derived from animals are collagen, chitosan or 
gelatin. Natural polymers offer the advantage of biological recognition, which reduces problems 
such as antigenicity, cytotoxicity and indiscriminate protein adsorption. The disadvantages of 
using the natural polymers are they often require chemical or physical pre-treatment to enhance 
their material properties (e.g., resistance to enzymatic degradation) so that degradation rate 
could be reduced by providing sufficient time to the cell to regenerate a complete tissue 
architecture guided by the scaffold. These treatments however may have the toxic effects and 
affect cell growth (i.e., cross-linking with glutaraldehyde). Moreover, natural polymers may also 
include pathogenic impurities, variations in batch [16] and in general offer low reproducibility.  
 Biodegradable synthetic polymers, on the other hand, offer high reproducibility and the 
possibility of large-scale production, as well as controlled mechanical and biodegradability 
properties through the usage of inorganic salts [13]. They lack, however, biological activity 
(cell-biomaterials recognition) and may be very hydrophobic. Despite of that, this type of 
polymer offers an advantage over naturally derived polymers in that they can be tailored to give 
a wide range of properties and which are more predictable [17]. In particular, many 
investigations have concentrated on synthetic biodegradable polymers that are already approved 
by the food and drug administration (FDA). The most common biodegradable synthetic 
polymers being used or studied include polyhydroxyalkanoates (PHAs), polylactic acid (PLA), 
polyglycolic acid (PGA), polyanhydrides, polyfumarates (PF), polyorthoesters, 
polycaprolactones (PCL) and polycarbonates (PC) [18]. One of the materials mentioned above 
used in this thesis are PHAs, in particular PHB and PHBV. This polymeric biomaterial has then 
been shaped and processed into three-dimensional (3-D) porous scaffolds to mimic the natural 
extracellular environment of bone marrow, enabling the study of abnormal haematopoiesis and 
providing a potential platform for drug discovery and therapeutic applications in vitro. This 
polymeric material will be described in detail in the following sections. 
 
2.2 Polymer of Microbial Origin Polyhydroxyalkanoates (PHAs) 
 
 Polyhydroxyalkanoates (PHAs) are a class of natural polyesters that are produced by 
numerous organisms as an internal carbon and energy storage, as part of their survival 
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mechanism [19]. Poly(β-hydroxybutyrate) (PHB), synthesized from Bacillus megaterium, was 
first mentioned in the scientific literature in 1925 by the French scientist Lemoigne [20]. He 
reported this bacterium can literally accumulate an intracellular homopolymer that consisted of 
3-hydroxybutyric acids which were linked through ester bonds between the 3-hydroxyl group 
and the carboxylic group of the next monomer. Bacterially synthesized polyhydroxyalkanoates 
(PHAs) have attracted much attention because they can be produced from a variety of renewable 
resources, truly biodegradable and highly biocompatible thermoplastic materials [20]. Although 
a great variety of materials of this family can be produced, the use of PHAs in tissue 
engineering has been mainly restricted to PHB and poly(hydroxybutyrate-co-valerate) (PHBV) 
[2, 21]. To date, only several PHA (Figure 2.1) including poly(3-hydroxybutyrate) (PHB), 
copolymers of 3-hydroxybutyrate and 3-hydroxyvalerate (PHBV), poly(4-hydroxybutyrate) 
(P4HB), copolymers of 3-hydroxybutyrate and 3-hydroxyhexanoate (PHBHHx) and poly(3-
hydroxyoctanoate) (PHO) are available in sufficient quantity for application research [22].  
 Often the production of PHAs in general is found in combination to a shortage in a non-
carboneous nutrient, e.g., nitrogen. Since the discovery of PHB more than 90 genera of archae 
(extremophiles: halophiles (salt lovers), thermophiles (heat lovers), and acidophiles (acid 
lovers)) and eubacteria (gram+ and gram−) have been detected in aerobic and anaerobic habitats, 
they are able to produce PHAs in wide range of molecular weight [23]. Moreover, types of 
bacterium and growth conditions determine the chemical composition of PHAs and the 
molecular weight which typically ranges from 2 × 105 to 3 × 106 Da [24, 25]. Today, PHAs are 
separated into three classes: short chain length PHA (scl-PHA, C3 to C5), medium chain length 
PHA (mcl-PHA, C6 to C14), and long chain length PHA (lcl-PHA, > C14) [26].  
 
 
Figure 2.1: General molecular structures of polyhydroxyalkanoates. m = 1, 2, 3, yet m = 1 is 
most common, n can range from 100 to several thousands. R is variable (side chain). When m = 
1, R = CH3, the monomer structure is 3-hydroxybutyrate, while m = 1 and R = C3H7, it is a                           
3-hydroxyhexanoate monomer [21]. 
 
 Research over the past 20 years focused on the substrate specificity of PHA polymerases. It 
was found that the supply of cells with a particular fatty acid is frequently reflected in the 
monomeric composition of the PHA. To date, more than 100 different monomers have been 
reported as PHA constituents [27, 28] but only few of these PHAs were produced in large 
quantities [29]. As a consequence little is known about the chemical and mechanical properties 
of the polymers. To date, PHA monomers with straight, branched, saturated, unsaturated, and 
also aromatic monomers were found. Of special interest are functionalized groups in the side 
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chain that allow further chemical modification, e.g., halogens, carboxyl, hydroxyl, epoxy, 
phenoxy, cyanophenoxy, nitrophenoxy, thiophenoxy and methylester groups [28, 30]. The 
length of the side chain (R) and its functional group considerably influence the properties of the 
bioplastic, e.g., melting point, glass transition temperature and crystallinity 
(stiffness/flexibility). Also the average molecular weight and the molecular weight distribution  
are dependent on the carbon source [28]. 
 
2.2.1 In Vitro Degradation of Polyhydroxyalkanoates (PHAs) 
 
 Degradation properties of a scaffold are of crucial importance in the long-term success of a 
tissue-engineered cell/polymer construct. The rate of degradation may affect many cellular 
processes including cell growth, tissue regeneration, and host response [31]. For that reason, in 
vitro degradation of the polymers is carried out to understand how these polymers degrade and 
how their physical and chemical properties change with hydrolytic degradation. In general, the 
in vitro degradation of PHAs usually happens in multistage process [32]. In the first stage, 
spanning a few weeks, the amorphous phase of the polymer begins to degrade. This was 
because the crystalline regions of the polymer were impermeable to water. Therefore, a 
hydrolysis process is only restricted to the amorphous regions of the polymer and to the fringes 
of the crystalline region [33]. Next, the crystalline part of the polymer begins to degrade; this 
resulted in the formation of monomers, dimers, and tetramers. Simultaneously, the molecular 
mass also decreased. As time progresses, the degradation process developed, and the polymer 
lost its mass. This hydrolytic degradation of PHAs has been known to be a slow process when 
compared to the enzymatic hydrolysis of PHAs [32, 34]. This is because of the relatively high 
crystallinity of PHAs, which leads to an increased impermeability of water into the crystalline 
regions [35] and is also due to the hydrophobic nature of long alkyl pendant chains [36].  
 Moreover, besides crystallinity and hydrophobic nature, the there are other factors that affect 
the biodegradability of PHAs such as stereoregularity, molecular mass, monomeric composition 
and sample thickness [32]. Studies have been carried out by Mochizuki and Hirami [37] and 
Tokiwa and Calabia [38] to show that the biodegradation of PHAs was influenced by the 
chemical structure (i.e., the presence of functional groups in the polymer chain, 
hydrophilicity/hydrophobicity balance) and the presence of ordered structures, such as 
crystallinity, orientation, and morphological properties. Generally, the degradation of the 
polymer decreases with the increase of highly ordered structure, that is, increased crystallinity. 
 In addition, form of the fabricated polymer also has an effect to the degradability. Study 
carried out by Grizzi et al. [39] have shown that with different thickness of plates (2 mm thick), 
films (0.3 mm thick), microspheres (0.125 to 0.25 mm diameter) and beads (0.5 to 1.0 mm 
diameter), the plates degraded the fastest. Thick samples of these polyester polymers can lead to 
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a heterogeneous degradation which is a combination of surface erosion and bulk degradation. 
Heterogeneous degradation may be ascribed to two phenomena [13]: (1) Random hydrolytic 
ester cleavage (de-esterification process) either on the outer surface or inside the thick scaffolds; 
(2) Weight loss through the diffusion of oligometric species from the bulk material into solvent 
media. The oligometric compounds from the outer surface are easy to diffuse into the solvent as 
compared from the inside of the thick material surface. However, in central, autocatalytic effect 
will make the degradation even faster than the outer surface which could leads to a premature 
structural failure due to the accumulation of carboxylic acid functional groups. 
 
2.3 Sustainable Production of Polyhydroxyalknoates (PHAs) 
 
2.3.1 Introduction 
 
 Malaysia is one of the world leaders in the production and export of crude palm oil. In 
Malaysia, the oil palm industry has contributed vastly towards the country’s economic well 
being. During the economic crisis in the late 1990s, the industry helped to cushion the impact of 
the economic downturn through its export-oriented activities which provided the much needed 
foreign exchange for the country. Crude palm oil (CPO) production has increased from only   
1.3 million tonnes in 1975, to 4.1 million tonnes in 1985 and 7.8 million tonnes in 1995 to 17.56 
million tonnes in 2009 [40] 
 The Malaysian palm oil industry has created various products as a consequence of the 
cultivation of oil palm and the production of the main product (palm oil) and secondary 
products (palm kernel oil and cake). The oil palm products are employed in numerous food and 
non-food applications [41]. In 2009, there were 418 crude palm oil mills, 59 refineries,             
57 downstream industries and 18 oleochemical plants. The Malaysian Palm Oil Board’s long-
term programme is to establish a biodiesel plant that will produce methyl ester (biodiesel) which 
can be used to replace petroleum diesel. There were 28 biodiesel plants with a production of    
2.7 million tonnes per year methyl ester, respectively [40]. Another potential revenue generator 
is to convert the large quantity of biomass (13.2 million tonnes dry weight) into added value 
products [42]. However, this important economic activity generates an enormous amount of 
liquid effluent from the milling processes [43]. Palm oil mills with the wet milling (grinding) 
process accounted for the major production of waste [44]. Hence, the increase in number of 
mills will generate more environmental problems. In general, the palm oil milling process can 
be categorized into a dry and a wet (standard) process. The wet process of palm oil milling is 
the most common and typical way of extracting palm oil, especially in Malaysia. According to 
the industrial standard, the milling process produces wastewater in the range 0.44 to 1.18 
m3/tonne fresh fruit bunches (FFB) with the average figure of 0.87 m3/tonne FFB. It is estimated 
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that for each tonne of CPO that is produced, 5 to 7.5 tonnes of water are required, and more than 
50% of this water ends up as palm oil mill effluent (POME) [45]. It has been reported that for 
every tonne of the CPO produced, about 3.5 m3 of POME is generated, which indicates that 
with some 500 palm oil mills, more than 17.5 million tonnes of CPO is produced annually. It is 
estimated that about 61.25 million m3 of POME is generated from the palm oil industry 
annually. POME is an oily wastewater generated by palm oil processing mills and consists of 
various suspended components. On average, for each tonne of FFB processed, a standard palm 
oil mill generated about 1 tonne of liquid waste with biochemical oxygen demand (BOD) 27 kg, 
chemical oxygen demand (COD) 62 kg, suspended solids (SS) 35 kg and oil and grease (O&G) 
6 kg [46]. The composition and characteristic of the raw POME obtained from a local palm oil 
mill factory is summarized in Table 2.1. 
 
Table 2.1: Composition and chemical properties of raw POME. 
 
Composition [47] % content 
Water  94.2 to 95.3 
O&G (oil and grease) 0.7 to 0.8 
Total suspended solids 4 to 5 
 
Parameters [46] Units Results 
pH - 4.8 ± 0.21 
Total suspended solids mg/L 35,000 ± 200 
Turbidity (cloudiness/haziness)Ψ NTU 21,000 ± 300 
COD mg/L 65,000 ± 800 
BOD mg/L 27,000 ± 800 
O&G (oil and grease) mg/L 8,000 ± 300 
TOC (total organic carbon) mg/L 12,300 ± 570 
Phosphorus mg/L 142 ± 19 
Ammonia mg/L 62 ± 10 
                     *Note: values represent means of triplicate determination. 
          
ΨA nephelometer, measures how much light is scattered/reflected by suspended 
                       particles in the water. The greater the scattering, the higher the turbidity. 
 
2.3.2 The Science of Biopolymers 
 
 The usage of conventional plastics has resulted in environmental degradation [48]. The 
production of biodegradable polymers is seen to be a viable alternative with the increasing 
environmental pressure to replace conventional plastics. The problem that is faced by industry is 
the high production costs of biopolymers. Biodegradable polymers derived from 
polyhydroxyalkanoates (PHAs) are considered to be good candidates for biodegradable plastics 
due to their large range application and capability of being produced from renewable resources 
[49, 50]. These materials have attracted interest because of their potential use as biodegradable 
alternatives to petroleum-based synthetic plastics such as polypropylene (PP) and polyethylene 
(PE). Polyhydroxyalkanoates (PHAs) are mainly produced by microbial fermentation processes, 
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and a major challenge is to reduce their production costs [49]. A feasibility study using 
fermentative volatile fatty acids (VFAs) as carbon source to synthesise PHA by activated sludge 
(treating sewage and industrial waste waters using air and microorganisms to reduce 
the organic content of the sewage) was carried out to simultaneously reduce the production cost 
of PHAs and disposal amount of organic wastes [51]. Several efforts have been investigated to 
produce PHAs by microbial fermentation on organic waste (palm oil mill effluent (POME), 
olive oil and kitchen waste). The production of biodegradable polymers from oil palm industry 
can be seen as beneficial to the environment as well as contributing to sustainable development 
[52, 53]. Until recently, the remaining 90% discharged (empty fruit bunches, fibres, fronds, 
trunks, kernels, POME) was considered as waste and either burned in the open air or left to 
settle in waste ponds [51, 54]. By utilizing the POME and empty palm oil fibre bunch (EPFB) 
as carbon source and support matrix, the disposal of POME that needed further treatment could 
be reduced. Although POME consists of high organic acids and is suitable to be used as a 
carbon source, POME is usually present in a complex form that cannot directly be utilised by 
PHA producing bacterial species for PHA synthesis. Typically, raw POME is difficult to 
degrade because it contains significant amounts of oil (tryacylglycerols) and degradative 
products such as diacylglycerols and monoacylglycerols and fatty acids [52, 55]. The fatty acids 
composition (C12 to C20) of each of this fraction are different from one another and contribute to 
a high value of pollution load in POME. Therefore, anaerobic treatment has been proposed to 
reduce the POME characteristics. It is one of the naturally occurring processes involving 
decomposition and decay, in which complex organic matters are broken down into their 
chemical constituents. Hydrolysis and acidogenesis are the first step to convert the wastes to 
short-chain VFAs (i.e., acetic, butyric and propionic acids) as shown in Table 2.2. After that, the 
VFAs will be utilised by PHA-producers for PHA production [51, 56]. 
 
Table 2.2: VFAs composition (%) of fermented POME in anaerobic reactor [46]. 
 
Systematic name Generic/trivial name  Compound % constituent  
Ethanoic Acid Acetic acid CH3COOH 57 
Butanoic Acid Butyric acid C3H7COOH 33 
Propanoic Acid Propionic acid C2H5COOH 6 
Pentanoic Acid Valeric acid C4H9COOH 4 
 
2.3.3 Biopolymer Production using POME 
 
 The price of PHAs is mainly dependent on substrate costs, accounting for about 40% of the 
total production cost [57]. In the last decade, a variety of low cost carbon substrates (e.g., starch, 
tapioca hydrolysate, whey and molasses) have been tested for PHA production to reduce the 
production cost. POME can be considered as an alternative to the above mentioned carbon 
substrates with no cost of using it for PHA production. The production of VFA and PHA using 
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POME as substrates are listed in Table 2.3. According to Ali et al. [58], with a content of 50% 
PHA in the dried cells and 2% dissolved in the chloroform, the calculated minimum cost for 
obtaining PHA from POME is below USD2/kg. By increasing the PHA content in the cell from 
50% to 80%, the unit cost of PHA could be slightly reduced; whereas an increase in the amount 
of PHA dissolved in chloroform from 2% to 5% would result in a remarkable reduction of the 
PHA cost to less than USD1/kg. The above mentioned price was in line with the latest market 
price which is quoted at about €1.50/kg (∼USD2/kg) produced by one of the largest volume 
manufacturers (Mirel™) [49]. This price was much higher than that of starch polymers and 
other bio-based polyesters due to high raw material costs (30% to 40% of total cost), small 
production volumes and high processing costs (particularly for purification) [49]. 
 Nevertheless, POME is usually presented in complicated forms that cannot be directly reused 
by PHA-producing species such as Ralstonia eutropha, a representative bacterium for PHA 
synthesis [52]. It was proposed that an anaerobic treatment of POME could be coupled with 
PHA production using heterotrophic bacteria (bacteria that use organic (carbon-containing) 
compounds as a source of energy and carbon)  to reduce PHA production costs [46]. According 
to Ali et al. [59], it was critical to maintain the pH at 7 in the anaerobic treatment of POME 
sludge in the first stage of the process, in order for only acetic and propionic acid to be produced 
and not formic acid and biogas. With increasing concentrations of formic acid (for a pH 
maintained below 4), the PHA yield and content in Rhodobacter sphaeroides IFO 12203 
dropped from 0.50 g/g and 67% to 0.21 g/g and 18%, respectively. Hassan et al. [60] later found 
that the presence of sludge in the anaerobically treated POME inhibited PHA accumulation by 
R. sphaeroides IFO 12203. Based on the studies, it seems that the PHAs are being produced in a 
POME without sludge as opposed to a treated POME with sludge. Moreover, a low 
concentration of ammonium would accelerate the PHA production in a synthetic waste with an 
organic acid profile which was observed during POME treatment. However, Hassan et al. [60] 
found that addition of ammonium and phosphate to anaerobically treated POME was required to 
maintain the cell activity and production of PHA since neither ammonium nor phosphate was 
present in the anaerobically treated POME. In total, the organic acid concentrations obtained 
from anaerobically treated POME were too low [51, 59] for it to be reused as raw material in the 
production of PHA on an industrial scale. The underlying reason was that this would require a 
production reactor with a much larger size than that of a reactor for normal bioplastic 
production (lab scale anaerobic reactor (organic acid production: 19 L; lab scale aerobic reactor 
(PHA production): 6 L) [46]. The organic acids in the anaerobically digested POME could be 
concentrated by evaporation for use as substrates in the fed-batch non-sterile PHA fermentation 
system using R. eutropha ATCC 17699. Although the proposed overall zero emission system 
appeared to be practical, major drawbacks were found, including the rather low yield and 
productivity of PHA by R. eutropha when the concentrated organic acids from POME were 
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used as compared to synthetic organic acids. This could be due to the high presence of 
ammonium (1.5 g/L) or other compounds in the anaerobically digested POME concentrate [61]. 
 Md. Din et al. [5] proposed the suitability of using mixed cultures (mixed with different 
bacteria strains) to produce PHA in POME since most prokaryotes are capable of PHA 
production. The study noted that by using mixed cultures and POME, different types of PHA-
constituents could be obtained. The harvesting of these PHA-constituents was more reliable for 
use as biodegradable plastics material as opposed to a single PHA-constituent.  
 
Table 2.3: Various products in bioprocesses using POME as substrates. 
 
Product Microorganism, fermentation substrate 
and fermentation conditions 
Maximum  
production 
References 
VFA Mixed cultures, POME + palm oil sludge. 
30 oC, pH was controlled at 7, SBR 
(sequenced batch reactor), 24 h 
7.8 g/L  
 
Ali et 
al. [59] 
VFA Mixed cultures, POME + palm oil sludge 
with a ratio of 1:1, 300 rpm, 30 oC, pH 
was controlled at 7, stirred tank bioreactor 
fermentation, 84 h 
10 - 14 g/L Yee et al. 
[62] 
VFA Mixed cultures, POME + palm oil sludge, 
pH was controlled at 7, SBR, 96 h 
10.27 g/L Cheong et 
al. [63] 
Single 
constituent  
PHA 
Rhodobacter sphaeroides IFO 12203, 
Synthetic waste based on organic acid 
profiles obtained during POME treatment. 
30 oC, pH was controlled at 7, 
photobioreactor fermentation, ≈ 200 h 
≈ 4.0 g/L Ali et 
al. [59] 
Single 
constituent  
PHA 
Rhodobacter sphaeroides IFO 12203, 
anaerobically digested POME, 30 oC, pH 
was controlled at 7, photobioreactor 
fermentation 
> 2.0 g/L Ali et 
al. [58] 
Single 
constituent 
PHA 
Alcaligenes eutrophus H16(ATCC 
17699), standard medium with feeding of 
acetic acid obtained from anaerobically 
digested POME (single VFA), 400 rpm 
with aeration rate of 0.75 L/min, 30 oC, 
pH was controlled at 7, stirred tank 
bioreactor fermentation, 17 h 
1.8 g/L Hassan et 
al. [60] 
Single 
constituent 
PHA 
Ralstonia eutropha ATCC 17699, 
concentrated organic acid from 
anaerobically digested POME (100 g/L of 
total acids with acetic:propionic = 3:1), 
400 rpm with aeration rate of 0.75 L/min,  
30 oC, pH was controlled at 7, bioreactor 
fermentation, ≈ 65 h 
≈ 6.25 g/L Hassan et 
al. [61] 
Multiple 
constituents 
PHA 
Mixed cultures (mixed with different 
strains), high concentration of POME 
with 490 COD/N ratio (g COD/g N) and 
160 COD/P ratio (g COD/g P), 1000 rpm 
with aeration rate of 1.5 L/min, 30 oC. pH 
was controlled at 7, SBR 
24.24 g/L Md. Din et 
al. [5] 
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 A type of mixed culture was maintained in a SBR and a high concentration of POME 
proposed for this system in order to generate autotrophic (an organism that produces 
complex organic compounds (such as carbohydrates, fats and proteins) from simple substances 
present in its surroundings (light, inorganic (CO2) and organic matters)) rather than 
heterotrophic bacteria (depending only on organic matters as an energy source) in the 
production of PHA. However, the average PHA production by using POME could only reach 
44% of the CDW, indicating that an optimisation of the PHA sludge content must be carried out 
by varying the oxygen rate, feeding regime or transient conditions (passing with time before 
changing to other condition). 
 As we have discussed in detail on how POME could come out with a promising biopolymer 
(PHAs) for many applications, the justification on why this material was used is to promote the 
usage of POME in producing PHAs via microbial fermentation process as added value materials 
for the study of leukaemia in a 3-D cell culture system. This will be discussed in detail in the 
next chapter onwards. The added value here is a rough estimation based on the above mentioned 
information and current market price. The rough estimation of PHAs revenue per annum that 
could be procured is shown in Table 2.4.  
 
Table 2.4: Rough estimation of PHAs revenue per annum on utilizing POME. 
 
Raw POME generated annually [45] 61.25 × 106 m3 = 612,50,000,000 L 
Concentrated POME (90% H2O removal) 0.1 × 612,50,000,000 L = 6,125,000,000 L 
Maximum PHA production (24.24 g/L) [5] 24.24 g/L × 6.13 × 109 L = 1,500 million 
kg/year  
Current market price (Mirel™) USD1.20/kg 
Value added of PHAs production (revenue) USD1.20/kg × 1,500 million kg/year = 
∴USD1,800 million/year 
 
2.4 Polymers for Tissue Engineering Applications: Polyhydroxyalkanoates (PHAs) 
   
 With all the advantages and disadvantages comprising from both naturally derived and 
synthetic biodegradable polymers as described in the earlier section, one of the synthetic 
biodegradable polymers that could compromise with all of the major requirements on 
fabricating three-dimensional (3-D) porous scaffold (i.e., porosity, mechanical strength, surface 
properties, biocompatible, etc.) is the naturally synthesized polyhydroxyalkanoates (PHAs). In 
this study, PHAs are used for tissue engineering of 3-D cell culture system due to its acceptable 
biodegradability [64], biocompatibility [25] and resemble as polypropylene (PP) in which 
offering a wide range of mechanical properties [2]. PHAs have already been studied to some 
extent for tissue engineering applications mainly for scaffold materials in combination with 
ceramic materials [65] as a vehicle for drug delivery [66] and also as a material for cardiac 
34 
 
tissue engineering [21]. The potential use of PHAs in tissue engineering is illustrated in Figure 
2.2. 
 
 
 
Figure 2.2: Role of PHAs in Tissue Engineering [2]. 
 
 To be useful as tissue engineering scaffolds, PHAs must possess the five key properties. 
They must be (1) biocompatible, (2) support cell growth, (3) guide and organize the cells, (4) 
allow tissue ingrowth and (5) ultimately, be able to degrade to non-toxic products [2]. If these 
key properties are met by the PHAs, then the additional benefits of using PHAs in tissue 
engineering are huge. For example, unlike many other degradable polymers, the properties of 
PHAs can be tailored with a wide range of building blocks, various treatments can be used to 
attach bioactive factors, alter surface and mechanical properties and a number of methods can 
be used to provide a range of degradation rates [2]. For instance, the brittleness of PHB was 
improved through copolymerization process of β-hydroxybutyrate with β-hydroxyvalerate [20] 
which was first commercialized in 1990. The copolymerization produces less crystalline, more 
flexible and more readily processable materials than pure PHB. Depending on the requirements 
of different applications, PHA can be either blended, surface modified or combined with other 
polymers, enzymes or even inorganic materials such as hydroxylapatite to further adjust their 
mechanical properties or biocompatibility [21]. In addition, tissue engineers have determined 
that the surface structure is also an important factor. Porous surfaces can be produced by the 
leaching technique, which is done by blending of PHA with a salt that can be washed out with 
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water. The surface of PHA materials can be rendered more hydrophilic as was shown by the 
treatment of P(HB-co-HV) with allyl alcohol gas plasma that led to an increase of wettability 
[67].  
 Apart from tailoring its physico-chemical properties, the biocompatibility of two PHA 
polymers, namely, PHB and PHBV have been studied by a number of different research groups. 
For instance, the polymers have been reported not to induce any prolonged acute inflammatory 
responses when implanted in vivo (subcutaneously into the neck folds of mice) for up to            
5 weeks in the form of tablet [68]. Separately, it has also been reported that when a highly 
porous well-interconnected PHBV structure was seeded with fibroblasts, it sustained a cell 
proliferation rate similar to that observed in collagen sponges for 35 days, with a maximum cell 
density being observed on day 28 [69]. An interesting aspect of PHA scaffolds is the fact that 
the tissue-engineered cells can be implanted together with the supporting scaffold [2]. This 
approach was exemplified by Sodian and coworkers [70] who used scl-PHA for the fabrication 
of a tri-leaflet heart valve scaffold. A porous surface was achieved with the salt leaching 
technique resulting in pore sizes between 80 and 200 µm. The scaffold was seeded with vascular 
cells from ovine carotid artery and subsequently tested in a pulsatile flow bioreactor. The cells 
formed a confluent layer on the leaflets. The authors pointed out that the whole scaffold was 
molded completely and that a simple melting process was used to fix the leaflets to a model 
conduit.  
 
2.5 Scaffolds Requirement for Tissue Engineering Applications 
 
 In tissue engineering, as in many other engineering fields, the design of the artificial 
structural may be as crucial as the material it is made of. As was mentioned earlier, the 
scaffolds, cells and signals are the main building blocks of tissue engineering. Moreover, 
scaffolds must provide the cells with the appropriate physical support (i.e., porosity, pores 
interconnectivity and pores size distribution), chemical signals (i.e., biosignaling components 
from ECM proteins) and mechanical strength to allow them to generate specific cells and 
tissues. Scaffold design and development is mainly an engineering challenge and is in fact one 
of the main goals of this study. In scaffold-based TE strategies, a key component of the scaffold 
that serves as a template for cells interactions and for the formation of the extracellular matrix 
(ECM) is providing structural support to the newly formed tissue. A temporary 3-D scaffold 
mimicking the physiological functions of the ECM is critical to preserve cells ability to 
differentiate into their native phenotypes and to constitute a structural template to fill the tissue 
lesion. Tissue engineering scaffolds are meant to be colonized by cells and should transmit the 
chemical and physical signal necessary to ensure adequate cells and tissues growth. An ideal 
tissue engineering scaffold should fulfill a series of requirements which are as follows [2, 71]:  
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1. The scaffold should be non-immunogenic, non-toxic, biocompatible and easily 
manufactured.  
2. The scaffold material has the ability to biodegrade. Its degradation products should not be 
toxic and should be easily eliminated from the implantation site by the body (i.e., secretion 
via urine or respiratory system; H2O and CO2). 
3. Macrostructure: Macro and micro-structural properties affect not only cells survival, 
signaling, growth, propagation and reorganization but play also a major role in modelling 
cell shape and gene expressions, both related to cell growth and preservation of native 
phenotypes [72, 73].  
4. Porosity and pore interconnectivity: Scaffolds should possess interconnected open pore 
geometry and spread porosity (usually exceeding 90%) with a highly porous surface and 
microstructure. This would allow in vitro cell adhesion, ingrowth and reorganization and 
would provide the necessary space for neovascularization in vivo [74]. Pore interconnectivity 
directly influences the diffusion of physiological nutrients and gases to cells as well as the 
removal of metabolic waste and by-products from cells [72].  The diverse nature of tissue 
architecture requires different microenvironments for regeneration, including the 
employment of scaffolds with optimal pore sizes. In addition, since the mechanical strength 
decreases by increasing the porosity, the void volume in scaffolds for load-bearing tissues 
must be tuned to allow both the accommodation of the large number of cells and the 
maintenance of the structural strength required [75].  
5. Pore size and surface area: Moreover, a good distribution of the large number of cells 
requires high internal surface area to volume ratios [72]. Since pore size and internal surface 
area are related linearly, a compromise between both properties has to be determined 
depending on the scaffold's application. When the pore diameter is too small, cells may 
provoke pore occlusion (blockage of pore) and prevent cellular penetration within the 
scaffold. 
6. Surface properties: Scaffold surface properties such as morphology, hydrophilicity, surface 
energy and charge are factors controlling in vitro cell adhesion, migration, phenotype 
maintenance and intracellular signaling as well as in vivo cell recruitment and healing at the 
tissue-scaffold interface [76-78]. Cell response to the biomaterial is not mediated by a direct 
contact but rather through an interfacial layer formed on material surface once it is in contact 
with a physiological environment. Such a layer is created as result of non-specific adsorption 
of ECM proteins. Polymer-surface engineering is a useful tool to improve scaffold 
multifunctionality and to design biomimetic materials able to interact with the surrounding 
environment by biomolecular recognition [79]. Moreover, surface modification is critical to 
elicit specific cellular responses and direct new tissue formation. Bioactive ligands, such as 
peptides and polysaccharides, may either be physically adsorbed (non-covalent interactions) 
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or covalently grafted onto the surface (chemically immobilized) or included in the bulk 
(during the fabrication process) to promote specific cell adhesion. Usually, the bio-molecular 
recognition of the material by the cells is achieved by incorporating cell-binding peptides in 
the form of native long chain of ECM proteins such as fibronectin, laminin and vitronectin 
[80] or more frequently, in the form of short peptide sequences derived from ECM proteins, 
such as arginine-glycine-aspartic acid (RGD) peptides [81]. The employment of the long 
chain proteins during adsorption onto the biomaterial surface is the most advantageous 
thanks to its stability, straightforward synthesis and absence of random folding [81].  
7. Mechanical properties: The scaffold should have sufficient mechanical strength during in 
vitro culturing to maintain the spaces required for cell ingrowth and matrix formation. 
Moreover, it must provide sufficient temporary mechanical support, matching the 
mechanical properties of the host tissue as closely as possible, to bear in vivo stresses and 
loading. Therefore, the materials must be selected and/or designed with degradation and 
resorption rate and mechanical properties, such that sufficient structural integrity of the 
scaffold is retained until the newly grown tissue is able to support loads and stresses and can 
assure its structural role [82].  
 
2.6 Techniques for Polymeric Scaffolds Preparation 
 
 Many fabrication methods as shown in Figure 2.3 have been developed in order to attain 
these requirements; these methods are briefly described as below. 
 
2.6.1 Solvent-Casting and Particulate-Leaching (SCPL) 
 
 The solvent casting and particulate leaching method was developed by Mikos et al. [83] 
amongst others for polylactic acid (PLA) and polyglycolic acid (PGA) polymers, and several 
authors have used the method to manufacture composite scaffolds [84, 85]. It consists of 
dissolving a polymer in a solvent and then adding particles of a leachable porogen (i.e., salt 
particles, glucose, paraffin spheres, etc.). The mixture forms a thick paste which is left to dry in 
air or under vacuum until the solvent has evaporated completely. The porogen is then leached 
out and leaves behind a network of interconnected pores. In the case of composites, the second 
phase is added with the porogen and remains within the structure after the porogen is leached 
out. Additionally, a thermal treatment can be used to modulate the crystallinity of the polymer 
by melting the polymer and controlling the cooling rate. The advantages of the solvent casting 
method are that it is a simple and fairly reproducible method which does not require 
sophisticated apparatus. The disadvantages include thickness limitations intrinsic to the particle 
leaching process, limited mechanical properties and some authors question the homogeneity and 
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interconnection of the pores in the scaffolds, as well as the presence of residual porogen and 
solvent [86]. 
 
 
 
Figure 2.3: Schematic of commonly used techniques for scaffold production: (a) Solvent 
casting-particle leaching process. (b) Freeze drying process (TIPS - below freezing point < 0o). 
(c) Supercritical fluid technology. (d) Phase separation technology (TIPS - above freezing point 
> 0o). (e) Wet spinning process for the production of 3-D polymer scaffold. (f) Electrospinning 
process. (g) Melt molding technique. A mould filled with polymer powder and porogen 
component is heated above the polymer glass-transition temperature (Tg) and a pressure (F) is 
applied to the mixture. Then the porogen is leached out leaving a porous structure. (h) Layout of 
Solid Free Form (SFF) process. A 3-D computer model, directly designed in CAD software 
(simplified CAD model) or obtained from a medical imaging technique (bio-mimetic model) is 
expressed as a series of cross-sectional layers. From the data, the SFF machine fabricates the 
physical model (Adapted from [74]). 
 
2.6.2 Thermally Induced Phase Separation (TIPS) 
 
  Thermally induced phase separation was first applied to PLA scaffolds by Schugens et al. 
[87] and several authors have applied this technique to composite scaffolds [88, 89]. It consists 
of inducing a solid-liquid or liquid-liquid of polymer-solvent phase separation. This is done by 
dissolving the polymer in a solvent and quenching the solution at a certain temperature. The 
quenching induces a phase separation into a polymer-rich phase and a polymer-poor phase. As 
the solvent crystallizes, the polymer follows accordingly to the crystallized solvent 
microstructural template. The solvent must then be removed from the phase separated solutions 
either by freeze-drying (sublimation process) or by solvent extraction [90]. The solvent leaves 
behind a microstructural foam of polymer as the solvent is sublimed during the freeze drying 
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process. The main advantage of the phase separation method is that pore morphology and 
orientation can be tailored by altering the thermodynamic (quenching temperature) and kinetic 
parameters of the processing (time of phase separation). Its disadvantages include the use of 
potentially toxic solvents and a high degree of anisotropy (not isotropic; not in the same 
direction) of the porosity.  
 
2.6.3 Gas-Foaming (Super Critical Fluid Technology) 
 
 The gas foaming process is used to fabricate highly porous foams without the use of organic 
solvents [91]. Organic solvents may leave residues behind which can have toxic effects in vitro 
and may cause inflammation in vivo. This high pressure CO2 gas technique can avoid the use of 
toxic solvents in scaffold fabrication. The process consists of saturating the polymer mix with 
gas at high temperatures and pressures. Then, a thermodynamic instability is created by quickly 
decreasing the temperature and pressure which stimulates the nucleation and growth of pores of 
gas within the polymer. Gas-foaming yields high porosities (up to 93%) and varying the 
temperature, pressure and rates of parameter reductions can modulate the pore sizes. The main 
disadvantage is the resultant scaffolds contain a nonporous surface film with mixed open and 
closed cell structures (poor interconnectivity) which is not suitable for application as tissue 
engineering scaffolds [17]. 
 
2.6.4 Fibre Bonding 
 
 The fibre bonding method was first developed by Cima et al. [92] who produced scaffolds 
made of polyglycolic acid (PGA) polymer. They took advantage of the fact that PGA was 
available as sutures and thus in the shape of long fibres. In fibre bonding, two fibre materials 
can be attached to each other via ‘heat fuse’ or ‘embed’ methods and then one material is 
dissolved in a selective solvent to obtain the fibre scaffold [93]. Mikos et al. [94] improved the 
structural stability of the constructs developing a fibre bonding technique in which the PGA 
fibres are joined at their cross-linking (interconnected) points by ‘sintering’ (bonding via 
heating) above their melting point temperature. The main advantage of the fibre bonding 
technique is the very high surface area-to-volume (m-1) ratio which makes them ideal for tissue 
engineering applications. Although the fibre bonding technique can produce highly porous 
scaffolds with interconnected pores that are suitable for tissue regeneration, this method 
involves the use of solvents that could be toxic to cells if not completely removed [95] which 
could reduce the ability of cells to form new tissue in vivo. 
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2.6.5 Electrospinning 
 
 The electrospinning process uses an electric field to control the formation and deposition of 
polymer fibres on a substrate. Sheets and cylindrical shapes can be fabricated with this 
technique. Electrospinning method is reported capable to fabricate polymer fibres range from a 
few nanometers to hundreds of microns [96]. The ability to co-spin polymers with various 
additives offers the possibility of functional fibres. PGA and PLA fibres are two commonly 
used biopolymers used with this technique [97]. They have been used either alone or combined 
with other biomaterials such as collagen to enhance their biocompatibility. 
 
2.6.6 Solid Free Form (SFF) 
 
 Solid free form fabrication (SFF) is a developing technology that enables the fabrication of 
custom made devices directly from computer data such as computer aided design (CAD), 
computed tomography (CT) and magnetic resonance imaging (MRI) data [98]. The digital 
information is then converted to a machine specific cross-sectional format, expressing the model 
as a series of layers. The file is then implemented on the SFF machine, which builds customer 
designed 3-D objects by layered manufacturing strategy whereby 3-D objects are fabricated 
with layer-by-layer building via the processing of solid sheet, liquid or powder material stocks 
[74]. For example, Chiang et al. [99] have used this technique to improve the in-vitro response 
of osteoblast cells with porous scaffolds of triblock PEG-PCL-PEG copolymer with pre-
determined pore size of 400 µm to 420 µm and porosity of 79%. These techniques allow 
obtaining complex customized scaffolds design, minimal manpower requirement, highly 
accurate and consistent pore morphology, anisotropic structure, diverse range of processing 
conditions. Shortcomings include dependence on the processing technique, high temperature, 
lack of mechanical strength (but much better than salt-leached technique), limited material 
range and pores are usually huge (suitable for bone tissue growth) [72]. 
 
2.7 Surface Engineering: Surface Modifications of Polymeric Porous 3-D Scaffolds 
 
 Several surface modifications techniques have been developed to improve wetting, adhesion, 
and printing of polymer surfaces by introducing a variety of polar groups (by introducing a 
random and non-specific groups surface rendering), with little attention to functional group 
specificity. However, when surface modification is a precursor to attaching a bioactive 
compound (i.e., drug delivery application), these techniques must be tailored to introduce a 
specific functional group.  
 
 
41 
 
2.7.1 Physico-Chemical Modifications (Surface Treatments) 
 
2.7.1.1 Wet Chemical Method 
 
 In wet chemical surface modification, a material is treated with liquid reagents to generate 
reactive functional groups on the surface. This classical approach to surface modification does 
not require specialized equipment and thus can be conducted in most laboratories. It is also 
more capable of penetrating porous three-dimensional substrates than plasma and other energy 
source surface modification techniques [100] and allows for in situ surface functionalization of 
microfluidic devices. For instance, concentrated sodium hydroxide and sulfuric acid have been 
used to generate carboxylic acid groups by base and acid hydrolysis of PMMA [101, 102]. 
Specifically, a 16 h treatment in 10M sodium hydroxide at 40 oC was reported to produce 0.66 
nmol/cm2 carboxylic acids on PMMA [101]. Unfortunately, these wet chemical methods are 
non-specific, producing a range of oxygen-containing functional groups. In addition, those 
which target modification of polymer side chains (as in PMMA ester modification) depend on 
the side chain surface orientation. The degree of surface functionalization may therefore not be 
repeatable between polymers of different molecular weight, crystallinity or tacticity [103]. 
These wet chemical methods also generate hazardous chemical waste and can lead to irregular 
surface etching [104]. Many of these techniques also require some extended treatment in 
concentrated corrosive solutions. For these reasons, while useful in the laboratory environment, 
these wet chemical processes may not be suitable for larger scale (e.g., industrial applications). 
 
2.7.1.2 Ionized Gas Treatments  
 
 There are several types of ionized gas treatments (e.g., corona discharge, UV irradiation and 
flame treatment) but plasma is the most practical one. Plasma is a high energy state of matter, in 
which a gas is partially ionized into charged particles, electrons, and neutral molecules [103]. 
Plasma can provide modification of the top nanometer of a polymer surface without using 
solvents or generating chemical waste and with less degradation and roughening of the material 
than many wet chemical treatments [104, 105]. The type of functionalization imparted can be 
varied by selection of plasma gas (Ar, N2, O2, H2O, CO2, NH3) and operating parameters 
(pressure, power, time, gas flow rate) [106]. Oxygen plasma is often used to impart oxygen 
containing functional groups to polymer surfaces such as PCL [107], PE [108] and PET [109]. 
In addition to oxygen, carbon dioxide plasma has been used to introduce carboxyl groups on PP 
and PE [110], PS [111] and air plasma has been used to oxidize PMMA [112]. Ammonia and 
nitrogen plasmas have been used to impart amine groups to the surface of PTFE [113] and PS 
[111], respectively. Inert gases (e.g., Argon) can be used to introduce radical sites on the 
polymer surface for subsequent graft copolymerization. However, with the exception of a recent 
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development of an atmospheric plasma system condition [114], plasma generation requires a 
vacuum to empty the chamber of latent gases (e.g., atmospheric gases), which presents 
complications for continuous operation in a large scale industrial setting. Also, results are 
difficult to repeat between laboratories as there are many parameters involved to optimize 
conditions, including time, temperature, power, gas composition/flow/pressure, orientation of 
reactor and distance of substrate from plasma source [103]. It should be noted that in addition to 
the monomers and gases intentionally introduced to the plasma chamber, latent (hidden) 
chemicals from prior users may be present thus posing a risk of contamination. The plasma 
chamber should therefore be adequately cleaned, for example by oxygen plasma, before 
introducing polymers for surface modification. 
 
2.7.2 Biological Surface Modifications (Biological Surface Coating) 
 
2.7.2.1 Protein-Surface Interactions 
 
 Protein adsorption on polymer surfaces has significant importance in biomedical applications 
both in vitro and in vivo [103]. The first event that usually occurs when a synthetic material in 
contact with a cell culture medium containing dissolved proteins is the adsorption of the protein 
to the surface. Other responses, such as the attachment of cells are secondary and depend on the 
nature of the adsorbed protein layer. Controlling adsorption from a single protein solution as 
well as more complex mixtures requires an understanding of (a) protein structure and property, 
in terms of stability, conformational dynamics and the tendency to aggregate; (b) the polymer 
surface that allows the introduction of functional groups at the surface to enhance 
biocompatibility with the biological surface; and (c) analytical techniques that can quantify the 
protein adsorption. The concept of biological surface modification consists of surface 
functionalization by imparting polar-containing functional groups through physico-chemical 
treatment. Next, the treated-surfaces are immobilized with bio-active compounds (e.g., peptide, 
oligonucleotide, enzyme and antibody) to provide biosignalling recognition surface template for 
increasing cell-material affinity. The concept is illustrated in Figure 2.4. 
 
 
 
Figure 2.4: The concept of biological surface modification (Adapted from [103]). 
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 Much published work on protein adsorption at the solid-liquid interfaces has mainly focused 
on the amount of protein adsorbed, with the little attention on the protein conformation, 
orientation and structural changes in the adsorbed layer. The major parameters that may 
influence protein-surface interactions include surface charge (electrostatic interactions) [115, 
116], hydrophobicity/hydrophilicity of the surface [103] or possibly a combination of both 
parameters. Figure 2.5 illustrates two types of chemical properties that affect protein adhesion. 
The chemical properties include surface charge (electrostatic interactions) and polarity 
(hydrophobicity/hydrophilicity) which actually affect (1) the amount of the adsorbed proteins 
and type of protein adsorbed, (2) protein-binding strength and (3) the adsorbed protein 
conformational and/or orientation. The above mentioned effects will eventually contribute to the 
promotion/inhibition of cell growth [103].   
 
 
 
Figure 2.5: Mechanisms of protein adhesion (Adapted from [103]). 
 
 Other factors include electrostatic forces between adsorbed molecules (e.g., electrostatic 
forces between other adjacent absorbed protein molecules), solvent-solute interactions and the 
morphology (e.g., surface roughness, pore size and porosity) and chemistry of the solid surfaces 
(e.g., surface free energy). The adsorption of proteins at the solid/liquid interface is a complex 
phenomenon that involves the following sequence of steps [117]: 
 
1. Transport of proteins towards the interface. 
2. Attachment at the interface. 
3. Final molecular structural rearrangement in the adsorbed position. 
4. Detachment from the interface. 
5. Transport away from the interface. 
 
 In protein-surface interaction, the governing factors are determined both by physical state of 
the material surface in contact with the protein solution, the molecular structure of the protein 
and the environment of the solution. Work in literature has highlighted a number of biologically 
active coatings on engineered material surface either from serum-supplemented media [118], 
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monocomponent ECM proteins in solution [103, 119] and the covalent attachment 
(grafting/bioconjugations) of the cell-adhesive peptide region of the ECM protein, Arg-Gly-Asp 
(RGD) [103, 120] where such modified surfaces have applications in bioartificial organs, 
medical devices and disposable apparatus [103]. 
 The primary aim of coating solid surfaces with adhesion proteins and peptides mentioned 
above is to provide a biosignaling recognition template on the material surface for cell 
attachment through receptor-ligand interaction and to provide a strong mechanical contact 
between the cells and the surface [6, 120]. Coating surfaces with adhesive proteins derived from 
ECM such as fibronectin, vitronectin and collagen provides an ‘adhesive interface’ between the 
scaffold materials and the cells that resemble the native cellular milieu (environment), whose 
organization and production modulates and enhances cell adhesion through transmembrane 
integrin receptors [103]. The advantage of complete ECM proteins to peptide sequence is that 
they not only provide the cell-binding sequence for cell adhesion, but also provide secondary 
interactions with other ECM proteins and growth factors strengthening cell adhesion which 
results in enhanced cell growth and maturation. Furthermore, ECM proteins being the natural 
ligands found in in vivo do not cause any harmful side effects. Whilst, short-chain peptides 
(frequently found in numerous adhesive proteins) have lower binding to cells and selective 
activity for distinct integrin subtypes and are easily cleaved by enzymes [121]. However, short 
peptides in particular arginine-glycine-aspartic acid (RGD), do offer some advantages of 
enhanced stability during immobilization, increased likelihood of retaining proper orientation of 
binding domains after immobilization and the economic advantage of laboratory synthesis 
[103]. Native ECM protein tends to be randomly folded upon adsorption to the biomaterial 
surface such that the receptor binding domains are not always sterically (related to spatial 
arrangement of atoms in a molecule) available [81]. There are three major functions for the 
ECM: 
 
1.  They provide structural support to the tissue.  
2.  They provide substrate for cell adhesion and cell migration. 
3. The ECM regulates cellular differentiation and metabolic function, for example by   
modulating the cell growth through the binding of growth factors.  
 
 Meanwhile, the in vivo ECM encompasses three major classes of biomolecules, which 
provide the complex structural entity surrounding and supporting the cells. These are:  
 
1.  Structural proteins (e.g., collagen and elastin). 
2.  Specialized proteins (e.g., fibronectin and laminin). 
3.  Proteoglycans (e.g., hydrophilic heteropolysaccharides, glycosaminoglycans (GAGs) - 
     They form extremely complex high molecular weight components of the ECM. 
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 The natural, ECM-derived polymers have biological properties (e.g., biosignaling 
mechanism) that synthetic polymers lack, whilst, synthetic polymers are cost-effective, exhibit 
less batch to batch variability and have physico-chemical properties which are readily modified 
to suit specific applications. Work in the literature on the 3-D ECM substrates for tissue 
engineering applications investigated a number of scaffolds that mimic the 3-D structures 
prepared from natural ECM-derived biopolymers, such as collagen, composite bioabsorbable 
(e.g., PLA and PGLA) with bioactive ceramic materials (e.g., hydroxyapatite, tri-calcium 
phosphate and wollastonite) or hybrid combination of natural and synthetic polymers [74]. For 
instance, the use of nanofibrous scaffolds (obtained by electrospinning) of combined poly(3-
hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) and type-I collagen for tissue-specific cells 
development in 3-D organization. The use of the above mentioned composite scaffolds resulted 
in acceleration of the adhesion and growth of NIH3T3 cells more effectively than the PHBV 
nanofibrous scaffold, thus making the former a good scaffold for tissue engineering [122]. 
Collagen is not the only ECM protein that has been extensively studied or applied in the hybrid 
biomaterials. Functional biomaterials have been designed utilizing fibronectin adsorption to 
poly(D,L-lactade) (PDLLA), poly(L-lactic-co-glycolic acid) PLGA, polystyrene (PS), 
poly(methyl-methacrylate) (PMMA), poly(caprolactone) (PCL) and polyurethane (PU) 3-D 
scaffolds to elicit cellular response and AML’s leukaemic cell lines adhesion strength as well as 
assist in the development of the in vitro 3-D leukaemia model [6]. 
 
2.7.2.2 ECM Proteins: Levels of Structure and Functions 
 
2.7.2.2.1 Collagen Type 1 
 
 Collagen is the major protein comprising the ECM. There are at least 12 types of collagen 
with type I, II and III being the most abundant protein in mammals, making up about 25% to 
35% of the whole-body protein content which form fibrils of similar structure [123]. Collagens 
are predominantly synthesized by fibroblast. However, epithelial cells are also synthesized these 
proteins. Collagen type I is found in high concentration in tendon, skin, bone and fascia 
(a connective tissue that surrounds muscles, groups of muscles, blood vessels and nerves - 
closely packed bundles of collagen fibres) which are consequently convenient and abundant 
sources for isolation of the natural polymers. This like rod proteins is 300 nm long, 1.5 nm in 
diameter and consists of three coiled polypeptide composed of two α1 chains and one α2 chain. 
Each chain consists of 1050 amino acids twisted around each other in a characteristic right-
handed triple helix [123]. There are three amino acids per turn in the helix and every third 
amino acid is a glycine (Gly). Collagens are also rich in proline (Pro makes up about 17% of 
collagen) and hydroxyproline (Hyp) [124]. The triple helix gives collagen a rigid structure. It 
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maintains the mechanical integrity of tissues. The 3-D structure of collagen fibres also provides 
flexibility and strength to the ECM.  
 
2.7.2.2.2 Fibronectin 
 
 Fibronectin is a high molecular weight, adhesive, glycoprotein found in both blood plasma 
(formerly called ‘cold-insoluble globulin’ (CIg) or soluble plasma fibronectin) [125] and the 
ECM (insoluble cellular fibronectin secreted by various cells, primarily fibroblasts) [126]. The 
role of fibronectin is to attach cells to a variety of ECM. Fibronectin attaches cells to all 
matrices except collagen type IV that involves laminin as the adhesive molecules [124]. 
Fibronectin is a dimer of two peptide chains with a molecular weight of approximately 275 kDa 
which are linked through two interchain disulphide bonds at the COOH-terminal end of the 
molecule. Each chain is 60 nm to 70 nm long and 2 nm to 3 nm thick. Fibronectin contains at 
least 6 tightly folded domains each with a high affinity for a different substrate such as heparin 
sulphate, collagen (types I, II and III), fibrin and cell-surface receptors.  
 
2.8 Leukaemias  
 
 The leukaemias are a group of diseases characterized by the clonal proliferation of malignant 
white blood cell precursors [127]. They can also be defined as a group of neoplasms (any 
abnormal growth of new tissue, benign or malignant and also called tumour) characterized by 
malignant proliferation of myeloblasts or lymphoblasts that replace normal bone marrow 
elements and infiltrate normal tissues [128]. They differ in the lineage and degrees of 
differentiation of the cells involved and are divided into two main groups: lymphoid and 
myeloid. These two groups are further subdivided into acute and chronic forms, where in the 
former relatively immature cells are produced and the untreated disease progresses rapidly 
(acute), and in the latter more mature cells are produced and the disease pursues a more indolent 
course (chronic). 
 
2.8.1 Acute Myleoid Leukaemia (AML) 
 
2.8.1.1 Definition 
 
 AML is a morphological heterogenous disease. Since several haematopoietic cell lines may 
be involved, granulopoietic cells, monocytes, erythroblasts and even megakaryocytes are 
frequently found together [129]. In AML, the bone marrow makes many unformed cells called 
blasts. Blasts normally develop into white blood cells that fight infection. However, the blasts 
are abnormal in AML. They do not develop and cannot fight infections. The bone marrow may 
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also make abnormal red blood cells and platelets. They crowd out the normal red blood cells, 
white blood cells and platelets the body needs which lose the ability to differentiate normally 
and to respond to normal regulators of proliferation. This loss leads to fatal infection, bleeding 
or organ infiltration, typically in the absence of treatment within 1 year of diagnosis [130].  
 
2.8.1.2 Incidence 
 
 AML is the most common type of acute leukaemia. The incidence of AML in the United 
States was reported approximately 2.4 per 100,000 and it increases progressively with age to a 
peak of 12.6 per 100,000 adult each year, mostly in older adults with the age of 65 years and 
older [131]. Moreover, leukaemia accounts for 3% of all cancers in the United States and for 4% 
of total cancer-related mortality [128]. Prevalence of AML is around 3 to 8 cases per 100,000 
rising to 17 to 19 cases per 100,000 adults aged 65 years and older [130]. 
 
2.8.1.3 Risk Factors 
 
 As reported by Carol [128], the etiology (the study of origin) of leukaemia is unknown, 
although a number of risk factors have been identified that may contribute to the development 
of this disease. The first and arguably most important of these risk factors are genetic mutations. 
Secondly is the ionizing radiation which has been well established as a risk factor in the 
development of acute leukaemia (e.g., exposed to ionizing radiation after the detonation of the 
atomic bombs at Hiroshima and Nagasaki [132] and the power plant accident at Chernobyl). 
Other risk factors as reported in the report is the exposure to certain chemicals and drugs      
(e.g., benzene in shoe making, pesticide in farming, painting, smoking [133] and hair dye).  
 
2.8.2 Chronic Lymphocytic Leukaemia (CLL)  
 
2.8.2.1 Definition 
 
 Chronic lymphocytic leukaemia (CLL) is a disease characterized by the relentless 
accumulation of CD5+ B lymphocytes in the peripheral blood, bone marrow and secondary 
lymphoid organs (lymph nodes and spleen) [134, 135]. As a leukaemia, it is usually 
characterized by an increase in the lymphocyte count in the peripheral blood > 5 × 109 L−1. The 
entity formerly defined as CLL of T lymphocytes is now renamed as T-prolymphocytic 
leukaemia (T-PLL) [136]. 
 At present, no chemotherapeutic regimens can be considered curative and all patients will 
die with (or because of) their disease [136]. Moreover, at a certain stage if the cancerous 
lymphocytic cells are too severe, it could turn into advanced CLL which is known as lymphoma 
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(a cancer of lymphatic system). About 5% of CLL cases will turn into lymphoma. They can be 
classified into two types: (1) Hodgkin’s lymphoma and (2) Non-Hodgkin’s lymphoma (NHL). 
These two types of lymphomas behave, spread and respond to treatment differently. The main 
difference between Hodgkin's and non-Hodgkin's lymphoma is in the specific lymphocyte each 
involves. A physician can tell the difference between Hodgkin's and non-Hodgkin's lymphoma 
by examining the cancer cells under a microscope. If in examining the cells, there is a presence 
of a specific type of abnormal cell called a Reed-Sternberg cell (usually B-cell), the lymphoma 
is classified as Hodgkin's. If the Reed-Sternberg cell is not present, the lymphoma is classified 
as non-Hodgkin's (could be B- or T-cell). Both types of lymphoma can start almost anywhere 
because of the lymphatic tissue can be found in many parts of the body (e.g., lymph nodes, 
lymph, tonsils, stomach, skins, etc.). Meanwhile, non-Hodgkin's lymphoma is actually a 
heterogeneous group of over 30 types of cancers with differences in the microscopic appearance 
and biological characterization of the malignant lymphocytes [137].  
   
2.8.2.2 Incidence and Prevalence 
 
 CLL is the most common leukaemia in adults, in the western countries, representing about 
25% to 30% of all leukaemias [135]. About 15,000 new cases are diagnosed in adults in the 
USA each year [138, 139]. CLL is more common in men than women, with a sex ratio of about 
1.5 to 2:1 [135]. The incidence rate is about 2 to 6 new cases every 100,000 individuals per year 
and increases with age, reaching 12.8/100,000/year at 65 years of age that is the mean age at 
diagnosis [136]. Prevalence of CLL, that is how commonly a disease or condition occurs in a 
population, is around 30 to 50:100,000 (0.03% to 0.05%), based on the estimated incidence and 
the long median survival of the disease [136]. 
 
2.8.2.3 Risk Factors 
 
 The occurrence of CLL is not due to any known environmental factor as ionizing radiations, 
chemical compounds and it is not more frequent in patients affected by immunodeficiencies 
[135]. In contrast, a genetic and familial predisposition appears to be relevant in the 
pathogenesis of the disease as supported by two series of evidences. First, CLL is very rare in 
China and Korea and virtually absent in Japan. The low incidence rate is maintained within the 
Japanese emigrants and their progeny (descendants from a mixed marriages), thereby excluding 
an environmental modifier of such genetic predisposition [140]. Secondly, epidemiological 
(studies on how often the disease occur) evidences indicate that in 5% to 10% of cases there is a 
familial susceptibility to CLL (and other lymphoid malignancies) [141] with two or more 
individuals affected in the same family. The overall risk to develop such diseases is between 
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two and seven times higher in first relatives of CLL patients as compared to the general 
population [142]. This familial predisposition is accompanied by the so-called anticipation 
phenomenon (symptoms of a genetic disorder become apparent at an earlier age as it is passed 
on to the next generation) [141, 143, 144]. 
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CHAPTER 3 Goals and Objectives 
 
 The in vitro cultivation of leukaemic cells in two dimensions is extremely difficult without 
the addition of exogenous cytokines to the culture. Survival of the cell blasts is enhanced if they 
are co-cultured with stroma or fibroblasts, suggesting that they are dependent on the 
extracellular matrix (ECM), adhesion proteins and cytokine expression of their bone marrow 
microenvironment for survival. The study of the impact of these physico-chemical influences on 
the leukaemic bone marrow and the process of leukaemogenesis is not only limited by the 
requirement of exogenous cytokines for the maintenance of such cells in culture, but also by the 
lack of a three dimensional growth micro-environment, which is not supported by 2-D cultures. 
 The proposed study focuses on the development and optimization of a 3-D culture system for 
the culture of human primary leukaemic cells in the absence of exogenous cytokines. Since the 
nature of the scaffold affects cell attachment, adhesion, growth and differentiation, preliminary 
studies on fabrication, physical and material characteristics, surface treatment and biological 
surface coating were conducted with respect to cellular response of AML (e.g., HL-60) and 
CLL (e.g., JeKo-1 and RL) cell lines to ensure that the human primary leukaemic cells were not 
wasted. Although the leukaemic cell lines are already cytokine-independent in 2-D static 
cultures, this main study of the cell lines in 3-D focusing on the material and physical culture 
characteristics required by cells wherein at the same time clarify the environmental needs of the 
human primary leukaemic cells as well.  
 Since leukaemic cell (e.g., AML or CLL) is a heterogeneous disease, the system is optimized 
for the culture of different leukaemic cell lines prior to the evaluation of human primary 
leukaemic cells. The possibility of mimicking the 3-D bone marrow structure seemed a solution 
to overcome the problem of culturing leukaemic cells in vitro. By recreating similar 
microenvironment it is hypothesized that cells would survive for long periods of time (up to 4 
weeks proliferation period) and they could be investigated in their natural environment without 
the addition of external growth factors and at the same time maintaining their self-renewal 
potential. 
 
The specific objectives of this thesis are outlined as follows: 
 
1. To fabricate a novel PHB and PHBV porous 3-D scaffolds with an improved thickness 
greater than 1 mm (in relative to the conventionally made PHA matrices) by using the 
solvent-casting particulate-leaching (SCPL) technique. 
2. To analyze the structural, material and physico-chemical characteristics (e.g., porosity, 
pore size, BET surface area, hydrophilicity/hydrophobocity and zeta-potential 
measurement) of PHB and PHBV porous 3-D scaffolds.  
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3. To study the in vitro degradation of polymeric porous 3-D scaffolds in the hydrolytic 
degradation media (phosphate buffered saline) and cell growth media by means of 
gravimetric analysis, pH change and structural morphology. 
4. To identify the suitable surface treatment of PHB and PHBV porous 3-D scaffolds by 
means of alkaline treatment and rf-O2 plasma treatment which could enhance cellular 
growth of CLL cell line (RL). 
5. To optimize the cellular growth of CLL cell lines (RL and JeKo-1) by immobilizing two 
main bone marrow ECM proteins (e.g., collagen type I and fibronectin) on the surface 
of PHB and PHBV porous 3-D scaffolds by means of a physical adsorption (non-
covalent interactions).  
6. To generate the cellular growth of abnormal 3-D culture system using human primary 
AML mononuclear cells (MNCs) without adding exogenous cytokines. 
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CHAPTER 4 Materials and Methods  
 
4.1 Materials 
 
 Poly(3-hydroxybutyric acid) (PHB; Mw = 300,000 g/mol; CAS No. 29435-48-1), poly(3-
hydroxybutyric acid-co-3-hydroxyvaleric acid) (PHBV; Mw = 680,000 g/mol with 12% (w/w) 
polyhydroxyvalerate (PHV) content; CAS No. 80181-31-3) [145, 146] and cell culture grade 
sodium chloride (particles size: 212 µm to 850 µm) were purchased from Sigma-Aldrich 
(Dorset-United Kingdom). Chloroform 99.9% in purity (AnalaR) was obtained from VWR 
International (Leicestershire, United Kingdom). GIBCO Iscove's Modified Dulbecco's 
Medium (IMDM), GIBCO Phosphate Buffered Saline (PBS) and Foetal Bovine Serum (FBS 
heat inactivated) were purchased from Invitrogen Ltd., United Kingdom. One well-
characterized human leukaemia cell line which is HL-60 (from a patient with acute 
promyelocytic leukaemia) and two human chronic lymphocytic leukaemia cell lines (RL and 
JeKo-1) were purchased from ATCC, UKCCL-240. MTS-based CellTilter 96 AQueous Assay 
was purchased from Promega (Madison, United States of America).  
 
4.2 Fabrication of an Improved Thickness of PHB and PHBV Porous 3-D Scaffolds using 
the Solvent-Casting Particulate-Leaching (SCPL) Technique  
 
4.2.1 Studies of Polymer Concentrations with Respect to Homogenization Time 
 
Polymer concentrations of 1%, 2%, 3%, 4% and 5% (w/v) PHB and PHBV (containing 12% 
by weight of polyhydroxyvalerate (PHV)) in powder and pellet forms respectively were 
prepared in 60 ml of boiled reflux chloroform (99.9% purity) at 60 oC by using 500 ml 
SCHOTT Duran bottle. Polymer solutions were considered as a homogenous solution if there 
were no apparent residues of glutinous materials in the solution or remains at the bottom of the 
bottle. Five replications were made on each polymer at a different concentration for data 
collecting (n = 5). All measurements were expressed as mean ± standard deviation (sd) and 
statistical analyses were computed for statistically differences between polymer concentrations 
as a function of time. 
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4.2.2 Studies of Polymer Concentrations with Respect to Polymeric Porous 3-D Scaffolds 
Thickness 
 
Polymer concentrations of 1%, 2%, 3% and 4% (w/v) for PHB and PHBV (containing 12% 
by weight of polyhydroxyvalerate (PHV)) were prepared in 60 ml of boiled reflux chloroform     
(99.9% purity) at 60 oC for 8.2 ± 1.48 min and 17.8 ± 2.28 min respectively in a fume cupboard 
(Vsuction = 1.24 ± 0.20 m/s; T = 20 ± 1 oC). The polymer solutions were cooled down for 10 min 
prior to the mixing with sodium chloride. Once cooled, the polymer solutions were then added 
evenly over a coated aluminum foil glass Petri-dish (internal diameter, 8.8 cm × height, 1.8 cm). 
Sodium chloride crystals (particles size: 212 µm to 850 µm) with a salt weight fraction of 99% 
(w/w) were then poured and stirred evenly into the polymer solutions with continuous stirring 
until the polymer-solvent solution became pasty, thick and packed (Table 4.1). The fully filled 
pasty Petri-dish was tapped a few times so that the content became compact and even. This 
procedure was carried out in the fume cupboard. Subsequently, the packed-in pasty were put 
immediately inside the lyophilization flask (to minimize rapid phase separation, which could 
result in an etched surface) and air-dried for 2 days for complete solvent evaporation. The dried 
cast polymers were peeled carefully from the aluminum foils and then dialyzed with 10 liters of 
cold deionized water (DIW) at 20 ± 1 oC for 2 days to remove all sodium chloride crystals (2 
dried casts/10 liters DIW). The deionized water was changed twice a day. The wet porous 
materials were put on top of the tissue paper for several times until they became partially dry. 
They were frozen at -70 oC for 3 h and then transferred into a cryostat bath containing ethylene 
glycol (-15 oC) to lyophilize the remaining deionized water and chloroform via the sublimation 
process under vacuum pressure of 2 mbar for 2 days. The thickness of these porous 3-D 
scaffolds was measured by using 150 mm digital LCD Vernier caliper. Ten replications were 
made for each polymers at different concentration (n = 10). Porous 3-D scaffolds from each 
replicate were cut into 10 sections, 5 of which were randomly selected for thickness 
measurements (expressed as mean ± standard deviation (sd) computed for differences between 
the polymer concentrations as a function of thickness). The schematic of the solvent-casting 
particulate-leaching (SCPL) process is illustrated in Figure 4.1.  
  
Table 4.1: Preparation condition of polymeric porous 3-D scaffolds. 
 
PHB/PHBV 
mass (g)[a] 
NaCl mass 
(g)[b] 
NaCl weight 
fraction (%, w/w) 
0.6 (1%, w/v) 
 
172.3 ± 6.1 
 
99 1.2 (2%, w/v) 
1.8 (3%, w/v) 
2.4 (4%, w/v) 
[a] Polymer solution was prepared in 60 ml of hot chloroform. [b] The amount of NaCI that was used to 
make a fully filled pasty Petri dish without spilling out the polymer solution. 
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Figure 4.1: Schematic of SCPL process. The process comprises (1) mixing of polymer solution 
with porogen; (2) adding the polymer solution with porogen into a Petri-dish and then incubated 
in the lyophilization flask to avoid development of etching surfaces; (3) evaporation of solvent 
for 48 h in the fume cupboard. The solvent evaporation is complied with the United Kingdom 
Solvent Emission Directive (SED), 2002 for Halogenated VOCs: < 20 mg/m3 (< ≅12 kg of 
CHCl3); (4) leaching out porogen from dried cast polymer + porogen by using 10 liters of 
deionized water for 48 h (changed twice/day) at 20 ± 1oC; (5) lyophilized porous 3-D scaffolds 
with the thickness greater than 1 mm; (6) Cuboids with the size of ∼10 mm x ∼10 mm x ∼5 mm 
were excised prior to the physico-chemical analysis, in vitro degradation measurement and 
cellular proliferation studies.     
 
4.2.3 Fabrication of Solvent-Cast Thin Film 
 
 Fabrication of PHB and PHBV thin films were prepared as described in previous studies 
[145, 147-154] and used to compare in terms of its wetting behaviour with porous 3-D scaffolds 
fabricated using SCPL. A solvent-cast film was made by pouring a polymer solution of 4% 
(w/v) into a casting block on a clean polypropylene (PP) sheet with the size of 30 cm × 30 cm. 
Then, the casting block was immediately moved upwards towards the end of the sheet so that 
the polymer solution can be smeared evenly. The sheet coated polymeric thin film was left for a 
day in a fume cupboard at 20 ± 1 oC for complete solvent evaporation prior to the wetting 
analysis.  
 
4.3 Determination of Salt-Leaching Efficacy Measured Via Ion Conductivity and 
Gravimetric Analysis 
 
 Polymer concentrations of 4% (w/v) for PHB and PHBV (containing 12% by weight of 
polyhydroxyvalerate (PHV)) were used for preparing dried cast polymers as described in the 
above protocol. The conductivities (κ) of standard sodium chloride solution (for standard 
calibration curve) and solution with leached sodium chloride from the dried cast polymers were 
measured by using OAKTONTM Con 11 conductivity meter. The Automatic Temperature 
INNER 
SIDE 
INNER 
SIDE 
Polymer solution 
in organic solvent 
Polymer solution + 
Porogen  
Solvent evaporation in fume 
cupboard (complied with the 
UK-SED, 2002: <20 mg/m3) 
Dried cast  
Polymer + Porogen 
Porous 3-D 
scaffolds 
Porogen + DIW 
leaching 
1 
2 3 4 
Polymer + 
Solvent + 
Porogen cast 
5 
Cuboid of polymeric porous 3-D 
scaffolds (> 1 mm) 
 
6 
Porogens (i.e., NaCl, sucrose, 
paraffin sphere, etc.)  
 
+ 
∼10 mm 
∼ 5 mm 
∼10 mm 
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Compensation (ATC) function was activated to compensate the reference temperature of 25 oC. 
The sodium chloride solutions was first prepared on the serial concentration (5 mg/ml, 10 
mg/ml, 20 mg/ml, 30 mg/ml) and the conductivities (mS/cm) at 20 ± 1 oC was plotted against its 
respective concentration to establish a standard calibration curve. The amounts of sodium 
chloride that have been leached out from the dried cast polymers were determined in 10 
replications (n = 10). The conductivity was measured twice a day (10 liters of the deionized 
water were changed twice a day) until it reached down to 2.73 µS/cm (conductivity of deionized 
water at 20 ± 1 oC). Then, the total concentration and mass of sodium chloride were determined 
from the standard curve (Appendix A) based on the sums of conductivities. Finally, to 
determine any potential of polymer weight loss during the salt-leaching process, a gravimetric 
analysis was conducted after the lyophilization process. The efficacy (%) of salt-leaching 
measured via ion conductivity and gravimetric analysis after the lyophilization process was 
determined based on the Eq. 4.1, Eq. 4.2 and Eq. 4.3 respectively. 
      
Efficacy of salt-leaching measured via ion conductivity (%) = [MNaCI in the dried cast - MNaCI dissolved in 
the DIW)]/MNaCI in the dried cast × 100%                                              (4.1)   
    
Efficacy of salt-leaching via gravimetric analysis (%) = [(MNaCI in the dried cast - MNaCI remains inside the 
lyophilized scaffolds)]/MNaCI in the dried cast × 100%                                   (4.2) 
 
Weight of NaCl remains inside the lyophilized 3-D scaffolds (g) = MLyophilized porous 3-D scaffolds -  2.4 
g (weight of polymer at 4%, w/v)                                   (4.3) 
 
4.4 Effect of Sodium Chloride Residual in Polymeric Porous 3-D Scaffolds on Cell Growth 
Media 
 
Polymer concentrations of 4% (w/v) for PHB and PHBV (containing 12% by weight of 
polyhydroxyvalerate (PHV)) were used for preparing polymeric porous 3-D scaffolds as 
described in the above protocol. The porous 3-D scaffolds were put into 50 ml centrifuge tubes 
containing cell growth media of 90% (w/v) Iscove's Modified Dulbecco's Medium (IMDM) +  
10% (w/v) Foetal Bovine Serum (FBS) + 1% (w/v) Penicillin-Streptomycin (PS) (V = 30 ml, 
pH 7.2) and incubated at 37 oC for 7 days. The scaffolds were taken out from the incubator and 
the conductivity was measured 5 min after the removal from the incubator. The conductivity (κ) 
of cell growth media in the presence of scaffolds was recorded daily at 20 ± 1 oC (room 
temperature). Three replications were prepared for each polymer (n = 3). All measurements 
were expressed as mean ± standard deviation (sd) and statistical analyses were computed for 
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differences between conductivity (κ) of cell growth media in the presence of scaffolds and 
control (cell growth media without a scaffold).  
 
4.5 Surface Treatment of Polymeric Porous 3-D Scaffolds  
 
4.5.1 Alkaline Treatment 
 
 To increase the biocompatibility of the polyesters used in this study, surface hydrolysis by 
NaOH was used to break the ester-linkage of the polymers and also to functionalize by the 
insertion of polar groups [155]. In fact, the hydrolyzation process will generate more hydroxyl 
groups which lead to increased surface hydrophilicity thus improving the capacity for the cells 
to adhere to the polymer surfaces [156]. PHB and PHBV (4%, w/v) porous 3-D scaffolds in a   
6-well tissue culture plate were soaked in 10 ml of NaOH solution with serial concentrations 
(0.2 mol/L, 0.4 mol/L, 0.6 mol/L, 0.8 mol/L, 1.0 mol/L) for 60 min at 20 ± 1 °C for surface 
treatment. The optimal treatment time was taken from the previous study [155]. The treated 
porous 3-D scaffolds were taken out and rinsed extensively with deionized water until the pH of 
the rinsing water became neutral. They were then air dried at 37 oC overnight prior to the water 
contact angle measurement and cell proliferation studies. Three replications were made on each 
polymer at different NaOH concentrations (n = 4).  
 
4.5.2 Oxygen Plasma Surface Treatment 
 
 For the comparison of the different surface treatments with respect to cell attachment and 
proliferation, another type of surface treatment was employed. This was using rf-oxygen 
plasma. The surface treatment was conducted as described in previous studies [150, 151]. The 
surfaces of the polymeric porous 3-D scaffolds were treated with rf-plasma (Diener Electronic 
GmbH, Nagold, Germany) using oxygen gas to make their surfaces more hydrophilic prior to 
the water contact angle measurement and cell proliferation studies. The main characteristics of 
the rf-plasma and treatment parameters used are summarized in Table 4.2. In brief, the porous  
3-D scaffolds with an approximate size of 10 mm × 10 mm × 5 mm placed into the 24-well cell 
culture plate were positioned on the sample stage in the reaction chamber. Initially, the reaction 
chamber was evacuated to about 0.1 mbar. Oxygen gas was introduced into the reactor at a rate 
of 30 standard cm3/min, and the plasma was ignited. The plasma treatment was performed at a 
13.56 MHz pulse frequency and power of 100 W. The temperature in the chamber was 
maintained at 17 oC. The scaffolds were treated for 10 min. The modified scaffolds were stored 
in deionized water in a refrigerator at 4 oC until use.  
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Table 4.2: Main characteristics and treatment parameters of the O2 rf-plasma reactor for 
polymeric porous 3-D scaffolds surface treatment. 
 
Main characteristics 
Plasma reactor manufacturer Diener Electronic GmbH, Nagold, Germany 
The plasma model Type Pico 
Plasma generator Frequency 13.56 MHz; power (P): 100 W 
Threshold volumetric flow rate (Q) 100 sccma 
Vacuum pump Leybod (D16BCS); vacuum flow rate (Q): 16 m3/hr 
Treatment parameters 
Power (P) 100 W 
Exposure time (t)  10 mins 
Volumetric gas flow rate (Q)  30 sccma 
[a] Gas conversion unit: 1 sccm = 7.43583 × 10-4 Ma (mg/s) [Ma = Atomic Mass Unit (AMU)]; O2 = 
15.9994 AMU]. 
 
4.5.3 Weight Loss after Surface Treatment 
 
The weight loss of the polymeric porous 3-D scaffolds, after treatment, was calculated 
through the following formula: 
 
Weight loss (%) = [M0 - M1]/M0 × 100%                             (4.4) 
 
where M0 and M1 are the weights of dried untreated and treated polymeric porous 3-D scaffolds, 
respectively. 
 
4.6 Effect of Sterilization on Surface Properties of Polymeric Porous 3-D Scaffolds 
 
Sterilization was carried out using a combination of 8 min under UV light (230 V, 50 Hz, 
0.14 A, Kendro Laboratory Products, United Kingdom) and immersion for 2 h in Ethanol (70% 
v/v). Subsequently, the polymeric porous 3-D scaffolds were washed several times (at least 3 
times) for 5 min in PBS as described in the previous study [6]. Lastly, both polymeric porous 3-
D scaffolds were vacuum dried for 24 h at 20 ± 1 °C prior to the ζ-potential and water contact 
angle measurement. 
 
4.7 Characterization of the Polymeric Porous 3-D Scaffolds 
 
4.7.1 Structural/Morphological Analysis: Scanning Electron Microscopy (SEM) 
 
The vertical cross-section through PHB and PHBV (4%, w/v) porous 3-D scaffolds were all 
analyzed by using SEM (JEOL JSM-5610LV, JEOL Ltd., Welwyn Garden City, United 
Kingdom) to observe the internal pore structure. The specimens were sectioned, mounted on 
aluminum stumps, followed by coating with gold in a sputtering device in an argon atmosphere 
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for 2 min at an acceleration current of 20 mA prior to the examination by SEM at an 
acceleration voltage of 20 kV. 
 
4.7.2 Structural Properties of the Polymeric 3-D Scaffolds 
 
4.7.2.1 Material Characterization of Polymeric Porous 3-D Scaffolds: Physical Properties 
 
Parameters such as apparent density (skeletal density) obtained by using helium 
displacement pycnometry (AccuPyc 1330 V3.00, Micromeritics) and geometrical bulk density 
(mass of scaffold/geometric volume of scaffold) by using gravimetric analysis were used to 
calculate % porosity of the scaffolds [157]. Four porous 3-D scaffold samples (an approximate 
size of 10 mm × 5 mm × 5 mm) were analyzed to obtain statistically relevant data (n = 4). 
Percent porosity is determined based on the given equation below (Eq. 4.5):  
 
Porosity (φ), % = 1 - [(Geometrical bulk density/Skeletal density)] × 100%    (4.5)   
 
4.7.2.2 Structural/Morphological Analysis: Pore Size Distribution  
 
A mercury intrusion porosimetry (AutoPore IV 9500 MIP; Micromeritics® Instrument 
Corporation, United States of America) was used to determine the pore size distribution of the 
PHB and PHBV (4%, w/v) porous 3-D scaffolds. A penetrometer with 6 ml bulb volume was 
used with sample weight in the range 0.09 to 0.12 g. The intrusion chamber was then filled with 
mercury at a pressure of 1.52 kPa and the samples were penetrated with mercury until a 
maximal pressure of 675.50 kPa at which the total intrusion volume reached a plateau [83]. As 
for the pore size distribution, the Laplace-Washburn equation (Eq. 4.6) was used to calculate the 
pore diameter dp in relation to the applied external pressure, p needed to force mercury into the 
pores. The mercury surface tension γlv is (480 mN/m) and the contact angle (θ) between 
mercury and polymer is assumed to be 130o. Details concerning the experimental and theoretical 
procedures for the measurements performed are reported elsewhere [158]. 
 
dp × p = 4 × γlv cos θ            (4.6) 
 
where p is pressure needed to force mercury into the pores, dp is the diameter of the pore with 
respect to the applied external pressure, γlv is the surface tension of the mercury (480 mN/m), 
and θ is the contact angle of the mercury on the solid surface (130o). 
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4.7.2.3 Material Characterization of Polymeric Porous 3-D Scaffolds: BET Surface Area 
 
The surface area of the polymeric porous 3-D scaffolds was determined using nitrogen 
adsorption isotherms at 77 K utilizing surface area analyzer gas absorption BET (ASAP® 2010; 
Micromeritics® Instrument Corporation, United States of America) [157, 159]. The sample 
holder was filled with polymeric porous 3-D scaffolds pieces. Before performing the gas 
sorption experiments, surface contaminants were removed via a ‘degassing’ step. The samples 
were dried inside the measuring cell at temperature below their glass-transition (Tg) temperature 
under vacuum overnight. For the analysis part, nitrogen (the adsorbate) was admitted into the 
evacuated sample chamber. The detailed explanations of the experimental and theoretical 
procedures for the measurements performed are reported elsewhere [160].  
 
4.7.2.4 Mechanical Testing of Polymeric Porous 3-D Scaffolds 
 
 Compressive tests were carried out using a Lloyds universal testing machine (Lloyds EZ50, 
Lloyds Instruments Ltd., Fareham, United Kingdom) to determine the compressive modulus (E) 
and compressive strength of the scaffolds. The samples (an approximate size of 10 mm × 10 
mm × 7 mm to 9 mm) were compressed at a loading rate of 0.6 mm/min by means of a 
compression plate with a load cell of 5 kgf ± 0.1 g (49.03325 N), until a compression of 85% of 
the initial test piece thickness is attained (Table 4.3). Afterward, the unloading curve was 
measured at the same rate until the separation between the compression plate and the base plate 
is equal to the initial test piece thickness. Two different type of polymeric scaffolds in 3 
replicates (n = 3) were analyzed to obtain statistically relevant data. 
 
Table 4.3: Main characteristics and operational parameters of the mechanical testing of 
polymeric porous 3-D scaffolds. 
 
Main characteristics 
Manufacturer Lloyds universal testing machine  
Instrument model Lloyds EZ50, Lloyds Instruments Ltd. 
Load cell 5 kgf ± 0.1 g (49.03325 N) 
Operational Parameters 
Loading rate 0.01 mm/sec (0.6 mm/min) 
Temperature 20 ± 1oC 
Sample thickness PHBV ∼7 mm; PHB ∼9 mm 
 
4.7.3 Surface Properties of Polymeric Porous 3-D scaffolds 
 
4.7.3.1 Physico-Chemical Analysis: Water Contact Angle and Surface Free Energy 
 
 Static water contact angle (θH2O) [161, 162] on the air surface of PHB and PHBV (4%, w/v) 
porous 3-D scaffolds and the corresponding solvent-cast thin films were measured using a Drop 
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Shape Analyzer (DSA30E, KRÜSS GmbH, Germany) [163]. Re-distilled water of 
approximately 10 µl was gently plated on the vertical cross section and on top of the surfaces of 
the porous 3-D scaffold and thin film respectively (10 µl was used to prevent gravitational 
distortion of the spherical profile) [148]. At least ten readings on different parts of the porous    
3-D scaffold and thin film were averaged for data collecting (n = 10). The capture was triggered 
as soon as the drop reached on the surface and the measurement time was less than 5 s. All 
measurements were conducted at 20 ± 1 °C. Meanwhile, Fowkes equation was chosen as the 
equation of state (EOS) to determine the surface free energy of the solvent-cast thin films (γs). 
In this case, an adhesion energy/work of adhesion is calculated wherein it is a sum of two partial 
contributions, each of which is expressed as the geometric mean polar of two adhesion 
parameters, γL and γs, the first of which characterizes the ‘adhesive power’ of the liquid, and the 
second, of the solid (Eq. 4.7). The surface free energy was determined by contact angles of two 
types of reference liquids which are water (H2O) and di-iodomethane (CH2I2) [164]. In addition, 
several calculations were made to verify the surface hydrophilicity/hydrophobicity of the thin 
films by means of the surface free energy (γSL), the work of adhesive (WSL) and spreading 
coefficient at solid-liquid interfaces [165] (Eq. 4.10). All calculations were based on Young (Eq. 
4.8), Dupree (Eq. 4.9) and Fowkes equations (Eq. 4.7) and expressed as follows:  
 
γL(1 + cos θ) = 2[(γdLγdS)½ + (γpLγpS)½]                                    (4.7) 
 
(cos θ)γL = γs - γLS                                                      (4.8) 
 
WSL = ∆G = Eadh = γL + γs - γLS                                                      (4.9) 
 
        
(SH20/thin film) = WSL - WLL (WLL = ∆G = 2 × γL = 72.8 × 2 = 145.6 mN/m)                              (4.10)   
  
where γdL  and γpL are the dispersive component, and polar component, respectively; θ is the 
contact angles to water and to di-iodomethane (CH2I2), respectively. For water, γL = 72.8 mN/m, 
γdL = 22.8 mN/m and γpL = 51.0 mN/m. For di-iodomethane (CH2I2), γL = 50.8 mN/m, γdL = 50.8 
mN/m and γpL = 0 mN/m. 
 
4.7.3.2 Surface Chemistry: ζ-Potential Measurements 
 
 To determine the ζ-potential of both polymeric scaffolds the Electrokinetic Analyser (EKA, 
Anton Paar KG, Graz, Austria) was used. This is based on the streaming potential method as 
described in the previous study [166]. Time- and pH-dependent ζ-potential measurements were 
performed in 1 × 10-3M KCl supporting electrolyte solutions. In order to determine the effect of 
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pH on the ζ-potential (ζ = f(pH)), the initial starting point (i.e., constant ζ-potential), was fixed 
by the long time measurement at a constant ionic strength (1 mM KCl). This was to discard the 
possible effects of hydrophobic recovery and the polymer swelling in water. For pH-dependent 
ζ-potential measurements the pH solution was varied with either 0.1M HCl (pH 1) or 0.1M 
KOH (pH 13) using a remote titration unit (RTU, Anton Paar KG, Graz, Austria) at a constant 
temperature of 20 ± 1 °C. A cylindrical cell compartment was used for polymeric porous 3-D 
scaffolds. 
 
4.8 In Vitro Degradation Studies of Polymeric Porous 3-D Scaffolds 
 
For the in vitro degradation studies, cuboids of PHBV and PHB (4%, w/v) porous  3-D 
scaffolds with an approximate size of 10 mm × 10 mm × 5 mm were weighed to measure their 
initial weight. The samples were put into 50 ml centrifuge tubes 1) containing Invitrogen 
GIBCO phosphate buffered saline (PBS) (V = 30 ml; product pH: 7.2 ± 0.05; measured pH 
7.14) and incubated for 12 weeks (short-term); 2) cell growth media of GIBCO RPMI 1640    
(V = 30 ml; product pH: 7.13; measured pH 7.14) and incubated for 8 weeks and 3) Invitrogen 
GIBCO phosphate buffered saline (PBS) (V = 30 ml; product pH: 7.2 ± 0.05; measured pH 
7.14) and incubated for 40 weeks (long-term) at 37 oC. At the end of the period (on a weekly 
basis), samples were removed from the PBS/cell growth media, gently washed with deionized 
water and vacuum dried (2 mbar) for 48 h prior to weighing. At the same time, pH in the 
supernatant was recorded to observe any acidic degradation. Residual weight of the porous 3-D 
scaffolds as opposed to its initial weight was calculated after each incubation period as shown in 
Eq. 4.11. All measurements were expressed as mean ± standard deviation (sd) relative to the 
initial values. 
 
% Residual weight of the scaffolds = [(Mt = 1 to 40 weeks - Mt = 0 week)]/Mt = 0 week × 100%            (4.11)          
 
4.9 Cell Culture on Porous 3-D Scaffolds 
 
4.9.1 Leukaemic Cell Lines Seeding and Culture 
    
One well-characterized human leukaemia cell line which is HL-60 (from a patient with acute 
promyelocytic leukaemia) and two human chronic lymphocytic leukaemia cell lines (RL and 
JeKo-1) were studied for the in vitro cell-biomaterials interaction study. The cells were 
cultivated in standard polystyrene non-pyrogenic tissue culture flasks (T-flask, Corning Inc., 
New York, United States of America) and in a humidified incubator at 37 oC, 5% CO2 using 
protocol recommended by the cell line provider. For static seeding of porous 3-D scaffold 
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cultures, 100 µl of cell suspension (3.7 x 105 cells/scaffold) were seeded onto the inner side of 
the sterile porous 3-D scaffolds. Prior to that, sterilization was carried out using a combination 
of 8 min under UV light (230v, 50Hz, 0.14A, Kendro Laboratory Products United Kingdom) 
and immersion for 2 h in Ethanol (70%). Then, the scaffolds were washed twice for 5 min in 
PBS before adding the media and placing in a humidified incubator for 2 days at 37 oC and 5% 
CO2. Next, it was placed into the 24-well tissue culture plate (Costar, Corning Inc., New 
York, United States of America) and incubated for 15 min at 37 oC and 5% CO2 before adding 
1.5 ml of a complete culture media in order not to wash the cells out and allow time for settling 
down. If this is not done, the cells will float in the medium and might not attach to the surface of 
porous 3-D scaffolds. Scaffold cultures seeded with cells underwent a half-medium exchange 
every two to three days (depending on the media colour changes) which is in the same way as 
cell cultures treated in the flasks.  
 
4.9.2 AML Blood MNCs Separation and Handling 
 
 Human primary acute myeloid leukaemia blood was obtained in accordance with regulatory 
and ethical policies (Brent Research Ethics Committee 10/H0717/3). The MNCs were isolated 
using Ficoll-Paque (GE Healthcare, Sweden) density gradient centrifugation. The frozen human 
aspirated primary AML blood cells were gently aspirated from the vial using a 10 ml syringe 
and 18G needle. The aspirated blood was placed drop-wise into 50 ml centrifuge tube 
containing 30% (v/v) foetal bovine serum (FBS; GIBCO Invitrogen), 70% (v/v) Iscove’s 
Modified Dulbecco’s Medium (IMDM; GIBCO Invitrogen) and 1% Penicillin/Streptomycin 
(Gibco, Invitrogen Ltd., United Kingdom) by adjusting the total volume to 20 ml. Then, 10 ml 
of Ficoll-Paque (GE Healthcare, Sweden) was gently injected into the blood and centrifuged at 
199.19 g (RPM = 936 (200 RCF); radius of rotation = 203 mm) for 35 min. The middle buffy 
coat layer which contains the mononuclear fraction was gently removed using a 10 ml syringe 
and 18G needle. The supernatant was collected into a single 50 ml centrifuge tube and the cell 
count was conducted using a standard hemocytometer. The supernatant containing MNCs were 
centrifuged again at 199.19 g for 10 min to remove any excess Ficoll-Pague (GE Healthcare, 
Sweden) and plasma. The remaining cells (precipitate) were re-suspended in 30% (v/v) foetal 
bovine serum (FBS; GIBCO Invitrogen), 70% (v/v) Iscove’s Modified Dulbecco’s Medium 
(IMDM; GIBCO Invitrogen) and 1% Penicillin/Streptomycin (Gibco, Invitrogen Ltd., United 
Kingdom) and adjusted to the final concentration of 20 × 106 cells/ml. 
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4.9.3 AML Blood MNCs Seeding and Culture  
 
 The AML blood MNCs were cultivated on scaffolds as follows: 100 µl of MNCs suspension 
(seeding density = 2.0 x 106 cells/scaffold) were seeded onto the sterile PHBV scaffolds      
(both protein and non protein-coated), placed in 24 tissue culture plates (Costar, Corning Inc., 
New York, United States of America) and incubated for 15 min at 37 oC and 5% CO2 before 
adding 1.5 ml of Iscove’s Modified Dulbecco’s Medium (IMDM, Gibco, Invitrogen Ltd., 
United Kingdom) with 30% foetal bovine serum (FBS, heat-inactivated, Invitrogen Ltd., United 
Kingdom) and 1% Penicillin/Streptomycin (Gibco, Invitrogen Ltd., United Kingdom). Half-
medium exchange was carried out every other day. Cytokines were not added at any stage of the 
cell culture. 2-D control cell culture was performed by seeding AML blood MNCs onto sterile 
standard 24-well tissue culture plates (Costar, Corning Inc, New  York, United States of 
America) at a concentration of 2.0 × 106 cells/well in 1.5 ml IMDM (Gibco, Invitrogen Ltd., 
United Kingdom) with 30% FBS heat-inactivated (Invitrogen Ltd.) and 1% 
Penicillin/Streptomycin (Gibco, Invitrogen Ltd.). Half-medium exchange was carried out every 
other day. 
 
4.9.4 Collagen Type I and Fibronectin Coating 
 
 The polymeric porous 3-D scaffolds were coated with collagen type I from 
calf skin and/or fibronectin from bovine plasma. The treated porous 3-D scaffolds were 
immersed into different protein concentrations inside the centrifuge tube (50 ml) containing    
25 ml of protein solutions: 125 µg/ml or 62.5 µg/ml of collagen type I soluble in 0.1M of acetic 
acid (Fisher Scientific, United Kingdom) and dissolved in deionized water from a NANOpure 
(Barnstead, Duque, IA, conductivity 1.8 mΩ/cm). Alternatively, 25 µg/ml or 50 µg/ml of 
fibronectin were as well diluted in deionized water (each protein is based on the lowest and the 
highest concentration used up to now) [6]. Throughout the immersion process, the protein 
solutions were forced into the porous structure by using a vacuum pressure of 2 mbar for 10 min 
for homogeneous protein coating. In order to unblock the pores window, remove the unbound 
proteins and to allow the cells seeded to penetrate deeper into the scaffold, the scaffolds were 
again immersed and washed thoroughly in the PBS under vacuum pressure (2 mbar) for 10 min. 
The protein-coated scaffolds were placed in a 24-well tissue culture plate at 20 ± 1 oC (room 
temperature) prior to the sterilization process. The vacuumed immersion surface coating process 
with ECM proteins is illustrated in Figure 4.2. 
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Figure 4.2: Schematic representation of the biological surface coating of two main bone 
marrow ECM proteins (collagen type I and fibronectin) on the PHB and PHBV porous 3-D 
scaffolds via physical adsorption method. The scaffolds were immersed with proteins solution 
under vacuum pressure to produce homogeneous surface coating. *4 porous 3-D 
scaffolds/polymer (n = 4).   
 
4.9.5 Characterization Methods of 3-D Scaffolds during Cell Culture 
 
4.9.5.1 Cell Seeding Efficiency of 3-D Scaffolds 
 
 The cell-seeded 3-D scaffolds were allowed to proliferate for 24 h and subsequently the cell 
seeding efficiency was calculated after 24 h as given by the equation below.  
 
Number of viable cells/ml = Average number of viable cells for both chamber x 104/ml (volume 
of one square chamber: 1 mm x 1 mm x 0.1 mm) x 2 (dilution factor)                                  (4.12) 
 
Seeding efficiency after 24 h (%) = [(Number of cell seeded onto the 3-D scaffolds - Number of 
cell remaining after 24 h)]/Number of cell seeded onto the 3-D scaffolds × 100%               (4.13) 
 
 The number of cells remaining in the old medium was counted using the haemocytometer 
with a magnification of x20. To perform the cell count, 20 µl of the cell suspension was added 
to 20 µl of Erythrosin B (ATCC, Manassas, VA) with the dilution factor of 2 (i.e., DF = 2 = 20 
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µl cell/20 µl cell + 20 µl Erythrosin B) in the 96-well plate. 10 µl of the solution was used to fill 
both chambers of the haemocytometer making sure that there was no air bubbles trapped inside 
the chambers. Using a light microscope (Leica DM microscope, Milton Keynes, United 
Kingdom) the number of viable (unstained) and non-viable (stained red) cells were counted in 
five 4 x 4 squares (or 0.1 cm2 area). After 24 h in culture, the seeded 3-D scaffolds were 
transferred to a new well plate with a new culture medium ready for a short-term (7 and 14 
days) and long-term cell proliferation studies (up to 6 weeks). The MTS assays were carried out 
on a proliferation period on a weekly basis.  
 
4.9.5.2 MTS-based CellTiter96® Aqueous Assay-Cell Proliferation 
 
 Cell proliferation was quantitatively assessed by changes in the number of metabolically 
active cells using the tetrazolium compound CellTiter96 Nonradioactive Cell Proliferation 
Assay (MTS Assay) (Promega, United States of America) [167]. The reaction solution (100 µl 
containing 95.2 µl MTS tetrazolium compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H tetrazolium] and 4.8 µl phenazine methosulfate 
(PMS)) [168] were added with cell seeded 3-D scaffolds with the ratio of 1 ml to 200 µl (growth 
media to MTS solution). The MTS cell proliferation is a calorimetric assay that measures the 
reduction of the tetrazolium compound by the cells into a coloured formazan product that was 
soluble in tissue culture media. The amount of formazan produced, as a measured by the 
absorbance, is directly proportional to the number of living cells in the culture. During the 
analysis, the seeded 3-D scaffolds were transferred to a new 24-well tissue culture plate. Then 
1.5 ml of the culture media (pre-warmed at 37 oC) was added to each of the cell seeded 3-D 
scaffolds. 300 µl of MTS solution, thawed for 10 min in a water bath at 37 oC, were added to 
each of the well. The cell seeded 3-D scaffolds with the MTS solution were incubated over 3 h 
at 37 oC and 5% CO2. Eventually, the intense purple solution became visible. Then, 100 µl of 
the purple solution was taken out and transferred into the ELISA 96-well plate. It was then 
diluted 3x with the cell growth media prior to the absorbance measurement (100 µl of growth 
media in 3 wells each). 100 µl of the diluted cell solutions was transferred into the new ELISA 
96-well plate in 2 replicates with 2 replicates of control (empty scaffold with no cell). The 
absorbencies of the produced formazan were recorded at 490 nm using a 96-well plate reader 
(Elx 808, Ultra Microplate Reader, Bio-TEK Instruments, Inc., Bath, United Kingdom).  
 
4.9.5.3 Assessing Cell Attachment and Spreading using SEM 
 
 Following the cultivation of the AML cell line (HL-60), CLL (RL and JeKo-1) and human 
primary AML MNCs on the scaffolds for 7, 14 and 28 days, the scaffolds were examined by 
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SEM (JEOL JSM-5610LV, JEOL Ltd., Welwyn Garden City, United Kingdom). Briefly, the 
scaffolds were fixed with 2.5% (v/v) PBS-buffered glutaraldehyde solution (Fluka BioChemika, 
Switzerland) for 40 min at 4 oC and washed twice with PBS. Serial dehydration in ethanol 
(50%, 70%, 90%, 95%, and 100%) followed, each for 10 min, after which the samples were 
dried in an aseptic environment for 4 h. The specimens were cut with the Amati 
POLITRAFOR hot-wired polystyrene foam cutter (4.5 V battery powered) to enable 
examination of longitudinal and transverse sections. The specimens were sputter-coated with 
gold in argon atmosphere for 2 min prior to the examination by SEM at an acceleration voltage 
of 20 kV. 
 
4.9.5.4 Cell Viability Measurement 
 
 The cells were manually extracted from the scaffolds using a tweezer (to hold the scaffolds) 
and pipette. The extracted cell solution was transferred into the eppendorfTM tube (1.5 ml) prior 
to the measurement. The cell viability was measured using a standard hemocytometer and 
erythrosine B stain solution (ATCC) at days 0, 7, 14 and 28; number of repetitions (n) = 2. 
Using a light microscope (Leica DM microscope, Milton Keynes, United Kingdom) the number 
of viable (unstained) and non-viable (stained red) cells were counted in five 4 x 4 squares (or 
0.1 cm2 area). 
 
5.0 Statistical Analysis 
 
 Data were presented as means ± standard deviation (sd) of mean. Statistical comparisons 
were performed using Students t-test (PASW version 17.0 IBM Co.) for the thickness, salt-
leaching efficacy and physico-chemical analysis. Statistical analysis of data for polymer 
concentrations, sodium chloride residual effect, in vitro degradation and the cellular 
proliferation studies were carried out by one-way analysis of variance (ANOVA) to determine 
the presence of any significant difference among sample means of the groups, followed by 
Tukey’s test (PASW version 17.0 IBM Co.) for multiple comparisons to determine the values 
that were significantly different. The p < 0.05 were considered statistically significant. 
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CHAPTER 5 Fabrication and Physico-Chemical Characterization of the Polymeric 
Porous 3-D Scaffolds with an Improved Thickness 
  
5.1 Introduction 
 
 Polyhydroxyalkanoates (PHA) are aliphatic polyesters that are synthesized by 
microorganisms under unbalanced growth conditions [169, 170]. They are generally 
biocompatible, biodegradable (via microbial degradation and enzymatic hydrolysis) and 
thermoprocessable, making them attractive as biomaterials for applications in medical devices 
and tissue engineering and regenerative medicine (TERM). Over the past years, PHA, 
particularly poly-3-hydroxybutyrate (PHB), copolymers of 3-hydroxybutyrate and                    
3-hydroxyvalerate (PHBV), poly-4-hydroxybutyrate (P4HB), copolymers of 3-hydroxybutyrate 
and 3-hydroxyhexanoate (PHBHHx) and poly-3-hydroxyoctanoate (PHO) were demonstrated to 
be suitable for tissue engineering and are reviewed thoroughly in many literature-cited 
publications [2, 21, 66, 147, 171-173]. The most common type is PHB, which comes from the 
polymerization of 3-hydroxybutyrate monomer. The physico-chemical features of PHB in 
addition to the mechanical properties are similar to those of polypropylene (PP) and polylactic-
co-glycolic acids (PLGA), except for reduced properties of stiffness [21, 170]. Besides PHB, its 
copolymers with diverse ratios of hydroxyvalerate (HV) which are known as PHBV is also 
extensively used. These copolymers are less crystalline, more flexible and more readily 
processable than PHB itself [174-179]. 
Apart from that, scaffold design and fabrication are one of the major areas of biomaterial 
research, and they are also important subjects for tissue engineering and regenerative medicine 
research. Briefly, the principal function of a scaffold is to manoeuvre cell behaviour such as 
migration, proliferation, differentiation, maintenance of phenotype and apoptosis by facilitating, 
sensing and responding to the environment via cell-matrix and cell-cell communications     
[180, 181]. Furthermore, the scaffold provides the necessary support for cells to proliferate and 
maintains their differentiated functions and its architecture defines the ultimate shape of a new 
organ [182]. Therefore, many methods have been developed to prepare porous 3-D scaffolds in 
tissue engineering including gas foaming, fibre extrusion and bonding, 3-D printing, phase 
separation, emulsion freeze-drying and porogen leaching [17, 83, 145, 183-188]. One of the 
prominent methods of making a porous 3-D scaffold is the solvent-casting particulate-leaching 
(SCPL). This method was first developed in the early 1990s by Mikos et al. [83] among other 
things for polylactic acid (PLA) and polyglycolic acid (PGA) polymers and several authors have 
used the method to manufacture composite scaffolds [167, 183]. Besides that, according to 
Chen et al. [90] and Mooney et al. [189] the extensive use of solvents (some of which are 
hazardous and essentially toxic) also presents an intricacy, as any residuals of the solvent would 
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hinder the cell attachment and proliferation onto the scaffold. On the contrary, Cao et al. and his 
colleagues [187] have shown that the low toxicity of solvents is detected from the use of SCPL 
can be brought down to acceptable levels for tissue engineering application. On the other hand, 
many studies have been reported using PHB and PHBV as biomaterials fabricated by both 
solvent casting and SCPL technique for in vitro and in vivo studies with various cell lines      
(i.e., osteoblasts, fibroblasts, epithelial cells and ovine chondrocytes (obtained from cartilage))       
[21, 146, 148, 149, 174, 190]. For instance, Rivard et al. [69] demonstrated that PHBV matrices 
(9% (w/w) 3-hydroxyvalerate) sustained a fibroblast cell proliferation rate similar to that 
observed in collagen sponges for up to 35 days. Köse et al. [150, 151] used the macroporous 
PHBV matrices for bone tissue engineering and the results showed that the growth of 
osteoblasts on matrices was observed after 29 and 60 days of incubation. For cartilage tissue 
engineering, Deng et al. [145] investigated the proliferation of rabbit articular cartilage-derived 
chondrocytes on the PHBHHx and PHB 3-D scaffolds fabricated from SCPL. The result 
showed that the chondrocytes proliferated on the 3-D scaffolds and preserved their phenotype 
for up to 28 days. However, as far as we know, among many other studies conducted using the 
PHB and PHBV as biomaterials, only two studies (Misra et al. [191] and Huang et al. [192])  
have successfully used porous 3-D scaffolds with a substantial level of thickness greater than    
1 mm with most of the rest in thin films formation of less than 1 mm. However, none of those 
studies used any hematopoietic cell origin (i.e., myeloblast and lymphoblast) for cell-
biomaterials interaction study.  
 
5.2 Aim and Hypothesis 
 
 This investigation was based on the hypothesis that the usage of solvent-casting particulate-
leaching (SCPL) process for PHB and PHBV will create a porous 3-D scaffold with an 
improved thickness greater than 1 mm (in relative to the conventionally made PHA matrices). 
These scaffolds will have interconnected pores to allow cell penetration and spread and would 
be able to mimic the 3-D microenvironment of bone marrow niches. Moreover, the 3-D growth 
configuration for AML (HL-60) expansion will replicate the in vivo bone marrow 
microenvironment more faithfully than 2-D culture, resulting in an enhanced in vitro culture 
without the need to add exogenous cytokines. 
 
5.3 Approach of Study 
 
In this study, an optimal polymer concentration, the 3-D scaffold thickness, the efficacy of 
the salt-leaching process and effect of sodium chloride remnants on cell growth media 
electrolytes balance were described thoroughly. Briefly, this work showed major improvement 
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in fabricating porous 3-D scaffolds using SCPL with a satisfactory thickness greater than 1 mm. 
Apart from that, the sodium chloride residual inside polymeric porous 3-D scaffolds showed 
irrelevant conductivity (κ) changes on cell growth media electrolytes content. These preliminary 
results have signified the suitability of that material for in vitro cellular proliferation. Then, 
physico-chemical characterizations (i.e., porosity, pore size distribution, BET surface area and 
hydrophobicity/hydrophilicity), short-term in vitro degradation in hydrolytic media (PBS) and 
mechanical testing (compressive test) were carried out. Finally, a cell-biomaterial affinity study 
was carried out by using a human acute myeloid leukaemia cell line (HL-60) (Table 5.1). Both 
polymeric porous 3-D scaffolds were cultured in vitro for 1, 7 and 14 days to observe cellular 
attachment and proliferation. 
 
Table 5.1: Acute myeloid leukaemia (AML) cell line properties. The table summarizes the main 
properties of the HL-60 cell line. 
 
Cell properties Cell line 
HL-60 
Cell phenotype Myelocytic cell 
Original disease of patient AML, M2 
Patient data 36-year-old Caucasian woman 
Source of material Peripheral blood 
Year of establishment 1976 
Culture Medium 90% IMDM + 10% FBS + 1% PS 
Sub-cultivation routine Maintain at 0.1 to 1 x 106 cells/ml. 
Renew media every 2 to 3 days 
Doubling time 36 to 48 hrs 
In situ morphology (cell size) 8 µm  
 
5.4 Results 
 
5.4.1 Polymer Concentrations with Respect to Homogenization Time  
 
The polymer concentrations in chloroform were selected based on the previous studies [145, 
147-153] in the range of 1% to 5% (w/v). The complete homogenization time was measured at 
those selected concentrations range for PHB and PHBV in powder and cylindrical pellet forms. 
The polymer solutions of PHB and PHBV were considered as homogeneous solutions in which 
it became a translucent and white milky solution with no apparent particles or glutinous 
substances in the solution. Based on the results (Figure 5.1), both polymers were able to 
dissolve 4-times higher than its initial mass of 0.6 g (1% w/v) in 8.2 ± 2.28 min (PHB) and 17.8 
± 1.48 min (PHBV). Then, as the mass increases from 2.4 g (4%, w/v) to 3.0 g (5%, w/v), the 
solution became inhomogeneous. However, after 41 ± 4.18 min (PHB) and 56 ± 8.22 min 
(PHBV) of continuous heating, the colour and the appearance of the solution was observed to 
change noticeably by turning from white milky solution into dark brown to indicate the 
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deterioration of a solution due to the thermal decomposition. On the other hand, the solubility 
rate of PHB was observed to be higher than that of PHBV (Figure 5.1; p < 0.05) as expected due 
to the 2.3-fold lower molecular weight (Mw) of PHB (300,000 g mol−1) compared with that of 
PHBV (680,000 g mol−1). The results were consistent with Sperling and Nicholson [193, 194] 
where the lower molecular weight (Mw) of polymer, the faster it dissolves into the bulk solution 
although the crystallinity (%) of PHBV was by far lowered than PHB (Table 5.2). Hence, the 
polymer molecular weight (Mw) was considered the prominent factors that put in order of which 
polymer solubilized first. Meanwhile, based on the visual observation, polymer concentrations 
of 1% to 4% (w/v) and 5% (w/v) for both polymers were considered as homogeneous and 
inhomogeneous solutions respectively. In fact, the visible accumulation of glutinous semi-solid 
substances was observed in both polymer solutions of 5% (w/v). Thus, it was suggested that the 
optimal polymer concentration (saturation point) for PHB and PHBV should be between of 4% 
to 5% (w/v). Furthermore, a statistical approach of using design of experiments (DOE) was 
suggested to determine the exact optimal concentration for both polymers.          
 
Figure 5.1: Kinetics of the PHB and PHBV homogenization process in chloroform with respect 
to different concentrations, % (w/v). (A): Inhomogeneous polymer solutions occurred with the 
appearances of glutinous polymer materials at the bottom of the SCHOTT Duran bottle. 
Results shown were means (±sd) of 10 experiments/concentration (n = 10). *Significant 
difference with p < 0.05 for the value changed as compared to the previous value. (Ψ) p < 0.05 
for solubility rate of PHB vs. PHBV. 
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Table 5.2: Melting temperature, heat of fusion at melting point and crystallinity of PHB and 
PHBV. 
 
Polymer[a][b][d] Melting 
temperature 
Heat of fusion  
at melting (∆Hm) 
Crystalinity (%)[c]  
PHB 179.9 oC 104,974 J/kg 71.9 
PHBV (12% PHV) 152.1 oC 72,708 J/kg 49.8 
[a] Thermal analysis data was provided by the Sigma-Aldrich. [b] Thermal analyses of PHB 
and PHBV was measured using a model DSC-7 differential scanning calorimeter (Perkin Elmer,  
USA) under a nitrogen atmosphere, at a heating rate of 10 oC/min. [c] Crystallinity was 
determined using the following heat of fusion values for 100% crystalline materials: ∆H0, PHB = 
146,000 J/kg. The ∆H0 for PHBV was assumed to be the same as that for PHB [195]. [d] The 
degree of crystallinity, H*(%); of the polymer could thus be estimated by using the following 
equation: H*(%) = ∆Hm/∆H0 × 100%. 
 
5.4.2 Polymer Concentrations with Respect to Polymeric Porous 3-D Scaffolds Thickness 
 
 The thickness of porous 3-D scaffolds was considered as one of the important physical 
characteristics to produce a 3-D bone marrow biomimicry in vitro, which supports cellular 
proliferation. As far as we know, no studies have demonstrated the formation of PHB and 
PHBV porous 3-D scaffolds with a thickness greater than 1 mm. Most of the studies [70, 147, 
152, 153, 177] have shown that PHB and PHBV can only be fabricated as thin films with a 
thickness of less than 1 mm irrespective of which methods were implemented. Based on the 
above mentioned results, the polymer concentrations of 1% to 4% (w/v) were selected for 
fabricating the porous 3-D scaffolds. During the fabrication process of SCPL, both polymers 
with concentrations of 1% and 2% (w/v) produced thin films with a thickness of 514 ± 4 µm. In 
fact, both polymers were exemplified brittle thin films with no apparent porous structure. As for 
both polymers with concentration of 3% and 4% (w/v), a significant increase of thickness was 
observed (p < 0.01) (3% (w/v): 1.80 ± 0.79 mm (PHB), 1.60 ± 0.79 mm (PHBV) and 4% (w/v): 
5.25 ± 0.36 mm (PHB), 4.40 ± 0.52 mm (PHBV)). Even though both polymers with a 
concentration of 3% (w/v) produced a substantial level of thickness, it also developed a brittle 
thin film on top of the porous 3-D scaffolds due to the rapid phase separation (etching effect). 
However, for both polymers with a concentration of 4% (w/v), there were no apparent 
irregularities of the thickness, no etching surfaces observed and the formation of porous 3-D 
scaffolds appeared to be ideal with a thickness greater than 1 mm (Appendix B). Based on the 
above mentioned findings, it can be concluded that a polymer concentration of 4% (w/v) was an 
ideal concentration in fabricating a good representative of porous 3-D scaffolds with an 
improved thickness greater than 1 mm (in relative to the conventionally made PHA matrices). 
These polymeric porous 3-D scaffolds of 4% (w/v) were further utilized to determine the 
efficacy of salt leaching process and the effect of sodium chloride residual over cell growth 
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media electrolytes balance via conductivity measurement. Morphology of the scaffolds prepared 
using SCPL on different polymeric concentrations are shown in Figure 5.2. 
 
  
 
  
 
Figure 5.2: Morphology of the polymeric porous 3-D scaffolds prepared using SCPL technique: 
(a) Aerial view of the PHB 5% (w/v) 3-D scaffold with scattered etching brittle thin films; (b) 
Aerial view of the PHBV 5% (w/v) porous 3-D scaffold with several ruptured spots due to the 
salt-leaching process; (c) Solid brittle thin film with apparent heterogeneous surfaces; (d) Aerial 
view of the PHB and PHBV 3% (w/v) which produced a solid etching brittle thin films on top 
of the porous 3-D scaffolds.    
 
5.4.3 Efficacy of SCPL Measured Via Conductivity and Gravimetric Analysis 
 
One of the disadvantages using SCPL is the existence of porogen residual. Until now, none 
of the previous studies who used SCPL in fabricating porous 3-D scaffolds have explained the 
salt-leaching efficacy and the amount of porogen remnants left inside the fabricated porous 3-D 
scaffolds. Only a few studies have shown some concern about the porogen residual [83, 174, 
176] but none of them have ever conducted any independent experimental work to validate such 
claims. It was observed that the salt-leaching efficacy of PHB porous 3-D scaffolds (92.95 ± 
2.39%) was significantly higher than PHBV (82.20 ± 4.87%) (p < 0.05). This indicates that salt-
leaching process in PHB porous 3-D scaffolds was more efficient than in PHBV. Moreover, it is 
expected that water will leach NaCl more efficient than PHBV because PHB is more 
hydrophilic than PHBV (Table 5.4) as it allows water to penetrate deep inside the porous 
PHB 3% (w/v) PHBV 3% (w/v) 
PHB 5% (w/v) PHBV 5% (w/v) 
PHB 1% (w/v) 
(a) (b) 
(c) (d) 
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structure. On the other hand, both polymers produced high efficacy of salt removal after the 
lyophilization process measured via gravimetric analysis (PHB: 99.66 ± 0.15%; PHBV: 99.96 ± 
0.02%). The results showed that there was no significant loss of polymer weight throughout the 
whole process. In fact, a visible observation was carried out to proof the above mentioned report 
wherein there was no apparent detachable material the scaffolds floating on the water during the 
salt-leaching process. However, there was approximately less than 0.2 g of NaCl extra weight 
(based on the gravimetric analysis) in the dried cylindrical shapes of porous 3-D scaffolds, 
which indicate that the salt remnants were still trapped inside the porous structure. Overall, the 
gravimetric analysis is considered the best method to determine salt leaching efficacy than the 
conductivity measurement. The insensitivity testing probe, inaccuracy of the automatic 
temperature compensation system, fluctuations of ambient temperature, inaccurate 
concentration of prepared standard salt solutions and unstirred salt solution during the 
conductivity measurement could be some of the reasons of a big difference between the 
gravimetric results. 
 
5.4.4 Effect of Sodium Chloride Residual in Polymeric Porous 3-D Scaffolds on Cell 
Growth Media 
 
Relating to the above mentioned findings, both polymeric porous 3-D scaffolds were 
subjected to 7 days incubations at 37 oC and 5% CO2 in cell growth media to observe 
conductivity (κ) changes due to the salt remnants inside the scaffolds (Figure 5.3). No media 
changes were conducted until day 7. The cell growth media were prepared according to the 
recommendation of the cell provider and the initial pH was adjusted to 7.2. Thus, the 
conductivity (κ) of cell growth media without a scaffold (control) was measured with a value of 
20.77 mS/cm at 20 ± 1 oC. It was observed that as the time of incubation progresses up to 7 
days, there were insignificant differences of conductivity (κ) between both polymers in 
comparison with the control (p > 0.05). This indicates that the amount of NaCI left inside the 
porous 3-D scaffolds was irrelevant in affecting the electrolytes balance of cell growth media. In 
fact, the amount of sodium chloride left inside the porous 3-D scaffolds might be considered as 
too small to produce any adverse effect to cell growth due to the imbalance of electrolytes from 
the hypertonic media solution (i.e., excessive inorganic salts). 
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Figure 5.3: Conductivity (κ) of cell growth media as a function of time at 20 ± 1 oC. The 
polymeric porous 3-D scaffolds were submerged in cell growth media (90% IMDM + 10% FBS 
+ 1% PS) and incubated at 37 oC, and 5% CO2 for 7 days. NS indicates no significant difference 
as compared with the control (n = 3).  
 
5.4.5 Structural Analysis: Mercury Intrusion Porosimetry (MIP) 
 
For tissue engineering applications, the most essential parameter of the pore network is 
diameter of the interconnecting pore apertures. However, the optimal value of the pore size and 
interconnection size are still open to debate [196]. Generally, the acceptance interconnection 
size to enable blood vessel ingrowth, cell invasion and enhanced biological response is between 
50 to 100 µm [197]. Values of ideal pore diameters have been reported between 100 to 500 µm 
[73, 198]. Figure 5.4 shows interconnected pore distributions obtained from mercury intrusion 
porosimetry (MIP). The vertical axis is a derivative of the volume of mercury intruded into the 
3-D porous scaffold relative to the interconnect pore diameter [199]. Moreover, majority of the 
interconnected pore window diameter (Dmode) for both of the scaffolds were observed to be more 
than 100 µm (PHB = 100 µm to 200 µm; PHBV = 211 ± 5.7 µm). The pore size distributions 
for both polymers were observed to be in the range of ∼1 µm to 350 µm. According to Safinia et 
al. [157] although this method could give incorrect pore size distributions (PSDs) due to the 
severe compression, MIP could still provide a reasonable pore size distribution. Alternatively, a 
maximum bubble point test could be the best non-destructive method to examine the pore size 
distribution accurately as it measures based on the number of bubble streams, which relates to 
the number of pores going through the entire scaffold. From this pressure, the values for the 
corresponding pore diameters could be eventually calculated. 
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Figure 5.4: Interconnected pore distributions of PHBV and PHB (4%, w/v) porous 3-D 
scaffolds determined by using mercury intrusion porosimetry (MIP). (Ψ) p < 0.05 for the volume 
of mercury intruded increase/decrease as compared to the previous value (n = 3).  
 
5.4.6 Material Characterization: Physical Characterization of the Polymeric Porous 3-D 
Scaffolds 
 
The physical properties of the porous 3-D scaffolds (i.e., geometrical bulk density, skeletal 
density and porosity) were summarized in Table 5.3. The geometrical bulk density, skeletal 
density and porosity of the PHBV were observed to be significantly higher than PHB (p < 0.05). 
In fact, both polymers have a total porosity in the range of 80% to 90%. However, the high 
porosity of PHBV might be due to the low crystallinity, high molecular weight [73] and more 
flexibility than PHB as both polymers used the same salt weight fraction (%, w/w) to develop a 
highly porous structure. As for the BET surface area, PHBV was exhibited to be significantly 
higher than PHB (p < 0.05), which is a clear indication that pore sizes decrease due to the high 
porosity of the scaffold (high surface area-to-volume ratio). Therefore, parameters such as 
average apparent density (skeletal density), porosity and BET surface area do not provide any 
relevant information about the structural properties of the polymer scaffolds. Although the 
physical properties were irrelevant in describing structural behaviour, the properties (i.e., 
porosity and skeletal density) would possibly provide a glimpse on the cellular response. As to 
guarantee the entrance of large numbers of cells and allow the formation of cellular 
associations, a scaffold should possess high porosity with a complex network of channels and 
interconnected pores of appropriate size and shape [200]. Hence, PHBV is expected to allow 
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better cellular attachment and growth inside the porous structure than PHB which is in fact in 
good agreement with the cellular proliferation result on day 14. 
 
Table 5.3: Physical properties of PHB and PHBV (4%, w/v) porous 3-D scaffolds. The table 
summarizes the principal physical properties of two polymeric porous 3-D scaffolds prior to the 
in vitro cell proliferation studies. 
 
Structural properties Polymeric porous 3-D scaffolds 
PHB (4%, w/v) PHBV (4%, w/v) 
Scaffold thickness (mm) 5.25 ± 0.36 4.40 ± 0.52** 
Pore size distributions (µm) Pore sizes in the range: ∼1 to 350 
Modal D (µm) 100 to 200 211 ± 5.7 
Physical properties 
  
BET surface area, As (m2/g)[a] 0.70 ± 0.02 0.82 ± 0.03* 
Geometrical bulk density (g/cm3) 0.084 ± 0.15 0.072 ± 0.28* 
Skeletal density (g/cm3)[b][c] 0.47 ± 0.52 0.92 ± 0.14* 
Porosity (%) 82.12 ± 0.18 92.17 ± 0.73* 
**(p < 0.01) - Results were considered statistically significant (n = 10) as compared with PHB.    
*(p < 0.05) - Results were considered statistically significant (n = 4) as compared with PHB.    
D = interconnected pore window diameter (Dmode: one of a range of values that has the highest 
frequency). [a] BET surface area (m2/g) = total skeletal surface area (m2)/skeletal mass (g). [b] 
ρs is the skeletal density of the crushed scaffolds, which was determined from helium 
pycnometry. [c] The higher pore volume (the higher the amount of absorbate intruded), the 
lower the skeletal volume.  
 
5.4.7 Morphology of Porous Structure Using Scanning Electron Microscopy (SEM) 
 
The morphology of internal PHB and PHBV (4%, w/v) porous 3-D scaffolds were observed 
using SEM. A rectangular cube of porous 3-D scaffold was sectioned vertically to permit 
examination of their micro- and macro-pore structure. It was observed that both fabricated 
polymeric porous 3-D scaffolds were displayed with quite irregular pore morphology with an 
angular shape, as shown by the scanning electron micrographs of longitudinal cross-sections 
(Figure 5.5e and f). In addition, both polymers produced large amounts of closed pores than 
open pores with low availability of interconnected pores. In theory, the closely packed adjacent 
porogens after the porogen-leaching process will leave a hole between two closely-tight face-to-
face contact porogens [201]. However, the two closely tight porogens might have been in the 
position of either side contact or point contact configuration which resulted in either no pores 
interconnectivity or small puncture inside the pores respectively (Figure 5.6) [202]. Therefore, 
based on the above mentioned reports, it was confirmed that both polymeric porous 3-D 
scaffolds demonstrate pore sizes in the range of ∼1 µm to 350 µm and availability of dispersed 
distribution of both open and closed pores with lower pore interconnectivity.   
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Figure 5.5: Morphology and SEM of polymeric porous 3-D scaffolds in cuboids with an 
approximate size of 10 mm × 10 mm × 5 mm: (a) Aerial view of  PHB (4%, w/v), (b) Side view 
of PHB (4%, w/v), (c) Aerial view of PHBV (4%, w/v), (d) Side view of PHBV (4%, w/v), (e 
and f) vertical cross-sections of PHB (4%, w/v), magnifications 35x (e) and 100x of the boxed 
area (f), (g and h) vertical cross-sections of PHBV (4%, w/v), magnifications 35x (g) and 100x 
of the boxed area (h). 
 
 
 
Figure 5.6: Influence of particle shape on the neck characteristics. 
 
5.4.8 Physico-Chemical Analysis: Water Contact Angle and Surface Free Energy 
 
Measuring the water contact angle (θH2O) is a standard method used to study the 
hydrophilicity of a biomaterial surface and can help to evaluate the possible effect of a 
biomaterial on cell adhesion and growth [203]. Evidently, both polymeric porous 3-D scaffolds 
exhibited a true water contact angle (θporous) in the range of about 94° to 117°, whilst all of the 
thin film counterparts fabricated by using the solvent casting showed values in the range of 
about 66° to 79° (Table 5.4) (Figure 5.7). The huge differences could be attributed to the 
heterogeneous wetting condition of the Cassie-Baxter regime where corrections of the contact 
angle need to be applied [204]. On top of that, both polymeric porous 3-D scaffolds and the 
corresponding thin films were considered as hydrophobic materials as they possess high degree 
of water contact angle of more than 65o [205]. Hence, the highly observed surface 
hydrophobicity of the polymeric porous 3-D scaffolds in comparison with that of solvent-cast 
thin films (in accordance with the Cassie-Baxter regime) was perhaps due to the 1) surface 
heterogeneity (e.g., availability of surface roughness which could lead to hysteresis, different 
phases or different materials conforming the whole topography); 2) air trapped inside the pore 
grooves (enhanced the surface hydrophobicity because the drop is then partially sitting on air) 
and 3) contaminants of salt on the pore surfaces (which could lead to a decrease of solid/vapour 
surface tension) [206]. Finally, to determine the amount of wetting that occurred on both 
polymeric solvent-cast thin films; surface free energy (γSL), work of adhesion (WSL) and 
spreading coefficient at solid-liquid interfaces were calculated (Appendix F). The results 
showed that both polymers produced (+) and (-) signs of the work of adhesion and spreading 
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coefficient respectively (the signs were described in Table 5.4). The wettibility of both scaffolds 
is shown in Appendix C. Thus, with all of the analyses taken, it is proved that both polymers 
were considered as hydrophobic materials.  
 
Table 5.4: Wetting and wettability of water on PHB and PHBV solvent-cast thin films surfaces. 
 
 
Surface physico-chemistry  
Solvent-cast thin film[a][b] 
PHB 
(4%, w/v) 
PHBV 
(4%, w/v) 
Contact angle, θapparent (deg.) 66.80 ± 0.2 79.24 ± 0.4* 
Surface free energy, mN/m (γs) 54.13 ± 0.3 46.93 ± 0.2* 
Work of adhesive, mN/m (WSL)[c] +109.42 ± 0.2 +97.41 ± 0.3* 
Spreading coefficient (SH20/thin film)[d] -36.38 ± 0.3 -48.39 ± 0.2* 
[a] Equilibrium contact angle on solvent-cast thin films on polypropylene sheet (n = 10). [b] 
Contact angle of polypropylene (PP) sheet without PHB and PHBV coating = 92.43 ± 0.3 o. [c] 
(+) or (-) work of adhesive: A non-spontaneous or spontaneous process respectively. [d] (+) or 
(-) spreading coefficient: Water will spread or not spread over the surface respectively.             
*p < 0.05 as compared with PHB. 
 
  
 
Figure 5.7: Morphology of solvent-cast thin polymeric films: (a) Aerial view of PHB (4%, w/v) 
and (b) Aerial view of PHBV (4%, w/v). 
 
5.4.9 In Vitro Degradation of the Polymeric Porous 3-D Scaffolds 
 
 Natural polymers degrade rapidly in the biological medium when appropriate hydrolytic 
enzymes are available and used [9, 207]. Whilst for the synthetic polymers since they are 
produced via chemical synthesis, they are quite resistant and disappear slowly from the 
environment [151]. Irrespective of polymer categories,  the rate and mode of degradation of the 
polymers influence their service life, mechanical properties and the response of the biological 
system towards them [207]. The 80 days of in vitro degradation study was selected  based on 
the reference of Yoshiharu et al. [208] where no mass loss was recorded on PHB films in a 
buffer solution at 37 oC until 180 days. A decrease in molecular weight was observed after an 
induction period of about 80 days. Therefore, based on that finding, a benchmark was set so that 
PHB PHBV 
(a) (b) 
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we can observe the polymers degradability in the form of porous scaffold for a period of 80 
days (short-term observation). The results would perhaps to give an initial indicator for studying 
its stability on a long-term in vitro cell proliferation (up to 6 weeks). Through visible 
observation, both PHB and PHBV porous 3-D scaffolds still preserved their structural integrity 
and morphology until the end of the incubation period although accumulation of medium 
particulates was observed from day 7 to day 48 and day 7 to day 37 respectively (Figure 5.8). 
The accumulation of medium particulates for both polymers was consistent with the mass 
analysis results. It was observed that mass of PHB porous 3-D scaffolds was gradually 
decreased (p < 0.01) from day 7 to day 48 by 13 ± 4.6% of their initial weight (Figure 5.8). 
Meanwhile, the mass of PHBV porous 3-D scaffolds decreased rapidly at day 7 (p < 0.01) and 
gradually reduced from day 7 to day 37 by 14 ± 3.7% of its initial weight. However, PHB and 
PHBV foams started to alleviate from day 48 and 37 respectively until day 81. Moreover, the 
extent of weight loss from the gravimetric analysis was seemed to be very significant due to the 
surface erosion where unlike the pH analysis on the same period, there was no prominent pH 
dropped to indicate any accumulation of acidic degradation products due to the autocatalytic 
hydrolysis effect. Apart from the mass analysis, it was observed that the rate of PHBV in vitro 
degradation process was noticeably much faster than PHB until day 48 (p < 0.01). However, 
both polymers then remained approximately at the same rate until day 81 (p > 0.05). Table 5.2 
summarizes the melting temperatures, the heat of fusion at melting point and the crystallinity of 
the polymers. PHBV showed the lowest crystallinity values and PHB, the highest as provided 
by the Sigma-AldrichTM. The in vitro degradation test showed that PHBV degrades more rapidly 
than PHB at the earlier phase (day 1 to day 25). The phenomenon could possibly due to the 
degree of open porosity which could easily uptake more water through the capillary action. 
However, the data on this was inconclusive. It is recommended to study its permeability to 
determine the ability of the porous scaffolds to absorb water. On top of that, the degree of 
crystallinity would have a significant effect on the water uptake of the porous scaffold. In 
theory, the lower the degree of the crystallinity, the higher the degradation rate of degradable 
polymers be likely to occur due to the higher amount of amorphous region which makes the 
solvent molecules (e.g., water) to easily absorb inside the polymer matrix (the absorption of 
solvent inside the highly crystallized polymer is hindered due to its nature plate-like structure) 
[209]. This phenomenon will eventually make the ester-linkages to weaken the molecular 
structure as a result of the hydrolyzed acidic degradation products accumulation (i.e., carboxylic 
acid groups). However, there was no correlation between the extent of degradation and the 
crystallinity of the polymers since PHBV, which had lower crystallinity than the PHB, also 
showed almost no severe degradation during the period of 25 to 81 days on both pH and weight 
examination. 
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Figure 5.8: Kinetics of in vitro degradation process for PHB and PHBV (4%, w/v) porous 3-D 
scaffolds were measured via mass analysis. The polymeric porous 3-D scaffolds were 
submerged in phosphate buffered saline (PBS) and incubated at 37 oC. Samples were 
periodically removed and dried under vacuum pressure prior to the analysis. (*) p < 0.05 for 
percent decreased as compared to the previous value (n = 6). ΨSignificant difference with           
p < 0.01 between each polymers are highlighted by the line (n = 6). 
 
5.4.10 Mechanical Properties of Polymeric Porous 3-D Scaffolds 
 
 The in vivo cancellous bone (containing soft marrow tissue) has porosity ranges 30% to 90% 
[210]. As we were mimicking the skeletal structure and microenvironment of the cancellous 
bone, the usage of compression testing on this porous 3-D scaffold is advantageous. Although 
the objective of this study is to produce a 3-D biomimicry in vitro model, this 3-D biomimicry 
scaffold has the potential to be used to treat leukaemia patient by replacing the abnormal 
cancellous bone with stem cells-loaded scaffolds via in vivo implantation.  
 Figure 5.9 shows the stress-strain behaviour of PHB and PHBV scaffolds under compressive 
loading. Table 5.5 shows the mechanical properties of the polymeric scaffolds. The results 
indicate that both polymeric scaffolds were not significantly different to their compression 
modulus (E) and ultimate compressive strength (p > 0.05). The insignificant differences in the 
compression modulus can be attributed to the fact that both PHB and PHBV scaffold possesses 
a fair distribution of the anisotropic pore size even though both of them contained different 
porosity. On top of that, under the compressive force, PHBV and PHB scaffolds underwent 
three main stages of deformation, which are commonly observed for porous structures (the so-
called ‘cellular structures’ in solid mechanics) [211]. Under compression, the scaffolds 
exhibited a non-linear elasticity at low stresses known as a toe region (high deformation/low 
force characteristic) and then followed by the stiffness regime (the linear elasticity is controlled 
0
10
20
30
40
50
60
70
80
90
100
110
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85
%
 
R
es
id
u
al
 
w
ei
gh
t o
f p
o
ro
u
s 
3-
D
 
sc
af
fo
ld
s
Time (days)
PHB (4%, w/v) porous 3-D scaffold
PHBV (4%, w/v) porous 3-D scaffold
Ψ 
* 
* * 
* * 
* 
82 
 
by cell wall bending). The stress rose steeply as it entered the densification regime where further 
compaction led to the collapse of the cells (of the ‘cellular structure’) [212]. When the cells 
have almost completely collapsed, opposing cell walls touch, with further strain compressing 
the solid itself, giving the ultimate compression stress with the ruptured of the structure. Apart 
from that, it is evident from Figure 5.9 that both, PHB and PHBV scaffolds did not undergo 
elastic deformation during compression (no unloading curves were observed) due to the fact that 
both polymeric scaffolds were crushed, compacted and ultimately shattered into several 
fragments until a compression of about 87% to 90% of the initial test piece thickness is attained. 
However, if both polymeric scaffolds were compared with other porous materials (e.g., porous 
biodegradable composites, porous bioactive ceramics and porous biodegradable polymers with 
75% porosity and mostly interconnected) and cancellous bone (elastic modulus: 0.1 to 0.5 GPa 
and compressive strength: 4 to 12 MPa) [13, 213], both polymers have a very low mechanical 
strength and perhaps unsuitable to be used for in vivo implantation application, unlike for the in 
vitro 3-D biomimicry culture that sustained structural integrity of the scaffold for up to 6 weeks 
in cell growth media. This phenomenon may well be explained by the fact that both polymers 
have high in porosity (> 80%) which resulted in fewer thick pore walls and apparently make 
them easier to bend and compress to a certain level [13].  
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Table 5.5: Mechanical properties of PHB and PHBV (4%, w/v) porous 3-D scaffolds. 
 
 
Polymers  
Mechanical Properties 
Compressive 
modulus (GPa)[a] 
Ultimate compressive 
strength (MPa)[b] 
PHB (4%, w/v) 0.00027 ± 0.15 1.97 ± 0.12 
PHBV (4%, w/v) 0.00019 ± 0.32 1.83 ± 0.09 
[a] Mean (±sd) slopes of the stiffness area (C) as shown in Figure 5.9. [b] Samples were 
crushed, compacted and eventually ruptured into several fragments (n = 3).  
 
5.4.11 Cell Culture on Porous 3-D scaffolds: Acute Myeloid Leukaemia (AML) 
 
5.4.11.1 Seeding Efficiency of Acute Myeloid Leukaemia Cell Line (HL-60) on Polymeric 
Porous 3-D Scaffolds  
 
The ability to support the attachment and promote the proliferation of cultured cells is a 
prerequisite of a functional scaffold [82]. To evaluate a cellular behaviour on the PHB and 
PHBV porous 3-D scaffolds, a human cell line of acute myeloid leukaemia (HL-60) was seeded 
initially in the 24-sterile cell culture well plate for 24 h. The seeding efficiency shows the 
percentage of cells that remained in the scaffold after 24 h of seeding. It can be seen that the 
seeding efficiency for PHB and PHBV were not statistically different (p > 0.05) with 56.10 ± 
20.73% (207,657 ± 76,869 cells) and 36.73 ± 11.21% (136,182 ± 41,574 cells) respectively 
(Figure 5.10). The results were consistent with earlier study [6] as most of the FDA-approved 
polymers (e.g., PDLLA, PLGA, PS, PMMA, PCL and PU) seeded with AML cell line (HL-60) 
have a seeding efficiency in the range of 40% to 70%.    
 
Figure 5.10: Cell seeding efficiency of PHB and PHBV scaffolds seeded with HL-60 cell line. 
The cultures were performed in parallel on 2 separate occasions, each in quadruplicate. 
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5.4.11.2 Cell Proliferation Assay of Acute Myeloid Leukaemia Cell Line (HL-60) on 
Polymeric Porous 3-D Scaffolds 
 
After the cell seeding efficiency on PHB and PHBV porous 3-D scaffolds has been 
determined, both polymers were then subjected to a short-term cell proliferation until day 14. 
The MTS assay was used to compare the cellular proliferation on two types of polymeric porous 
3-D scaffolds via absorbance measurement (λ = 490 nm) as shown in Figure 5.11. Evidently, 
the cellular growth of HL-60 was significantly higher (p < 0.05) for both polymers from day 1 
to day 7. Then, the cellular growth of HL-60 was significantly higher for PHBV (p < 0.05) from 
day 7 to day 14 whilst PHB remains unchanged. The probable explanation for this phenomenon 
might be due to the highly porous nature of PHBV 3-D scaffolds which has provided extra 
surfaces onto which the cells can propagate deep inside the scaffolds (Figure 5.13a to d). In fact, 
it also provides more structural space for the accommodation and attachment of cells and 
enables the efficient exchange of nutrients and metabolic waste. Apart from the MTS analysis, 
viability of the cells extracted from the scaffolds was assessed at days 0, 7 and 14 (Figure 5.12). 
The cells cultivated in the PHBV 3-D porous scaffolds had the best viability compared with 
those supported by the PHB scaffolds (p < 0.05). Overall, the low seeding efficiency, low 
viability of the cells and slow cellular growth from day 1 up to day 14 on both polymeric porous 
3-D scaffolds were possibly due to the high surface hydrophobicity and availability of dispersed 
open pores with lower interconnectivity. The high surface hydrophobicity could lead to a low 
absorption of important adhesive ECM proteins (i.e., fibronectin and vitronectin) from the 
supplemented serum-containing culture media for modulating cell adhesion and proliferation. 
Whilst dispersed open pores with lower interconnectivity could produce insufficient mass 
transport across the porous 3-D scaffolds (i.e., nutrients and metabolites) or possibly cells 
clogged during the initial cell seeding due to the overcrowded cells inside the non-
interconnected pore which could trigger necrosis. 
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Figure 5.11: Cellular growth of AML cell line (HL-60) on PHB and PHBV. The MTS assay 
was used as a measure of proliferation of leukaemic cell line (HL-60) on both polymers. (*) 
PHBV displayed a significantly higher (p < 0.01) absorbance in comparison to PHB at day 14. 
Results shown were means (±sd) of quadruplicate wells (n = 4) obtained by subtraction from 
cell-free equivalents, to eliminate A490 produced by the scaffold + media (negative control) 
alone. 
 
 
 
Figure 5.12: Viability of the HL-60 cells seeded onto the PHB and PHBV porous 3-D scaffolds 
during a period of 14 days. *p < 0.05, compared between groups. For all panels, results were 
means (±sd), n = 2 replicates per experiment, N = 2 separate experiments.  
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Figure 5.13: SEM of cell-loaded PHBV and PHB scaffolds. Micrographs are shown of HL-60 
cells cultured on PHBV (a, c) and PHB (b, d) scaffolds at 1 (a, b) and 2 (c, d) weeks of culture. 
The cells (arrows) were observed deep within the pores of the inner section of the scaffolds 
(middle transverse sections at approximate scaffold depth of ∼2.5 mm). 
 
5.5 Discussion 
 
Both natural and synthetic scaffolds for tissue engineering provide a matrix onto which cells 
may adhere and aid in shaping and defining in vivo cell growth [146, 149]. In fact, the use of 
scaffolding materials for tissue engineering is an attempt to mimic a 3-D microenvironment of 
the extracellular matrix (soft or hard connective tissue) [187]. For that reason, to promote a 
tissue formation and other cellular proliferation mechanisms, an ideal scaffold should provide a 
highly biocompatible 3-D substrate to enable cell adhesion, migration, proliferation and 
differentiation function [181]. Most of the fabricated scaffolds made from PHB and PHBV 
using the SCPL method produced matrices, which was lesser than 1 mm in thickness. This 
could possibly due to several uncontrolled process parameters (i.e., polymer concentrations, 
polydispersity (Mw/Mn), rate of solvent evaporation, salt weight fraction, etc.) which have 
resulted in the formation of various scaffolds architecture (i.e., uneven surfaces, formation of 
etching brittle thin films, etc.). These problems were consistent as reported by Hutmacher [214] 
(d) (c) 
(b) (a) 
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and other studies [13, 158, 215] whereas this technique is very likely to produce a limitation to 
thin structures, residual particles in the polymer matrix and irregularly shaped pores. However, 
to the extent of our knowledge, no other researchers have investigated an ideal polymer 
concentration that could create a reasonable thickness of porous 3-D scaffolds specifically using 
SCPL technique. Up to now, there are two studies [191, 192] which have successfully fabricated 
the PHB and PHBV/apatite composite porous 3-D scaffold with a thickness greater than 1 mm 
prepared by using SCPL with a polymer concentration of 3% (w/v) and 10% (w/v) respectively. 
However, the study done by Huang et al. [192] was contrary to our findings that further 
incremental of polymer concentrations up to 5% (w/v) would eventually produce an 
inhomogeneous solution (Figure 5.1). In fact, the usage of 5% (w/v) onwards might have 
resulted in structural instability (i.e., the detachable part of the scaffolds), formation of etching 
surfaces and irregularities of shape and sizes. Moreover, it has been expected that a composite 
material would actually produce porous 3-D scaffolds with a thickness greater than 1 mm 
because any incorporating of reinforced materials (i.e., inorganic materials) might have 
increased the sturdiness and flexibility of the formed 3-D structure due to the reduced polymer 
crystallinity [216]. As for the study done by Misra et al. [191], they used sugar cubes as the 
porogen preform with thickness of 10 mm. The PHB solution in chloroform was impregnated 
into the sugar cubes until saturated, dried and leached using water. This ingenious foam 
replication method will eventually produce a    
Besides the structural instability issues with respect to polymer concentration, another 
problem that could occur during the fabrication process is the formation of brittle thin film 
(known as the ‘etching effect’) on surface of the scaffolds. The formation of etching thin films 
for polymers concentration of 3% and 5% (w/v) were consistent with the reference of 
Hutmacher [214] where skin layers are formed during rapid evaporation of solvent and 
eventually resulted in agglomeration of salt particles underneath the skin layers. This 
agglomeration of salt makes the pore size difficult to control and detachable sections of polymer 
cast during salt leaching process were seems to be unavoidable [214]. Apart from that, 
irregularities of scaffold thickness were due to the difficulty in removing salt particles deep 
inside the matrix of polymer-porogen cast (during the salt-leaching process) [83]. This problem 
was consistent as reported by Thomson [217] wherein the thicker the scaffold produced from 
SCPL (i.e., greater than 1 mm), the harder the salt needed to be removed deep inside it. As the 
scaffold accumulated such amounts of salt, it can easily produce detachable sections during the 
salt-leaching process due to the unbearable extra weight content, which could have resulted in 
irregularities of scaffold thickness. Equally important, the author has also raised some doubt as 
to whether the technique was applicable in the reconstructive applications where scaffolds with 
several centimetres (cm) thick may be required for mimicking the thickness of extracellular 
matrix (ECM) and other parts of tissue or bone. However, we have proof that with a thickness 
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greater than 1 mm, the structural integrity of both polymeric porous 3-D scaffolds remained 
intact with no apparent weight losses. In fact, we have also proof that with the thickness greater 
than 1 mm, there were irrelevant electrolytes changed in cell growth media, although there was 
a significant amount of salt remnants left inside both polymeric porous 3-D scaffolds.  
Furthermore, an in vitro degradation study was carried out to measure the stability of PHB 
and PHBV porous 3-D scaffolds in the hydrolytic media of phosphate buffer saline (PBS). The 
results showed a significant mass loss due to the surface erosion [218] (Figure 5.8). The above 
finding was consistent with the insignificant pH change’s result which indicate that there was no 
autocatalytic degradation (breakdown products produced in the initial phase accelerate the rate 
at which subsequent degradation proceeds) going on inside the porous 3-D scaffolds throughout 
the whole incubation period. In fact, the results were also in line with Zinn et al. [9] study 
wherein PHB was degraded by surface erosion at a slower rate than PHBV due to their high 
crystalline properties.  
On the other hand, both polymeric porous 3-D scaffolds were considered high in surface 
hydrophobicity as compared to the corresponding solvent-cast thin films (Table 5.4). Thus, the 
huge differences in water contact angle (θH2O) were possibly due to the rough surfaces in which 
can be attributed to a surface heterogeneity (from the distribution of pore size), [161] air that 
may be trapped on the rough surface (the droplet is partially sitting on air), high crystallinity 
(compressed aggregate of plate-like chain packing of the outermost groups of atoms at the 
air/solid interface) which could hinder wetting through H-bonding due to the hidden polar 
functional groups [219] and possibility of salt remnants on the pore surfaces, which influence 
the interfacial behaviour between vapour, liquid and solid. In fact, one of the above mentioned 
influences was well in agreement with Ito et al. [220] wherein water contact angles of 3-D 
PHBV (2%, w/w) nanofibre mat were greater than that of the corresponding solution-cast thin 
films (i.e., approximately 110o versus 81o respectively). The observed hydrophobicity of the 
fibre mats in comparison with that of the films was due to the surface roughness that introduced 
multiple contact points on the surface of the water droplet such that the interface between the 
water droplet and the fibre mat surface was not exactly solid/liquid [221]. However, it was 
suggested that in order to alter the hydrophobicity of the surfaces, one possible method is to 
modify the surface chemistry by using several well known treatments (i.e., acids-bases, 
enzymes, gas plasma and other chemical reagents). 
Finally, by analyzing the in vitro cell proliferation results, we found out that there were 
several physico-chemical characteristics that have significantly affected low density of cell 
attachment and proliferation. First, the availability of randomly open pores with fewer amounts 
of pore throats interconnectivity linking to individual pores in both polymeric scaffolds 
although there are many interconnected pores with diameters greater than 100 µm (Figure 5.4). 
This has led to a weak distribution of cells throughout the porous structure. This phenomenon 
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has resulted in less cell migrations, leading to greater cell death in the initial growth phase due 
to the increased overcrowding situation [222]. However, the cellular growth trend changed (an 
increase in absorbance) as time progresses due to the microenvironment changes inside the cell-
loaded porous scaffolds. This is well in agreement with our in vitro degradation result 
suggesting that within 2 weeks of incubation, the internal porous structure of the scaffold has 
changed dramatically. This implies that the microenvironment of the cells whose number 
increase in time within the structure carrier is expected to become less restrictive as time 
progresses because the foam gets gradually more hollow making more volume available for cell 
proliferation [151]. For that reason, we absolutely agreed that a good arrangement of physical 
properties may promote high cell attachment and proliferation by providing more spaces for 
better gas, nutrients exchange or more serum protein adsorptions and adequate chemical 
signaling for migration, differentiation and apoptosis [6, 163].  
Apart from the influence of pore interconnectivity, it seems that the surface chemistries of 
both polymers might also contribute to the low cell attachment and growth observed. Wang et 
al. [223, 224] have reported that the appropriate hydrophilic or hydrophobic area distribution 
was very important for cell attachment. The appropriate hydrophilicity/hydrophobicity of 
material has to do with the certain degree of surface free energy. This surface free energy might 
play a role in attracting particular proteins (i.e., collagen type I and fibronectin) to the surface of 
the scaffold and in turn improving the attraction (affinity) of the cells to the scaffolds. High 
surface free energy would also facilitate the serum-supplemented cell growth media to spread 
out further and enhance the adsorption of ECM proteins monolayer onto the polymeric surface 
which in turn, increased the cell adhesion, spreading and proliferation.  
Third, in nature, leukaemic stem cells growth in a soft marrow tissue (a 3-D gel-like micro-
environment) which consists of heterogeneous population of haematopoietic stem cells and non-
haematopoietic stem cells. The 3-D gel-like microenvironment biomimicry scaffolds (e.g., 3-D 
hydrogel) would be the best environment for culturing leukaemic cells rather than on the porous 
3-D scaffold as it can support high cell density and no need of any treatment to render its 
surface hydrophobicity. Vu et al. [225] have shown an increased in leukaemia cell viability and 
an improved 3-D cell proliferation (27-fold) by using a standard 3-D hydrogel compared to 2-D 
cultures (18-fold). Moreover, immobilization with RGD peptides promoted further cell growth 
(43-fold). The cells were packed in clusters form inside the alginate hydrogels and 
spontaneously differentiated into a more diverse myeloid population. However, the limited 
mechanical stability and fast bulk degradation of hydrogels in cell growth media have been a 
major drawback in cell culture work. For that reason, the best way to mimic the real 
microenvironment of bone marrow is to fill a porous 3-D scaffold structure with hydrogel which 
acts as a soft marrow tissue housed inside the 3-D skeletal structure. This infusion method could 
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possibly provide a great potential for studying extrinsic contributions inside the abnormal bone 
marrow by providing a robust and faithful 3-D platform.    
 
5.6 Conclusion 
 
 In conclusion, a polymer concentration of 4% (w/v) for PHB and PHBV was an ideal 
concentration to promote a good representative of porous 3-D scaffolds with an improved 
thickness greater than 1 mm (in relative to the conventionally made PHA matrices). In fact, both 
polymers have produced stable structural 3-D porous scaffolds with no etching brittle thin films 
on top of the scaffolds, detachable sections and irregularities in its shape and size. Moreover, the 
insignificant differences of conductivity (κ) for both polymeric porous 3-D scaffolds immersed 
in cell growth media in comparison with the control (cell growth media with no scaffolds) 
demonstrated that the availability of salt remnants inside the porous structure were irrelevant in 
affecting the electrolytes balance which could lead to cellular damage. Overall, an improved 
thickness of PHBV (4%, w/v) porous 3-D scaffolds had shown better performances of HL-60 
cellular attachment and proliferation than PHB. This result has demonstrated that either these 
artificial structures were fabricated as solvent-cast thin films or porous 3-D scaffolds, the low 
degree of cellular attachment and slow proliferation observed seem to be prominently affected 
by the highly hydrophobicity surfaces. Apart from that, the development of randomly open 
pores with lower interconnectivity for both polymeric scaffolds might also contribute to the 
observed problem. Therefore, it could be suggested that by modifying to a certain levels of 
surface modification (i.e., rf-O2 plasma or alkaline treatment) and fabrication techniques (i.e., 
spherical porogen with compression), both polymeric porous 3-D scaffolds would perhaps to 
allow better cellular attachment and growth due to the well adsorption and distribution of the 
ECM proteins and dispersive interconnected pores. However, further evaluations are still 
required to confirm such preliminary results. 
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CHAPTER 6 Surface Treatments of the Polymeric Porous 3-D Scaffolds with an 
Improved Thickness to Enhance Cell-Biomaterial Adhesions and Interactions 
 
6.1 Introduction 
 
 Polyhydroxyalkanoates (PHA) are a class of biodegradable polyesters, attracting research for 
the use in tissue engineering application due to its slowly degrading characteristics. These 
stereoregular polymers (having an ordered arrangement of pendant groups along the chain) are 
synthesized by numerous bacteria as an intracellular carbon and energy storage compound and 
accumulated in granules in the cell’s cytoplasm [226]. Most of the naturally occurring reserved 
polymer granules contain specifically poly(3-hydroxybutyrate) (PHB). Depending on the 
bacterial species and carbon substrates, copolymers with a variety of side-chains and 
corresponding properties can be produced by fermentation technologies [227]. Although a 
thermoplastic polyester with properties similar to polypropylene, PHB is considered to be too 
brittle for many applications. Copolymers and blends of -3HB with other monomers such as     
3-hydroxyvalerate, 3-hydroxyhexanoate, and 4-hydroxybutyrate, provide superior mechanical 
characteristics to PHB and permit modulation of the degradation dynamics [21, 170, 228-230]. 
In contrast to 3-hydroxyvalerate (as PHBV), the incorporation of 4-hydroxybutyrate as [P(3HB-
co-4HB)] has a much stronger influence on the polymer properties. Therefore, it has been 
considered as one of the most suitable PHA for implantable medical scaffolds due to its 
nontoxic degrading products which is occurring naturally in the human body [231]. 
Although it might be highly suitable for implantable medical material, cell culture 
experiments on that particular polyester suggested a different kind of story. It seems that 
mammalian cell line (e.g., human umbilical vein endothelial cells (HUVECs)) attached to PHB 
suffered from altered cell morphology, cytoskeletal characteristics and cell adhesion formation 
as compared to other surfaces such as glass or tissue culture polystyrene [227]. Despite the fact, 
there were some studies that relate to some alteration of the cell physico-chemical 
characteristics, there is a much bigger problem faced by this type of biodegradable polyester, 
which is a low cell affinity due to its highly hydrophobic material. As a hydrophobic polymer 
material, the poor hydrophilic property of PHA has hindered the extensive usage in the field of 
medical application [232]. Thus, it is necessary to improve the hydrophilic properties of PHA to 
meet the rigorous tissue engineering requirements. A possible and effective way is through 
surface modification. In order to trigger the cell-matrix adhesion on PHA surfaces, several 
surface treatment techniques [2] have been recently applied including alkaline hydrolysis, [233, 
234] ion implantation, [235] ammonia plasma treatment [236, 237] or rf-oxygen plasma 
treatment [151] followed by chemical grafting [238, 239] and lipase treatment [156]. However, 
in some cases of the surface chemical grafting (e.g., immobilization of bio-molecules), the 
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interaction between bulk polymer and the bioactive molecules is usually very weak (non-
covalent interactions) and thus the surface is quite unstable [240]. In this study, we are looking 
at the rf-oxygen plasma and alkaline treatment since both methods have been used extensively 
in surface modification. Yet, both have their advantages and disadvantages. One of the problems 
of plasma treatment is that the effect of surface treatment is not permanent since the surface 
tends to revert to the untreated state in a short time (potential aging) [241]. However, it is likely 
depending on how it is stored or preserved prior to the usage (e.g., storage in low temperatures 
of 0 oC to 4 oC) [242, 243]. In comparison, alkali treatment has been proven to be an effective 
method to improve the wetting and adhesion property of polymer surface [227]. 
However, the impact of the surface modifications on the adsorption and displacement 
patterns of proteins and the subsequent cell response are hardly understood so far [227]. For 
instance, Rouxhet et al. [233] found that alkaline hydrolysis of PHA films increased adsorption 
of fibronectin and albumin. This effect could not be solely attributed to the altered wettability 
by the surface hydrolysis (functionalized with oxygen-based polar groups) but has to be seen in 
the context of the well-known complexity of protein interaction with solid substrates. Although 
hydrophobicity plays a major role in the attachment of proteins to biomaterials, other 
interactions like electrostatic charges (surface charges), dipole-dipole interactions, hydrogen 
bonding as well as sterical and entropical forces have also to be considered as providing 
important contributions [244]. 
 
6.2 Aim and Hypothesis 
 
 This investigation was based on the hypothesis that surface treatments (alkaline and rf-O2 
plasma) on the PHB and PHBV porous 3-D scaffolds would facilitate the adsorption of two 
bone marrow ECM proteins (collagen type I and fibronectin), enhance the cell affinity on the 
treated surface and cells expansion on the 3-D cell culture system. 
 
6.3 Approach of Study 
 
 In the light of these recent findings and in order to provide a better understanding of the 
effective interactions arising from the physico-chemistry of PHA substrates towards cell 
affinity, the current study aimed to allow for a selection of the appropriate physico-chemical 
modifications to be used for the biological surface coating with two types of bone marrow main 
extracellular matrix (ECM) proteins (e.g., collagen type I and fibronectin) in the sense that the 
cell-biomaterial affinity could be increased sufficiently and in turn increasing cell growth. The 
surface of porous 3-D scaffolds of PHB and PHBV (4%, w/v) were modified by two different 
procedures: (i) alkaline hydrolysis (serial concentrations of aqueous NaOH solution) and (ii) 
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low radio frequency oxygen plasma (rf-O2 plasma) treatment. The changes of its physico-
chemical properties were confirmed by measurement of water contact angle, ζ-potential 
measurement, helium pycnometer, nitrogen absorption BET measurement and scanning electron 
microscopy (SEM). Other miscellaneous measurement was also conducted such as in vitro 
degradation in cell growth media. The cell-biomaterial affinity on PHB and PHBV scaffolds 
before and after the surface modification were also evaluated for a human lymphoid cell line 
(RL) (Table 6.1) by means of MTS assay and cell viability measurement. 
 
Table 6.1: Chronic lymphocytic leukaemia (CLL) cell line properties. The table summarizes the 
main properties of the RL cell line. 
 
Cell properties Cell line 
RL 
Cell phenotype B lymphoblast 
Original disease of patient non-Hodgkin's lymphoma 
Patient data 52-year-old Caucasian male 
Source of material Ascites tissue 
Year of establishment 1983 
Culture Medium 90% RPMI 1640 + 10% FBS 
Sub-cultivation routine Maintain at 0.1 to 1 x 106 cells/ml. 
Renew media every 2 to 3 days. 
Doubling time 12 h 
In situ morphology (cell size) 10 µm 
 
6.4 Results 
 
6.4.1 Effect of NaOH and Oxygen Plasma Treatment on Surface Hydrophilicity 
  
Water contact angles of the untreated and treated solvent-cast thin films measured by sessile 
drop techniques are listed in Table 6.2. It was reported that the water contact angles of a typical 
hydrophobic surface were approximately 65o to 95o [245]. The average contact-angles of 
untreated PHB and PHBV solvent-cast thin films were 66.80 ± 0.2o and 79.24 ± 0.4o 
respectively which indicate high surface hydrophobicity. Hence, to identify which NaOH 
concentration suit best for the surface treatment, scaffolds and thin films were immersed in 
varies NaOH concentration (0.2M, 0.4M, 0.6M, 0.8M and 1.0M) and the selection/optimization 
was made based on the scaffold physical morphology and water contact angles (Figure 6.1). The 
observation showed that only NaOH concentrations of 0.4M and 0.6M were seemed to be the 
appropriate selection of all since the other NaOH concentrations (i.e., 0.2M, 0.8M and 1.0M) 
used in the treatment were resulted in either no changes in water contact angles (for solvent-cast 
thin films) or sustained from the structural integrity problem (several fragments detachment). 
However, only 0.6M NaOH PHB and PHBV treated polymeric scaffolds were selected for the 
cell-biomaterial affinity study because the water contact angle of their corresponding 0.4M 
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NaOH-treated solvent-cast thin films have changed to an extreme wetting surface (possibly less 
than 15o) and insignificant changes of contact angle as observed on PHB. As for the oxygen 
plasma treatment, both polymeric solvent-cast thin films were also changed to a complete 
wetting surface. Nevertheless, they were all considered for the cell-biomaterial affinity study to 
observe the cell behaviour on the completely wet surface.  
 
  
 
Figure 6.1: Morphology of the polymeric porous 3-D scaffolds with an approximate size of 10 
mm × 10 mm × 5 mm post alkaline surface treatment: (a, j) 0.8 mol/L NaOH; (b, k) 1.0 mol/L 
NaOH; (c, i) 0.6 mol/L NaOH; (d) Control - treated with deionized water; (e, g) 0.4 mol/L 
NaOH; (f, h) 0.2 mol/L NaOH. 
 
Table 6.2: Water contact angle (θH2O) of PHB and PHBV 4% (w/v) solvent-cast thin films after 
(a) rf-O2 plasma and (b) NaOH surface treatment.  
 
Polymeric porous 
3-D scaffolds 
Surface physico-chemistry [Contact angle, θapparent (o)] 
rf-O2 plasma treatment NaOH treatment 
100 W, 10 min[a] 0.4 mol L-1 0.6 mol L-1 
PHB (4%, w/v) < 25[b][c] 65.88 ± 0.72 15.44 ± 0.33** 
PHBV (4%, w/v) < 25[b][c] < 25[b][c] < 25[b][c] 
**p < 0.01 as compared to 0.4 mol/L NaOH and untreated PHB (66.80 ± 0.2o) (n = 10). [a] The 
optimized operational parameters based on the surface morphology observation and cellular 
response studied by Köse et al. [150, 151]. [b] The surface was completely wet by re-distilled 
water droplet (n = 10). The contact angle of a fully wetting surface was < 25o [103, 211]. [c] 
Thin films of PHB and PHBV were fabricated on the polypropylene (PP) sheet and then treated 
with both treatments. 
 
6.4.2 Structural/Morphological Analysis: Scanning Electron Microscopy (SEM) 
 
The surface properties of the polymer are very important because the surface is where the 
interaction between the cell and the material takes place. Prior to the NaOH and rf-oxygen 
plasma treatment, the surfaces of the scaffolds appeared to have cavities and pores that were 
possibly covered with a thin film formed during the solvent evaporation stage of the scaffold 
preparation. However, both polymeric scaffolds treated with NaOH seemed to develop a degree 
of sharpening of the morphological which has resulted in pronounced etching effects (Figure 
6.2a to d). As for the oxygen plasma treatment, the surfaces also changed substantially upon 
PHB (4%, w/v) porous 3-D scaffolds PHBV (4%, w/v) porous 3-D scaffolds 
(a) 
(d) 
(c) (b) 
(e) (f) 
(g) (h) 
(i) 
(j) 
(k) 
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treatment probably because of the etching of the skin layer of the scaffolds have been smoothed 
thus exposing the pores created by the leaching of sodium chloride crystals (Figure 6.2e and f). 
Similarly, both polymeric scaffolds treated with both types of treatments presented 
distinguishable angular pores with some additional appearance of small voids as compared to 
before the treatment implying that they were left behind after solute leaching.  
 
   
 
   
 
   
 
Figure 6.2: SEM of PHB and PHBV (4%, w/v) porous 3-D scaffolds subsequent to alkaline and 
rf-oxygen plasma treatment. (a) 0.4M NaOH PHB; (b) 0.4M NaOH PHBV; (c) 0.6M NaOH 
PHB; (d) 0.6M NaOH PHBV; (e) PHB rf-oxygen plasma; (f) PHBV rf-oxygen plasma. 
Treatment conditions for rf-oxygen plasma: 100 W, 10 min. 
 
 
(a) (b) 
(c) (d) 
(e) (f) 
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6.4.3 Weight Loss after Surface Treatment 
 
The weight loss on different surface treatment conditions is shown in Table 6.3. When the 
PHB and PHBV scaffolds were placed in a 0.4M and 0.6M NaOH solution at 20 ± 1 °C, the 
weight loss was in the range of 2% to 6% (w/w) after 1 h of treatment. Only PHBV produced a 
smaller amount of weight loss as compared to PHB (p < 0.05) for the 0.6M NaOH treatment. As 
for the oxygen plasma treatment, the weight loss was considerably less than the above 
mentioned range (p < 0.05). In addition, both plasma- and NaOH-treated polymeric scaffolds 
have sustained no structural integrity problem (sturdiness of the scaffold) throughout the 
treatment period without any apparent detachable fraction of the scaffolds. Severe scaffold 
rupture was only observed for 0.8M and 1.0M NaOH solutions possibly due to the excessively 
attacked by hydroxide nucleophiles (from the strong alkaline) to the electrophilic C of the ester 
(carbonyl carbon: C=O), which leads to the cleavage of ester bonds and eventually produced 
structurally unstable material [246].   
 
Table 6.3: Weight loss of PHB and PHBV 4% (w/v) porous 3-D scaffolds after (a) rf-O2 plasma 
and (b) NaOH surface treatment.  
 
Polymeric porous 
3-D scaffolds 
Weight loss (%) after surface treatments  
rf-O2 plasma treatment NaOH treatment 
100 W, 10 min[a] 0.4 mol L-1 0.6 mol L-1 
PHB (4%, w/v) 1.64 ± 0.15 3.58 ± 0.48* 5.56 ± 0.42* 
PHBV (4%, w/v) 1.45 ± 0.25* 2.79 ± 0.75* 3.57 ± 0.87*Ψ 
*p < 0.05 as compared with PHB or PHBV treated with rf-O2 plasma (n = 4). Ψp < 0.05 as 
compared with 0.6M NaOH- treated PHB scaffolds (n = 4). 
 
6.4.4 Material Characterization of Polymeric Porous 3-D Scaffolds: Physical Properties 
and Surface Area 
 
Helium displacement pycnometry (AccuPyc 1330 V3.00, Micromeritics) was carried out to 
characterize the scaffolds in terms of their apparent density and porosity after surface treatment. 
The results showed that the porosity (the fraction of the surface that is void) of the untreated and 
treated PHB and PHBV were more or less the same (Table 6.4). It is quite interesting 
that NaOH and oxygen plasma treatment did not alter the porosity of the scaffold even though 
the SEM revealed lots of exposing pores created from the solute leaching process [151]. 
Therefore, both untreated and treated polymeric scaffolds were expected to allow better 
leukaemic cell growth inside the porous structure if the surface hydrophilicity is not taken into 
account. Apart from that, BET surface area of the untreated and treated PHB and PHBV 
scaffolds is also listed in Table 6.4. An obvious difference between the surface morphologies of 
the original and modified PHB and PHBV scaffolds was observed. It is important to note that 
the surface of the untreated PHB and PHBV scaffolds is relatively rough. However, after the 
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NaOH treatment, the surface turned rougher, which was a sign of NaOH etching or removal of 
the surface layer (Figure 6.2a to d). The observation was well in agreement with the BET 
surface area wherein it has shown a significant changed than the untreated and plasma-treated 
scaffolds (p < 0.05). As for the oxygen plasma treatment, slight etching effects were observed 
on the plasma-treated samples leading to a limited degree of sharpening of the morphological 
features (Figure 6.2e and f) as compared to the NaOH-treated and untreated scaffolds (p < 0.05) 
since the majority of the pore have been smoothed by the plasma radiation.  
 
Table 6.4: Physical properties of PHB and PHBV (4%, w/v) porous 3-D scaffolds before and 
after surface treatment.  
 
 
Physical properties 
Polymeric scaffolds (4%, w/v) 
Before treatment 
PHB PHBV 
BET surface area, As, m2/g[a] 0.70 ± 0.02 0.82 ± 0.03 
Geometrical bulk density, g/cm3 0.084 ± 0.15* 0.072 ± 0.28 
Skeletal density, g/cm3[b][c] 0.47 ± 0.52* 0.92 ± 0.14 
Porosity, % 82.12 ± 0.18* 92.17 ± 0.73 
 
 
Physical properties 
Polymeric scaffolds (4%, w/v) 
Alkaline treatment (0.6 M) rf-O2 plasma treatment 
PHB PHBV PHB PHBV 
BET surface area,  
As, m2/g[a] 
0.89 ± 0.02* 0.97 ± 0.01* 0.78 ± 0.03* 0.91 ± 0.01* 
Geometrical bulk  
density, g/cm3 
0.078 ± 0.15 0.077 ± 0.19*Ψ 0.083 ± 0.15Ψ 0.070 ± 0.17* 
Skeletal density,  
g/cm3[b][c] 
0.41 ± 0.52 0.87 ± 0.11* 0.44 ± 0.52Ψ 0.89 ± 0.14*Ψ 
Porosity, % 80.97 ± 0.21 91.03 ± 0.52 81.13 ± 0.55 92.13 ± 0.42 
*(p < 0.05) - Results were considered statistically significant (n = 4) as compared to before the 
treatment. Ψ(p < 0.05) - Results were considered statistically significant (n = 4) as compared to 
rf-O2 plasma treatment. [a] BET surface area (m2/g) = Total skeletal surface area (m2)/skeletal 
mass (g). [b] ρs is the skeletal density of the crushed scaffolds, which was determined from 
helium pycnometry. [c] The higher pore volume (the higher the amount of absorbate intruded), 
the lower the skeletal volume.  
 
6.4.5 Surface Properties of Polymeric Porous 3-D Scaffolds: ζ-Potential  
 
 Figure 6.3a and b shows the measured ζ-potential as a function of pH (ζ = f(pH)) for plasma- 
and NaOH-treated PHB and PHBV scaffolds as obtained by streaming potential measurements. 
Both polymers showed a similar characteristic. Unaltered PHB and PHBV surfaces showed an 
isoelectric point of pH 3.8 and 3.1 respectively which indicate the slightly acidic character of 
the surface. In this case, a clear difference between the samples can be seen (Table 6.5). The iep 
shifts, and the decrease in the modulus of the ζ-plateau value as compared to the untreated 
[(PHB: ∆(iep) = 0 to 1.1; ∆(ζ-plateau) = -15 mV to -91 mV and PHBV: ∆(iep) = 0.1 to 0.4; ∆(ζ-
plateau) = -16 mV to -91 mV)]. All scaffolds demonstrated a distinct downshift in iep and an 
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increased modulus of ζ-plateau with the increase of the NaOH concentration except for the 
0.4M NaOH-treated PHB which produced almost the same profile as the untreated PHB 
scaffold. 
 
 
 
 
Figure 6.3: Measurement of ζ-potential as a function of pH (ζ = f(pH)) for plasma- and NaOH-
treated PHB and PHBV scaffolds as obtained by streaming potential measurements. Shown are 
(a) PHB and (b) PHBV porous 3-D scaffolds before and after rf-oxygen plasma and NaOH 
treatment. Arrows highlight the shift of the iep after NaOH treatment. 
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 This phenomenon can be attributed to the increased number of acidic dissociating surface 
functional groups. Theoretically, during the NaOH hydrolysis, the hydroxide anion (OH-) 
hydrolyses the ester groups resulting in the breaking of the polymer chain and the formation of 
carboxylic acid and hydroxyl groups on the termini of the two new chains [247]. This will lead 
to a certain increment of negatively charged ether carbon group (C-O) and carboxyl group         
(-C(=O)OH) due to the increased number of hydroxyl group (-OH) and reduction of ester bond 
(O-C=O) respectively. Whilst for the rf-oxygen plasma treatment, there are also certain 
increment in ether carbon group (C-O) content and a C-C bond content decrease with possibly 
no ester linkages cleaved at the polymer surface. Apart from that, the ζ-potential measurements 
correlated well with the water contact angle measurements (Table 6.2). A complete wetting (less 
than 25o) [103] was observed on both polymeric plasma-treated and NaOH-treated PHBV 
solvent-cast thin films whilst the water drops spread further across the NaOH-treated PHB thin 
film surface, as compared to the untreated thin films (except for the 0.4M NaOH treated PHB 
scaffolds).  
 
Table 6.5: ζ-potential results: iep and ζplateau values of the ζ = f(pH) for PHB and PHBV (4%, 
w/v) porous 3-D scaffolds before and after surface treatment. 
 
Polymer iep ζplateau (mV) 
PHB, untreated  3.8 -29 
PHB, untreated, EtOH (2 h) 3.7 -29 
PHB, NaOH 0.4M 3.7 -31 
PHB, NaOH 0.6M 2.7 -81 
PHB, 100W 10 min - -120 
PHBV, untreated 3.1 -37 
PHBV, untreated, EtOH (2 h) 3.2 -36 
PHBV, NaOH 0.4M 3.0 -53 
PHBV, NaOH 0.6M 2.7 -93 
PHBV, 100W 10 min - -128 
 
6.4.6 Effect of Sterilization on the Surface Properties of Polymeric Porous 3-D Scaffolds 
 
 Some well established techniques to sterilize 3-D tissue engineering scaffolds are 
disinfection in 70%, (v/v) ethanol (EtOH), ethylene oxide (ETO), radio frequency glow 
discharged (RFGD) plasma sterilization method and more recently a combination of ultra-violet 
light (8 min) and ethanol [6]. All untreated and treated PHB and PHBV (4%, w/v) porous 3-D 
scaffolds were sterilized by using a combination of 8 min under UV light and immersion for 2 h 
in ethanol (70%, v/v). ζ-potential measurements (Figure 6.3) show that sterilizing the polymer 
scaffolds as mentioned above has no impact on the surface charge. Taking the untreated PHB 
and PHBV scaffolds as an example, there were no significant changes in the iep (PHB: 3.7; 
PHBV: 3.0) and ζplateau value (PHB: -29 mV; PHBV: -36 mV) pre- and post-sterilization. This is 
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shown in Table 5. Moreover, the wetting characteristics of both polymers thin film surface pre- 
and post-sterilization also revealed that there was good correlation with the ζ-potential 
measurements where no significant changes in water contact angles (Table 6.6). 
 
Table 6.6: Water contact angle (θH20) of untreated PHB and PHBV (4%, w/v) solvent-cast thin 
films pre- and post-sterilization (n = 4).  
 
Surface physico-chemistry  Polymeric porous 3-D scaffolds 
PHB (4%, w/v) PHBV (4%, w/v) 
Before sterilization process 
Contact angle, θapparent (o) 66.80 ± 0.2 79.24 ± 0.4 
After sterilization process 
Contact angle, θapparent (o) 65.43 ± 0.3 78.11 ± 0.5 
            
6.4.7 In Vitro Degradation Study of Polymeric Porous 3-D Scaffolds 
 
6.4.7.1 pH Measurements  
 
 As polymer degradation leads to acidic by-products, we investigated the potential effects on 
the pH surrounding the scaffolds. The pH measurements were performed in the absence of cells 
to eliminate potential changes caused by cell growth (Figure 6.4b). The pH of all the scaffold-
soaked culture medium fluctuated relatively in the range of pH 7 to 8 until day 21, after which, 
the pH became increasingly acidic and reached to a final value of 5.60 ± 0.10 (PHBV) and 6.07 
± 0.04 (PHB) at day 56. The pH of the control (culture media without scaffold) remained 
constant in the range of 7.4 to 7.8 (p > 0.05) throughout the experiments. In comparison of that 
control, the pH of a media with PHB scaffold was significantly lower from day 21 to the end of 
the experiments (day 56) (p < 0.05) whilst PHBV scaffold, the pH of a medium started to 
become acidic from day 35 until day 56 (p < 0.05).  
 
6.4.7.2 Gravimetric Analysis 
 
 Gravimetric measurement for both polymeric porous 3-D scaffolds revealed that there were 
significant changes to its weight over a period of 60 days. However, both PHB and PHBV 
scaffolds sustained their structural integrity and morphology over a period of 60 days although 
accumulation of medium particulates was observed within 47 days of incubation (Figure 6.4a). 
It was observed that the mass of PHB scaffold decreased gradually (p < 0.05) within 47 days of 
incubation by 17.35 ± 3.75% of its initial weight. Meanwhile, the mass of PHBV scaffold 
decreased rapidly within 14 days of incubation and then slowly degraded until day 47 with the 
total loss of 36.33 ± 9.73% from its initial weight (p < 0.05).  Then, both polymers were seemed 
to stabilize from day 47 until day 66. Moreover, the extent of the weight losses seemed to be 
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well correlated with the pH analysis on the range of day 21 to day 47 which showed a 
prominent pH drop to indicate the occurrences of accumulated acidic degradation products     
(i.e., carboxylic acid groups) due to the autocatalytic hydrolysis effect. However, only PHBV 
scaffold became ruptured (pointed by the arrows) and shattered into several large fragments at 
day 66 to indicate the effect of accumulated acidic by-product inside the porous structure 
(Figure 6.5b).   
 
 
 
Figure 6.4: Kinetics of the in vitro degradation process for PHB and PHBV (4%, w/v) porous 
3-D scaffolds were measured via (a) mass and (b) pH. The polymeric porous 3-D scaffolds were 
submerged in cell growth media and incubated at 37 oC. Samples were periodically removed 
and dried under vacuum prior to the analysis (n = 4). Control was a cell growth media without 
porous 3-D scaffolds. (Ψ) p < 0.05 for the value compared to each of the polymers or control 
(pH analysis) and (*) p < 0.05 for the value change compared to the previous value. 
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Figure 6.5: Morphology of the polymeric porous 3-D scaffolds with an approximate size of 10 
mm × 10 mm × 5 mm pre- and post-incubation in cell growth media. (a) PHBV at week 4 and 
(b) PHBV at week 9. (c) PHB at week 4 and (d) PHB at week 9. Ruptured PHBV scaffolds      
(as circled in the picture (b)) were observed at week 9 and some of the incubated scaffold were 
shattered into several big pieces (n = 4).     
 
6.4.8 Cell culture on Porous 3-D scaffolds: Chronic Lymphocytic Leukaemia (CLL) 
 
6.4.8.1 Seeding Efficiency of Chronic Lymphocytic Leukaemia Cell Line (RL)  
 
The ability to support the attachment and promote the proliferation of cultured cells is a 
prerequisite of a functional scaffold [82]. To evaluate the cellular behaviour on the treated 
porous 3-D scaffolds of PHB and PHBV, chronic lymphocytic leukaemia cell line (RL) was 
initially seeded and cultured for 24 h. The seeding efficiency shows the percentage of cells that 
remained in the scaffold after 24 h of seeding. It was observed that the seeding efficiency of all 
untreated and treated PHB and PHBV were not statistically different in the range of 81.54 ± 
15.07% to 95.34 ± 9.23% (p > 0.05). Moreover, it seems to indicate that RL prefers to attach 
and interact initially on all scaffold surfaces regardless of its surface 
hydrophilicity/hydrophobicity and morphological conditions.  
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6.4.8.2 Effect of Surface Treatments on Cell-Biomaterial Affinity  
 
After the cell seeding efficiency had been determined, all the untreated and treated polymeric 
scaffolds were then subjected to a short-term cell proliferation of 14 days. The MTS assay was 
carried out to make further comparison on a different type of treated scaffolds with the untreated 
scaffolds via absorbance measurements (λ = 490 nm) as shown in Figure 6.6. Evidently, the 
proliferation of RL on day 7 and day 14 for all treated and untreated polymeric scaffolds 
increased tremendously in comparison with day 1 (p < 0.01). As on day 7, the treated scaffolds 
cellular growth (except NaOH-treated PHB) was significantly higher than the untreated PHBV 
scaffold only (p < 0.05). On day 14, the cellular growth of all treated polymeric scaffolds 
showed a significant increased of absorbance as compared to day 7 (p < 0.05). On top of that, 
the cellular growth of all treated scaffolds on day 14 was statistically higher than the untreated 
scaffolds (p < 0.05). Viability of the cells extracted from the scaffolds was assessed at days 0, 7 
and 14 (Figure 6.7). Cells cultivated in and supported by all of the treated 3-D porous scaffolds 
had the best viability compared with those supported by the untreated scaffolds (p < 0.05). 
Overall, it seems that this abnormal lymphoblastic cell line (CLL) has a specific preference on 
choosing which surface properties and material characteristics (i.e., surface wettability and 
morphological conditions) to attach and growth effectively. Moreover, this phenomenon 
showed that the cells adapted efficiently to their new 3-D microenvironment (Figure 6.8a to f), 
and it is expected to support long-term proliferation (i.e., more than 2 weeks) in cytokine-free 
conditions. However, it may be subjected to the surface properties such as wettability, 
electronegativity and chemical composition that determines the availability, conformational and 
orientational of the absorbed ECM proteins to trigger further cell adhesion, spreading and 
growth [248]. 
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Figure 6.6: Cellular growth of a CLL cell line (RL) on PHB and PHBV (4%, w/v) porous 3-D 
scaffolds without treatment (control) and with surface treatment (alkaline and rf-oxygen 
plasma). The MTS assay was used to measure the proliferation of CLL cell line (RL) on all 
scaffolds. (*) p < 0.05 for absorbance decreased/increased as compared to the previous day. 
Results shown were means (±sd) of 6 separate instances, each in quadruplicates wells (n = 4) 
obtained by subtraction from cell-free equivalents, to eliminate A490 produced by the scaffold + 
media (negative control) alone.  
 
 
Figure 6.7: Viability of the RL cells seeded onto the treated and untreated PHB and PHBV 
porous 3-D scaffolds during a period of 14 days. *p < 0.05, compared between groups. For all 
panels, results were means (±sd), n = 2 replicates per experiment, N = 6 separate experiments. 
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Figure 6.8: SEM of cell-loaded PHBV and PHB treated scaffolds. (a) RL cells cultured in 0.6M 
NaOH PHB scaffolds at day 14. (b) Magnified views (1100x) of (a). (c) RL cells cultured in 
0.6M NaOH treated PHBV scaffolds at day 14. (d) Magnified views (550x) of (c). (e) RL cells 
cultured in plasma-treated PHBV scaffolds at day 14. (f) Magnified views (950x) of (e). The 
cells (arrows) were observed to have penetrated the pores of the inner section of the scaffolds 
with large aggregates seen. 
 
6.5 Discussion 
 
Most polymeric materials demonstrated poor cell adhesion properties due to their low 
surface energy, chemical inertness and smooth surface. For this reason, it is very essential for 
the polymeric scaffolds used in the biomedical application to be surface modified by some 
additional treatments to raise surface bioactivity, thus to enhance hydrophilic properties as well 
(d) 
(e) (f) 
(a) (b) 
(c) 
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as the adhesive properties. It has been approved that surface treatment is an effective method to 
improve the cell compatibility of polymers by improving the surface hydrophilic property [249]. 
In fact, surface properties such as the availability of certain functional groups, domain structure, 
electrical charge, hydrophilicity/hydrophobicity, interfacial adaptability and surface roughness 
are considered to determine the outcome of cells interacting with the materials which in turn, 
can induce several cascade reactions and activation phenomena [250]. Therefore, for different 
type of materials (e.g., PLLA, PHB, PHBV, etc.) it is thought that their different cell affinity 
may be due to their different surface properties. 
The results in our work show that surface treatment at a specific NaOH concentration might 
be considered to be an effective method to improve surface hydrophilicity of the polymeric 
scaffolds at the appropriate level (not too hydrophilic and hydrophobic except for PHBV, which 
produced a highly hydrophilic surface). The discrepancy between NaOH-treated PHB and 
PHBV could possibly due to the surface roughness and large availability of the polar-containing 
functional group of PHBV solvent-cast thin films (due to the less crystalline region for easy 
solvent penetration) which ultimately induced the spreading coefficient of the water droplet on 
the surface during the water contact angle measurement. However, the improved surface 
properties based on the optimized operational parameters used by Kose et al. [150, 151] have 
rendered both of the polymeric scaffolds surface to excessively hydrophilic (Table 6.2). For that 
reason, it would be suggested that a proper optimization process needs to be re-examined by 
coupling with the water contact angle measurement since the authors were fundamentally 
correlated different plasma operational parameters with only the surface morphology and cell-
biomaterial responses. Meanwhile, the improvement in the hydrophilic property of the 
polymeric material is normally attributed to changes in surface chemical and physical property. 
It was reported that the main mechanism that leads to the wettability improvement of polymeric 
scaffolds by using rf-O2 plasma and alkali treatment is surface functionalization by the insertion 
of polar groups as well as topography changed (surface roughness) [251-254]. This 
phenomenon has been shown by Li et al. [254] where the hydrophilic property of the surface-
hydrolyzed PHBHHx matrices was improved due to the increase of specific surface areas and 
surface roughening. In this work also, the microstructure in Figure 6.2a to d clearly shows that 
the NaOH treatment led to a rougher surface (Table 6.4) with many pores on the surface due to 
the etching function of NaOH which provides mechanical interlocking and in turn contributes to 
the improvement of hydrophilic properties [232]. On the other hand, the weight lost during the 
surface modifications should also be taken into consideration. Fortunately, both treated 
polymeric scaffolds sustained for minor losses of less than 5% (w/w) and though retaining their 
structural integrity (sturdiness of the scaffold) throughout the whole treatment period. However, 
further experimental work could be done by optimizing several processing parameters such as 
concentration of NaOH (i.e., from the range of 0.4M to 0.6M), time of treatment, temperature 
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and power of plasma radiation so that the weight loss could be controlled and minimized [246]. 
The physico-chemical characteristic of the modified PHB and PHBV surfaces showed distinct 
differences (subjected to type of treatment applied). The hydrophobic and slightly acidic surface 
of the original PHB and PHBV has been altered significantly into a hydrophilic material due to 
the insertion of oxygen-containing polar group from the NaOH and rf-O2 plasma treatments. 
The later wetting condition measured by means of water contact angle has verified the change to 
a certain degree with the largest effect caused by the rf-O2 plasma (Table 6.2). Additionally, the 
abundant formation of negatively charged ether carbon (C-O) is evident to the electrokinetic 
measurements as shown in Table 6.5 and Figure 6.3 to confirm the changes of the surface 
properties after the treatments as compared to the untreated scaffolds.  
Biological polymers (natural polymers) degrade rapidly in the biological medium when 
appropriate hydrolytic enzymes are available [151]. However, as for the synthetic organic 
polymers which are mostly produced via chemical synthesis, they disappear slowly from the 
environment [207]. Irrespective of polymer categories, the rate and mode of degradation of the 
polymers usually influence their service life, mechanical properties and the response of the 
biological system towards them [151, 255]. Many previous studies have used gravimetric and 
pH analysis to determine the degradability of polymers in the form of thin film and porous 
scaffold.  However, most of the pH change caused by the degradation of the biomaterial was so 
insignificant that it might not be used as a degradation indicator. For that reason, density and 
weight changes, on the other hand, are significant enough to serve as an appropriate indicator of 
degradation. Results in our work indicate that the pH and weight changes were well correlated 
as time progresses (Figure 6.4). The sample weights changed dramatically within 14 days in the 
cell culture media (especially for PHBV). At this phase, it believed that the samples absorb the 
solvent (a water-based media), start to break by swelling and at the same time eroded the 
scaffold surface. Later, both polymeric scaffolds degraded slowly from day 28 up to day 47 due 
to the autocatalytic degradation inside the bulk scaffolds [218]. On top of that, this drastic 
weight changed in the first 14 days was possibly due to the chain scission created a polyester 
chain shortening as it absorbed large amount of solvent [255]. These data indicate that the 
microenvironment of the loaded cells inside the scaffold will become less restrictive as time 
progresses (at least after the initial 14 days) and therefore, increases in cell numbers within the 
scaffold structure will not be excessively hindered by the confined space in the scaffold [151, 
255]. 
PHB and PHBV polymers have a significant role to play in tissue engineering and in the 
development of living tissue products for therapeutic applications [2, 66, 256]. In this study, a 
cell line of chronic lymphocytic leukaemia (RL) was grown on the untreated and treated PHB 
and PHBV scaffolds and their metabolic activity for day 1, 7 and day 14 was measured by 
means of MTS assay. Comparisons were made between the untreated and treated scaffolds to 
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identify which physico-chemical modifications suit best for biological surface coating apart 
from improving cell-biomaterial affinity. On the 7th and 14th day of incubation, the cellular 
growth increased immensely for all untreated and treated polymeric scaffolds as compared to 
day 0 (p < 0.05) (Figure 6.6). On balance, the cellular growth of all treated scaffolds showed 
tremendous improvement as compared to all untreated scaffolds. All of these data has shown 
that the adhesion and growth of the chronic lymphocytic leukaemia cell line (RL) seemed to 
have specific preferences to a different polymeric surface physico-chemical characteristic in 
which largely affected the adsorption of protein monolayer on the treated polymeric surface. 
However, the NaOH treatment (0.6M) might be the appropriate choice of surface treatment and 
later for the biological surface coating due to their appropriate wetting changed (the surface is 
not too hydrophilic or hydrophobic except for the PHBV) as compared to the plasma treatment 
even though the weight loss during the treatment revealed slightly higher than the plasma 
treatment. In addition, many studies have demonstrated that cell adhere, spread and grow more 
easily on moderately hydrophilic substrates than on hydrophobic or very hydrophilic ones [257-
260]. For that reason, choosing the appropriate wettability could increase the adsorption of 
particular extracellular matrix proteins (to provide cell attachment recognition sites) from the 
supplemented serum-containing culture media and during the biological surface coating which 
in turn, favoring the cellular attachment, spreading, migration and growth [121]. Besides that, 
the treated polymeric scaffolds will have the advantages of adsorbing extra amount of the ECM 
proteins (e.g., collagen type I and fibronectin) during the biological surface coating which will 
be useful in increasing cell adhesion, spreading and growth on the polymer surface for a long 
culture period (i.e., up to 6 weeks). As for the untreated polymeric scaffolds, they might have a 
problem in retaining high cellular growth and cell spreading across the porous structure for a 
long culture period (more than 14 days) although the result showed good cell attachment and 
growth up to 14 days. The main problem could be due to the lack of these adsorbed ECM 
proteins that provide cell attachment recognition site and mechanical strength [6]. 
 
6.6 Conclusion  
 
  In the present study, controlled surface hydrolysis and surface rendering by NaOH and rf-O2 
plasma respectively are proposed to functionalize and modify the surface of PHB and PHBV 
scaffolds. The results show that the surface hydrophilicity of PHB and PHBV were improved 
noticeably after NaOH treatment. However, the rf-oxygen plasma treatment rendered the 
surface of PHB and PHBV scaffolds by becoming too hydrophilic (fully wetting). Moreover, it 
seems that both alkaline and rf-oxygen plasma treatments have altered the morphology of the 
scaffold by making more voids available for occupation by the CLL cell line (RL) in which 
otherwise covered by a thin film formed during the solvent evaporation stage of scaffold 
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preparation. The analysis of the structural and material characteristics of the treated PHB and 
PHBV showed that the surface morphology and porosity were noticeably similar in this regard 
except for the BET surface area. Thus, both the plasma and NaOH treatments have proven their 
worth to modify the surface properties of the scaffold without having any structural and 
sturdiness problems. Therefore, the concentration of 0.6M NaOH was chosen due to the 
appropriate amount of the hydrophilicity they embraced apart from having a stable and well 
interconnected scaffold structure. It is undoubtedly that the treated polymeric scaffolds will 
have the advantage of attracting the ECM proteins from the supplemented-serum growth media 
or during the biological surface coating which in turn, will provide a good cell adhesion during 
the initial stage and expansion. pH change caused by the heterogeneous degradation of the 
biomaterial was quite well correlated with the weight changed to indicate the occurrences of 
degradation. Weight changes, on the other hand, also significantly served as an appropriate 
indicator of degradation. The decrease of the weight upon degradation without the loss of 
structural integrity is a good sign for the well-being of the loaded cells. In this study, CLL cell 
line (RL) was proliferated immensely on all treated polymeric scaffolds as compared to the 
untreated after 14 days of incubation. This result indicates a great potential in developing an in 
vitro 3-D biomimicry of the human haematopoietic microenvironment model for the study of 
leukaemia.  
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CHAPTER 7 Development of Biomimetic Polymeric Porous Scaffolds of an In Vitro 
Three-Dimensional (3-D) Human Leukaemia Model 
 
7.1 Introduction 
 
 The development of biomaterials for tissue engineering applications has recently focussed on 
the design of biomimetic materials that are capable of eliciting specific responses mediated by 
biomolecular recognition signals which can be manipulated by altering the design parameters of 
the material [81]. In many cases, the lack of these biomolecular recognition signals on the 
material surfaces coupled with their inevitable hydrophobicity has resulted in the inability of the 
material (fabricated as 3-D porous scaffolds) to mimic the 3-D microenvironment bone marrow 
(BM) niches for regulating the self-renewal haematopoietic stem cells (HSCs) functions. The 
biomolecular recognition signals of the niches consist of stroma cells, such as macrophages, 
adipocytes and fibroblasts in the BM and control cellular behaviour either in the function or 
dysfunction of normal or malignant bone marrow [261]. Therefore, in order to mimic the BM in 
both its 3-D structure and its provision of appropriate bio-signals for cell attachment, the surface 
and bulk modification of the biodegradable polymer via chemical or physical methods with 
bioactive molecules such as a native long chain of ECM proteins offers an ideal solution to 
overcome the limitations of the scaffolds.  
 However, to the extent of our knowledge, there are no studies concerning the coating of the 
native long chain of ECM proteins onto the surface of PHB and PHBV porous 3-D scaffolds. 
Only one relevant study conducted by Dong et al. [262] can be highlighted in this investigation 
wherein an amphiphilic PHA granule binding protein (PhaP-RGD) was used to bind to the 
hydrophobic surfaces of PHBV matrices without the use of surface treatment to improve cell 
growth. However, one study actually established and modelled the 3-D culture system of 
leukaemia cell lines (AML: HL-60, K-562 and Kasumi-6) by using variety of synthetic 
polymers [6]. For that reason, we intend to follow the previous mentioned protocols to prove 
that other leukaemia entities (such as CLL: RL and JeKo-1) can be modelled in a similar 
manner. Moreover, the coating of the scaffolds with ECM proteins would actually create an 
adhesive interface and a strong mechanical contact between the scaffold material and the cells 
whose organization and production modulates and enhances cell adhesion through 
transmembrane integrin receptors. Meanwhile, the incorporation of the ECM proteins to the 
biodegradable polymeric scaffolds is that not only would they provide the cell-binding sequence 
for cell adhesion, but also provide secondary interactions with other ECM proteins and 
interactions with growth factors. This would stabilize the cell binding thus enhancing cell 
adhesion which results in better cell growth and maturation [263]. Before the establishment of 
an in vitro 3-D biomimicry of the human haematopoietic microenvironment of the AML studied 
111 
 
by Blanco et al. [6] there were only traditional two-dimensional (2-D) cultures and in vivo 
animal models of AML available to explain the molecular determinants of leukaemogenesis, the 
cellular and microenvironmental elements that enhance leukaemia growth and protect the 
leukaemic stem cells from chemotherapy [264, 265]. However, the methods were too difficult to 
investigate due to these three major limitations. This difficulty arises from; i) 2-D cultures 
cannot support long-term primary leukaemic cell growth without exogenous growth factors or 
stromal cell support, ii) 2-D culture conditions cannot structurally provide the native 
haematopoietic microenvironment (HM) for human leukaemic cells, especially the 3-D niches 
which protect the leukaemic stem cell and iii) animal models, although superior to 2-D cultures, 
cannot completely replicate the human microenvironment and require extensive animal facilities 
and expertise for use [266, 267]. 
 
7.2 Aim and Hypothesis 
 
 It was hypothesised that by using a 3-D culture system that resembled the highly porous 
structure of the cancellous bone (containing soft abnormal bone marrow tissue); a good 
representation of the original leukaemic bone marrow microenvironment will be reproduced. 
Leukaemic cell culture could be maintained with its original phenotypic features, independent 
of cytokine addition and the natural leukaemic cells expansion could be studied in its natural 
state in vitro. 
 
7.3 Approach of Study 
 
 In order to recreate an ideal 3-D BM microenvironment for the investigation of leukaemia in 
vitro, polymeric scaffolds need to be fabricated and optimized with desirable physical properties 
(e.g., high porosity, adequate pore size and distribution, a high surface area-to-volume ratio 
through the presence of a network of channels and interconnected pores) and wettability which 
will facilitate enhanced penetration by cells and media deep into the scaffolds and the formation 
of cellular associations [157, 268] Furthermore, polymeric scaffolds need to be biocompatible 
and should offer bio-recognition signals that support cellular growth and tissue formation 
through, possibly, immobilization with ECM proteins. In this investigation, 2 different CLL cell 
lines, namely RL and JeKo-1, were used as a substitute for human primary leukaemia, a 
heterogeneous disorder, in order to account for differences in the growth requirements of the 
different leukaemia subtypes as well as assist in the development of the in vitro 3-D leukaemia 
model (Table 7.1). The leukaemic cell lines were tested on the polyhydroxyalkanoates (PHA), a 
class of biodegradable polyesters, in particular PHB and PHBV. Prior to the coating of the 
proteins, both polymeric scaffolds were subjected to the NaOH treatment (0.6M) to accelerate 
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the adsorption of ECM proteins by providing large amounts of polar groups through polar 
interaction and hydrogen bonding. Bio-recognition signals were provided to the selected 
scaffolds by coating with either the highest or the lowest concentration of fibronectin and/or 
collagen based on the study carried out by Blanco et al. [6] This is to provide an adhesive 
interface (fibronectin) or strong mechanical contact (collagen) between the scaffold material and 
the CLL cells [269]. 
 
Table 7.1: Chronic lymphocytic leukaemia cell lines (JeKo-1 and RL) main properties used in 
the optimization process.  
 
Cell properties Cell line 
JeKo-1 [270, 271] RL [272] 
Cell phenotype Lymphoblast B lymphoblast 
Original disease of patient Mantle cell lymphoma Non-Hodgkin's lymphoma 
Patient data 78-year-old Caucasian female 52-year-old Caucasian male 
Source of material Peripheral blood Ascites tissue 
Year of establishment N/A 1983 
Culture medium 80% RPMI 1640 + 20% FBS 90% RPMI 1640 + 10% FBS 
Sub-cultivation routine Maintain at < 2.5 x 106 
cells/ml. Renew media every 2 
to 3 days 
Maintain at 0.1 to 1 x 106 
cells/ml. Renew media every 
2 to 3 days 
Doubling time 55 h 12 h 
In situ morphology  7 µm 10 µm 
 
7.4 Results 
 
7.4.1 Unmodified Polymeric Scaffolds Evaluation 
 
 PHB and PHBV polymeric scaffolds were evaluated for their ability to support the growth 
and maintenance of two cell lines, RL and JeKo-1 over a period of 6 weeks. Unmodified PHB 
and PHBV displayed a seeding efficiency for RL and JeKo-1 higher than 50% (p < 0.05) 24 h 
(RL: 91.33 ± 1.17% (PHB), 72.86 ± 11.06% (PHBV); JeKo-1: 59 ± 3.61% (PHBV)) following 
inoculation except PHB cultured with JeKo-1 (55.74 ± 18.78%) (Figure 7.1). Both polymers 
were able to support long-term (over a period of 6 weeks) cellular growth (Figures 7.2 and 7.3). 
CLL-cell-line-specific cell growth kinetics was consistently observed in both the PHB and 
PHBV scaffolds. Both scaffolds with RL cells showed a statistically significant higher 
absorbance (i.e., metabolic activity of cells) starting from week 3 up to week 6 of culture (p < 
0.05), compared with that of JeKo-1; this absorbance stabilized after week 4. In contrast, the 
JeKo-1 cell line exhibited slower, two-stage growth kinetics, peaking at different culture phases 
which were at week 1 (PHB), week 3 (PHBV) and week 6 (PHB and PHBV). This growth 
kinetics in 3-D was consistent with what is known of the RL and JeKo-1 cell lines in standard  
2-D cultures (Table 7.1: RL had a faster growing time (doubling time), established as a culture 
faster than the JeKo-1 cell line).  
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Figure 7.1: Cell seeding efficiency on ECM-coated scaffolds. The PHB and PHBV scaffolds 
were coated with collagen type I (125 µg/ml or 62.5 µg/ml), fibronectin (50 µg/ml or 25 µg/ml), 
and collagen and fibronectin (62.5 µg/ml and 25 µg/ml, respectively). The CLL cell lines used 
were (a) RL and (b) JeKo-1. (*)Significant differences with p < 0.05 between the samples were 
highlighted by lines. ΨThe tested scaffolds were displayed a seeding efficiency of over 50%     
(p < 0.05). The cultures were performed in parallel on 2 separate occasions, each in 
quadruplicates. 
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7.4.2 Treated Polymeric Scaffolds Evaluation (0.6M NaOH)  
 
 As shown in Figure 7.1, majority of the treated PHB and PHBV displayed a seeding 
efficiency higher than 50% (p < 0.05) 24 h (RL: 91.30 ± 3.06% (PHB), 73 ± 7% (PHBV); JeKo-
1: 61.17 ± 6.10% (PHB), 81.33 ± 6.11% (PHBV)) following inoculation. Moreover, PHBV-
treated scaffold exhibited higher seeding efficiency than the unmodified and 25 µg/ml 
fibronectin-coated PHBV scaffold cultured with JeKo-1 (p < 0.05). As shown in Figure 7.2 and 
Figure 7.3, both polymers were able to support long-term (over a period of 6 weeks) cellular 
growth. Both scaffolds with RL cells showed a statistically significant higher absorbance 
starting from week 2 to week 3 up to week 6 of culture (p < 0.05), compared with that of the 
other cell line (JeKo-1). Only PHB exhibited stable absorbance 1 week earlier than the 
unmodified foams (after week 3). As for the JeKo-1 cell line culture, the cell also exhibited a 
slower increase in metabolic activity with two-stage growth kinetics, peaking at different culture 
phases which were at week 1 and week 6 (PHB). However, PHBV stabilized after 1 week of 
culture peaking at week 2 and remained stable until week 6. As to compare cellular growth 
trends between the treated and untreated (unmodified) scaffolds, both polymers seemed to 
establish a similar growth trend except for the treated PHB RL culture and treated PHBV    
JeKo-1 which was stabilized earlier after week 3 and week 1 respectively.  
 
7.4.3 Polymeric Scaffolds Coating with ECM Proteins 
 
 In order to mimic the bone marrow microenvironment and enhance the cell culture, PHB and 
PHBV scaffolds were coated with two of the main bone marrow ECM proteins, collagen type I 
and fibronectin, evaluated at either high (125 µg/ml for collagen type I and 50 µg/ml for 
fibronectin) or low concentrations (62.5 µg/ml for collagen type I and 25 µg/ml for fibronectin). 
The effect of the protein coating of PHB and PHBV on the seeding efficiency and cell growth of 
the CLL lines was compared with that on uncoated scaffolds. The seeding efficiency shows the 
percentage of cells that remain in the scaffold after 24 h of seeding. For the RL cell line, seeding 
efficiency for majority of the protein-coated scaffolds were consistently over 50% (p < 0.05) 24 
h following inoculation except 125 µg/ml and 62.5 µg/ml collagen-coated PHBV scaffolds 
(71.17 ± 15.91% (125 µg/ml), 75.17 ± 13.38% (62.5 µg/ml). As for the JeKo-1 cell line, seeding 
efficiency for some of the protein-coated PHBV scaffolds was over 50% (p < 0.05) 24 h (75.10 
± 2.05% (Fibronectin 50 µg/ml), 69.33 ± 8.08% (Collagen 125 µg/ml), 90.33 ± 6.11% 
(Collagen 62.5 µg/ml)). However, none of the protein-coated PHB scaffolds achieved over than 
50% seeding efficiency.   
 Cellular proliferation of the 2 CLL cell lines cultivated on ECM-coated PHB and PHBV was 
measured using the MTS assay over a period of 6 weeks. Although quite different growth 
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patterns were evident at each time point, a common finding in all of the cultures was that cell 
growth on the ECM-coated scaffold was at least as good as and at most time points better than 
that on the control uncoated scaffold. In the cell-line specific analysis, RL growth was enhanced 
at the early stages of the culture (the first 2 weeks) when supported by both of the polymers 
coated with collagen (irrespective of the concentration); peaking at week 2. This is shown in 
Figure 7.2 (Figure 7.2a when seeded onto PHB and Figure 7.2b when seeded onto PHBV). By 
week 4, the culture was best supported by PHB-coated collagen (62.5 µg/ml) as compared with 
fibronectin and other collagen concentration (p < 0.05). On the other hand, the same cell line 
displayed similar behaviour when seeded in PHBV, with enhanced growth in the collagen 
coated scaffold (irrespective of the concentration) at the early stages of culture (by week 2) and 
later improvement in proliferation (after week 5) with collagen 125 µg/ml coating. Meanwhile, 
the differences between both polymers only occurred at week 5 with all PHB protein-coated 
scaffolds exhibiting a slightly higher growth than PHBV (p < 0.05). Overall, an enhanced RL 
growth is observed when coating the scaffolds with ECM proteins (p < 0.05); with an initial 
higher proliferation onto the PHB and PHBV collagen-coated scaffolds (irrespective of the 
collagen concentration) which changed to the specific collagen concentration in the last stages 
of the culture.  
 Growth trend lines were added to the collagen-coated scaffolds with 62.5 µg/ml (the best 
protein concentration to produce homogenous results) and to the untreated scaffolds to show 
that coating results in a two step process. First, when the cells were seeded they needed to adapt 
to the new environment and remained without differentiation for a few days to adapt. Second, 
once adapted, they start expanding until they reach a peak proliferation point. For the protein-
coated scaffolds this period (peak proliferation point) took 2 to 3 weeks and when seeded onto 
the uncoated scaffold it took 4 to 5 weeks.  
 As for JeKo-1, the cells grew slower than the RL cell line on both collagen- and fibronectin-
coated scaffolds as indicated by the lower absorbance readings obtained with similar trend as 
observed in 2-D cultures. However, both polymers exhibited the same growth trend with the 
62.5 µg/ml collagen-coated scaffolds (peaking at week 2) although the absorbance reading was 
considered lower than the RL cellular proliferation (p < 0.05) (Figure 7.3: (a) PHB and (b) 
PHBV). With cultures on PHB, the initial cellular growth of 125 µg/ml collagen-coated scaffold 
was higher than 62.5 µg/ml until both polymers were peaking at week 2 (p < 0.05). Whilst on 
PHBV, 62.5µg/ml exhibited higher initial cellular growth than the 125µg/ml collagen-coated 
scaffold with the same peaking time point (week 2) (p < 0.05).   
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Figure 7.2: Cellular proliferation of RL cells on ECM protein-coated PHB and PHBV 
scaffolds. RL cells cultured in (a) PHB and (b) PHBV scaffolds coated with collagen type I 
and/or fibronectin were assessed by standard MTS assay. *p < 0.05 for the value change 
compared to the previous value. Week 0.14 represented an initial cellular growth of cell seeded 
scaffolds after 24 h incubation. A comparison of the growth trends on the 62.5 µg/ml collagen-
coated scaffolds (dotted line), the treated 0.6M NaOH (A) and the uncoated controls (B) 
(straight line) revealed a significant difference (p < 0.05). Cultures were performed in parallel 
on 2 separate occasions, each in quadruplicates. 
 
 Meanwhile, PHBV 62.5 µg/ml collagen-coated scaffolds exhibited higher cellular growth 
than PHB at week 2 (p < 0.05). Whilst on PHB, the 125 µg/ml collagen-coated and 50 µg/ml 
fibronectin-coated scaffolds exhibited higher cellular growth than PHBV at week 2 and week 3 
respectively (p < 0.05). In contrast to the behaviour observed with the collagen coated scaffolds, 
fibronectin-coated conditions displayed a similar growth trend of RL cellular proliferation on 
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the untreated and treated scaffolds which was peaking at week 4 to week 5. For the untreated 
(control) and treated scaffolds, this culture adaptation and proliferation period took 4 to 5 weeks 
again for both scaffolds after their first peaking at week 1 to week 3. After the cells adapted to 
their new environment, the proliferation stabilized; in the case of the collagen coated scaffold 
the cultures stabilized at week 2 and in the untreated (control) and treated scaffolds the culture 
did not stabilized until week 5. 
 
 
 
 
Figure 7.3: Cellular proliferation of JeKo-1 cells on ECM protein-coated PHB and PHBV 
scaffolds. JeKo-1 cells cultured in (a) PHB and (b) PHBV scaffolds coated with collagen type I 
and/or fibronectin was assessed. *p < 0.05 for the value change compared to the previous value. 
Week 0.14 represented an initial cellular growth of cell seeded scaffolds after 24 h incubation. 
A comparison of the growth trends on the 62.5 µg/ml collagen-coated scaffolds (dotted line), 
the treated 0.6M NaOH (B) and the uncoated controls (A) (straight line) revealed a significant 
difference (p < 0.05). The cultures were performed in parallel on 2 separate occasions, each in 
quadruplicates. 
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7.4.4 Examination of the 3-D In Vitro Microenvironment 
 
 The 3-D microenvironment provided by the PHB and PHBV scaffolds was characterized 
using SEM at 2 and 4 weeks after seeding. The RL cell line grew in large clusters (Figure 7.5a 
and b), similar to that observed in 2-D (Figure 7.4a and b). In contrast, JeKo-1 cells aggregated 
within the pores without clustering (Figure 7.5c and d). Over a period of 4 weeks, the cells had 
migrated into the central pores of the scaffold establishing and defining “niches-like” areas of 
growth. Cellular density increased with culture time and by week 4 the central pores of the 
scaffolds were populated by cells that had adhered to the walls of the pores, regardless of the 
cell line tested. Consistent with previous data, all scaffolds coated with ECM proteins supported 
higher cell growth compared with that of the untreated and NaOH-treated scaffolds. The 
analysis of cell-loaded scaffold structure throughout the culture period (irrespective of cell and 
polymer type) indicated that large voids and degraded fragments were generated as time 
progressed (especially at week 2 and week 4). The observation was well in agreement with the 
in vitro degradation kinetics of the scaffolds in cell growth media study (data not shown). The 
cell-free scaffolds at week 2 and week 4 (negative control: picture not shown) exhibited similar 
3-D microenvironment as the cell-loaded scaffolds. Therefore, with the less restrictive space in 
the porous structure as time progresses, this would allow an increase of cell number which was 
consistent with the previous cell growth kinetics data. 
 
  
 
Figure 7.4: RL cell morphology under light microscope in 2-D culture system. Panel (a) shows 
the 2-D culture of RL cells at day 1 of culture (100 µm scale). Panel (b) shows the 2-D culture 
of RL cells at day 3 of culture (50 µm scale). 
 
(a) (b) 
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Figure 7.5: SEM of PHB and PHBV scaffolds coated with ECM proteins. (a) RL cells cultured 
in the PHB scaffold coated with 62.5 µg/ml collagen at week 2. (b) RL cells cultured in the 
PHBV scaffold coated with 62.5 µg/ml collagen at week 2. (c) JeKo-1 cells cultured in the PHB 
scaffold coated with 50 µg/ml fibronectin at week 4. (d) JeKo-1 cells cultured in the PHBV 
scaffold coated with 50 µg/ml fibronectin at week 4. The cells (indicated by arrows) have 
penetrated deep inside the central section of the scaffolds. 
 
7.4.5 Effect of Collagen Solution Residual on Cell Growth Media  
 
Protein-coated scaffolds (collagen type 1) were subjected to 3 h of incubations at 37 oC and 
5% CO2 in cell growth media to observe any changes to the pH and media colour due to the 
excess collagen solution inside the scaffolds. No media changes were conducted until the end of 
the incubation. The cell growth media were prepared according to the recommendation of the 
cell provider and the initial pH (cell growth media without a scaffold) was measured with the 
value of 7.16 at 20 ± 1 oC (room temperature). It was observed that as the time of the incubation 
progresses, there were insignificant differences of pH between all polymers preconditioned with 
collagen type 1 in comparison with the control (p > 0.05). Moreover, there was also no changed 
to the colour of the media as compared to the samples that have not preconditioned with 
collagen solution. These results indicate that the amount of any excess collagen left inside the 
porous 3-D scaffolds have been removed sufficiently with PBS under vacuum condition            
(2 mbar) prior to the cell seeding. This is important to consider that if the cell growth media 
(c) (d) 
(b) (a) 
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became acidic; this could result in an initial loss of cells post seeding and later during the 
proliferation phase. Meanwhile, the results were in support of the work done during the cell 
seeding where most of the protein-coated polymers (collagen type 1) result was over 50% of 
cell seeding efficiency irrespective of cell types (Figure 7.1).    
 
7.4.6 Long Term In Vitro Degradation Study of Polymeric Porous 3-D Scaffolds 
 
 Degradation behaviour of porous scaffolds plays an important role in the engineering process 
of a new tissue. The rate of degradation may affect many cellular processes including cell 
growth, tissue regeneration and host response [31, 151]. Visual assessment of both polymeric 
porous 3-D scaffolds in PBS for 214 days of incubation revealed that their structural integrity 
and morphology were intact although accumulation of medium particulates was observed in the 
initial incubation period of day 7 up to day 48. Accumulation of particulates from day 50 was 
too small as it remained plateau until day 214 (Figure 7.6). The accumulation of medium 
particulates for both polymers was consistent with the mass analysis results as it changed in a 
similar manner. It was observed that mass of PHB porous 3-D scaffolds was gradually 
decreased (p < 0.01) from day 7 to day 48 by 13 ± 4.6% of their initial weight (Figure 7.6). 
Meanwhile, the mass of PHBV porous 3-D scaffolds decreased rapidly at day 7 (p < 0.01) and 
gradually reduced from day 7 to day 37 by 14 ± 3.7% of its initial weight. The weight loss 
started to stabilize from day 50 until day 312 with no structural damage and rupture. Unlike 
PHB, PHBV started to give off large chunks of its structure from day 214 and eventually 
ruptured into several big parts at day 312 (weight loss: 28 ± 3.7% of their initial weight). The 
extent of weight loss in this investigation (gravimetric analysis) seemed to be very significant 
due to the surface erosion. However, unlike the pH analysis on the same period, there was no 
prominent pH drop to indicate any accumulation of acidic degradation products due to the 
autocatalytic hydrolysis effect. However, when the scaffolds were incubated in the cell growth 
media, the pH of the medium became significantly acidic at week 4 until week 6 which 
eventually cause the structure of the scaffolds to rupture at week 6 (data not shown). This was 
probably due to the autocatalytic degradation process which induced the breakage of the ester 
linkages to form acidic by-products. 
 In summary, it appears that the samples might have absorbed the solvent (water) and strain 
by swelling for 50 days and by then chain scission had created chains short enough to leave the 
matrix. This caused the changes in the weight and structural integrity. Then, the samples 
became stabilized with no weight change until day 312 (except PHBV). These all indicate that 
the microenvironment of the loaded cells becomes less restrictive in time (at least after the 
initial 2 months) and therefore increases in the cell numbers within the porous scaffold as it will 
not be hindered by the confined space in the porous structure. However, if the cell growth media 
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simulated fluid scaffolds were taken into account, the scaffolds would not sustain its structural 
integrity up to 2 months. For that reason, these optimization studies were only conducted in a 
confined time frame (6 weeks) where the structural of the cell-loaded scaffolds were still intact 
for cellular proliferation. 
 
Figure 7.6: Kinetics of in vitro degradation process for PHB and PHBV (4%, w/v) porous 3-D 
scaffolds were measured via gravimetric analysis. The polymeric porous 3-D scaffolds were 
submerged in phosphate buffered saline (PBS) and incubated at 37 oC. Samples were 
periodically removed and dried under vacuum prior to the analysis. ΨSignificant differences 
with p < 0.01 between the samples were highlighted by lines (n = 4). OSamples were ruptured 
into several large pieces.  
 
7.5 Discussion  
 
 The interaction of the cells with the material where they are seeded is a result of specific cell 
surface adhesion receptors which are integrins and ECM proteins that have a cell-binding 
domain. However, the synthetic polymeric scaffolds tested in many studies lack the natural 
recognition sites of the cells to the material and are very hydrophobic, making it difficult for the 
cells to interact with the material. It is well known that hydrophobic surfaces favour the 
adsorption of proteins from aqueous solutions thermodynamically but it may induce strongly 
irreversible adsorption and denature the protein’s native conformation and bioactivity (a natural 
conformation of a protein is a prerequisite for its bioactivity) [120]. Even though the mechanical 
properties and biocompatibility criteria needed for some of the tissue engineering area has been 
met previously by the naturally synthesized polymeric scaffolds selected: PHB and PHBV     
[21, 151, 273] it proved that it was not enough. In order to overcome the hydrophobicity 
problem, a surface treatment was employed by using an optimized concentration of NaOH 
(0.6M). Since it has now been well accepted in the biomaterial community that both very 
0
10
20
30
40
50
60
70
80
90
100
110
0 50 100 150 200 250 300
%
 
R
es
id
u
al
 
w
ei
gh
t o
f p
o
ro
u
s 
3-
D
 
sc
af
fo
ld
s
Time (days)
PHB (4%, w/v) porous 3-D scaffold
PHBV (4%, w/v) porous 3-D scaffold
Ψ 
 
Ψ 
 
122 
 
hydrophilic and hydrophobic surface are not good for cell attachment and proliferation, it is 
better to produce a moderate wettability so that proper amounts of proteins such as the 
fibronectin and collagen used in this study could be adsorbed and at the same time preserve 
their natural conformation, resulting in a positive cell response [120, 259, 274].  
 In addition, as scaffolds designed to mimic the bone marrow should resemble the in vivo 
architecture, morphology and function in order to optimize cellular proliferation in vitro, it was 
thought to mimic its composition as well in the sense to provide bio-recognitions signalling site 
for later interaction. On top of that, scaffold physico-chemical properties such as hydrophobicity 
and/or hydrophilicity, surface area, porosity and pore size should also considered as critical as 
the above mentioned specifications to influence cell adhesion, spreading, proliferation and 
differentiation [157, 166]. Fundamentally, bone marrow is formed of three different 
constituents: living cells; non-living organic matter such as collagen and non-living inorganic 
crystals (hydroxycarbonate apatite, HCA). The crystal structure is deposited within an organic 
matrix formed mainly (95%) of collagen type I [73]. Since ECM-coating of scaffolds is an 
important parameter to consider in the tissue engineering of 3-D cellular cultures [275-277], it 
was decided to investigate this further and to coat the scaffolds with two very common ECM 
proteins: collagen type I and fibronectin. Given that cellular growth can be affected by the 
method used to coat scaffolds with proteins, it was very important to achieve homogeneous 
coating and suitable results. Most methods have been based on the immersion of polymer films 
and matrices [275] which may result in non-uniform distribution and poor penetration of the 
protein into the scaffold. In this investigation, the simple and non-destructive method of 
vacuum-immersion protein coating was employed. This method was selected due to fact that the 
previous study carried out by Blanco et al. [6] using centrifugation process has resulted in 
structural damage. This method was probably the best method so far for these types of polymers 
which have issues (e.g., structural integrity) in dealing with the centrifugal force. Previous 
studies (pore interconnectivity observation through color staining using Alirazin Red S) have 
shown that this method might have resulted in a good penetration and homogeneous protein 
coating of the scaffold even in the central sections (Appendix D). 
 Although the CLL cell lines have already been adapted to 2-D cytokine-independent static 
cultures, to the extent of our knowledge, their 3-D culture has not been demonstrated and no 
appropriate culture models of leukaemic cells exist except the studies done by Blanco et al. [6] 
using AML cell lines. Conventionally, haematopoietic cell cultures have relied on the 2-D 
growth configuration provided by T-flasks or well-plates which do not recapitulate the 
haematopoietic inductive microenvironment (HIM) required for supporting the development of 
multiple cell types at different maturation stages as well as the maintenance of the 
haematopoietic stem cells [6]. In contrast, ample evidence exists that 3-D culture systems 
provide a growth environment that promote cell-cell and cell-matrix contact, recreating the 
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haematopoietic niches, as well as being able to support high cell density. Their attributes make 
the 3-D culture systems advantageous [261]. Therefore, direct comparison between 2-D and 3-D 
cultures is not appropriate in terms of their growth kinetics and requirements. 
 Meanwhile, selecting appropriate parameters for the PHB and PHBV scaffolds that support 
the growth of all two CLL lines would provide a suitable growth environment for the culture of 
human primary leukaemic cells. The CLL cells displayed cell line-specific growth kinetics. The 
growth kinetics of RL is three times higher than that of JeKo-1 and established rapidly in the   
3-D culture systems generated by PHB and PHBV. Even though, PHB and PHBV have 
different properties in terms of porosity (PHB: 81.97% and PHBV: 92.17%) and specific pore 
volume (PHB: 9.30 cm3/g and PHBV: 10.51 cm3/g) no big difference was observed between the 
two scaffolds for the fast-growing RL and the slow-growing JeKo-1 cells suggesting that the 
scaffolds did not present any mass transport limitations for 3-D leukaemia cultures. Since the 
above mentioned growth kinetics cannot guarantee the best selection of the polymers for 
studying primary leukaemia cell, other prominent characteristics between PHB and PHBV were 
summarized in Appendix H. In this table, it summarized the advantages of using PHBV as 
compared with the PHB from the start of its fabrication process, material characteristics, 
physico-chemical modifications, in vitro degradation and lastly cellular growth response on the 
other types of leukaemic cell line, e. g., AML: HL-60 (Chapter 5). All the essential factors that 
are summarized in Appendix H came from the optimized parameters that have been studied 
beforehand (Appendix G). In this respect, the PHBV scaffolds were considered advantageous 
for the use in developing an in vitro model of the primary leukaemia. 
 Extensive studies have been performed to render materials biomimetic. The surface 
modification of biomaterials with bioactive molecules is a simple way to make biomimetic 
materials. The early work has used the long chains of ECM proteins such as fibronectin (FN), 
vitronectin (VN) and laminin (LN) for surface modifications [81]. The use of peptides, e. g. 
RGD, YIGSR, etc. instead of ECM proteins as coating material to optimise scaffolds was 
additionally considered in this investigation. However, the use of complete ECM proteins was 
considered to be better for porous 3-D scaffolds because not only they could provide the cell-
binding sequence for cell adhesion, but also provide secondary interactions with other ECM 
proteins and growth factors. Small peptides have lower binding site to cells and selective 
activity for distinct integrin subtypes and are easily cleaved by enzymes [121]. As a result, 3-D 
systems were developed: scaffolds made of 2 different naturally synthesized polymers: PHB 
and PHBV and treated with 0.6M NaOH (based on the optimized surface treatment), to culture 
CLL cell lines and the potential of coating with different concentrations of collagen type I and 
fibronectin to improve cellular proliferation was tested. Overall, there was no big difference 
between the PHB and PHBV protein-coated scaffolds with the fast growing RL and the slow-
growing JeKo-1 cells. However, there was a big difference in the kinetics of cellular growth 
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between the untreated, treated and treated with protein-coated scaffolds. Specifically, it was 
observed that both polymers coated with 62.5 µg/ml of collagen type I has shown a 
homogeneous result with similar cellular growth kinetics peaking at week 2 that was validated 
with the two cell lines. It sustained the best growth of leukaemic cells compared with that of 
untreated, treated, fibronectin and a higher concentration of collagen (125 µg/ml). This 
difference can be attributed to the improvement of the treated porous scaffolds architecture and 
wettability which have proven to produce more voids and increase the chances of sufficient 
protein adsorption. These extra spaces coupled with an increase in surface hydrophilicity would 
literally allow more sites of the treated scaffold to be coated with protein monolayer due to the 
increased perfusion of the media containing proteins deep into the scaffold. With more protein 
monolayer covered on the pore surface, the cell-cell and cell-matrix contact are becoming better 
which has been demonstrated to improve cell expansion. This was in agreement with our results 
which showed that coating with collagen, primarily or fibronectin was beneficial in a CLL cell 
type-specific manner. Moreover, collagen can accelerate cell adhesion when compared with 
other ECM proteins [278]. This due to the fact that a large amount of polar groups on the 
surface (such as -OH, -COO-) could provide many sites to obtain the collagen by polar 
interaction and hydrogen bonding. This may have explained the superiority of the collagen-
coated scaffolds with all cell lines.  
 To conclude this investigation, after considering all factors (Appendix G and Appendix H), 
the combination of the treated PHBV with collagen 62.5 µg/ml was best for the 3-D cultivation 
of the CLL cell lines studied in this work and later for the human primary leukaemia cell. 
Although the fibronectin-coated scaffolds on the slow-growing JeKo-1 cells produced the 
highest absorbance between week 5 to week 6, selecting a long period of culture (more than 4 
weeks) for the cell culture stabilization would not definitely compromise the structural damage 
of the PHB and PHBV scaffold due to the acidic degradation observed in the in vitro 
degradation in cell growth media (Chapter 6, Figure 6.5b). For these protein-coated scaffolds, 
culture stabilization was accelerated and the cultures became steady by week 1 to week 2 
depending on the cell line whilst in the case of uncoated scaffolds, it occurred after week 4 and 
some of the condition could not be stabilized even at the end of the investigation. For this 
reason, coating the scaffold with collagen and fibronectin accelerated the growth kinetics of the 
cells perhaps through enhanced adherence of the cells to the scaffold. 
 
7.6 Conclusions  
 
 We have shown that a highly porous scaffold (PHB and PHBV), similar to that defined by 
the highly porous structure of the spongy cancellous bone (containing soft bone marrow tissue), 
combined with bone marrow-specific ECM proteins (collagen type I and fibronectin) can 
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provide a 3-D structure for sustainable in vitro cultivation of CLL cells lines for at least 4 weeks 
and provides a platform for the study of human primary leukaemia cell in vitro. The increased 
hydrophilicity and availability of functional groups after physico-chemical modification would 
allow increased perfusion of protein molecules, media and cells deep into the scaffolds and thus 
increasing cell attachment, proliferation and migration. On balance, both treated polymeric 
porous scaffolds coated with collagen type I at a concentration of 62.5 µg/ml sustained the 
growth of all CLL cell lines tested in vitro well, although each cell line preferentially grew with 
different cellular growth rates at different phases of the cultures. However, after considering all 
prominent factors as shown in Appendix H, the combination of the treated PHBV-collagen 62.5 
µg/ml is best for the 3-D cultivation of the studied CLL cell lines and later the primary 
leukaemia cell. These microenvironmental differences in this novel experimental system in vitro 
may provide specific understanding in that both cell-matrix and cell-cell interactions, the later 
investigation of the pathogenesis of the disease and exploration of novel treatments for 
leukaemia. 
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CHAPTER 8 Generation of an Abnormal 3-D In Vitro Bone Marrow Biomimicry 
 
8.1 Introduction 
 
 Leukaemia is a form of cancer that begins in the blood-forming cells of bone marrow known 
as hematopoietic stem cells (HSCs). This form of cancer usually occurs when there is an excess 
of abnormal white blood cells (known as leukocytes) in the blood and lymphoid tissues. For that 
reason, a study on this abnormal bone marrow which produced the leukaemic stem cells is 
needed to elucidate the molecular determinants of leukaemogenesis and to identify the cellular 
and microenvironmental elements that enhance leukaemia growth [6]. To do so, we need to look 
into the building block of the bone marrow that produces HSCs. In general, in order to sustain 
blood cell formation, a unique microenvironment of haematopoietic stem cells (HSCs) is 
essentially required [279]. The availability of stroma cells such as macrophages, adipocytes and 
fibroblasts which formed the bone marrow niches make this 3-D microenvironment an essential 
location for hematopoiesis [6, 261]. In addition, the stroma cells elaborate extracellular matrix 
proteins including fibronectin, collagen, vitronectin and tenascin which create specialized 
compartments with localized chemokines and cytokines resulting in the regulation of 
proliferation, differentiation and self-renewal of HSCs [280]. The organization/regulation of the 
bone marrow niches is critical for the function or dysfunction of normal or malignant bone 
marrow [281]. Acute myeloid leukaemia is one such malignant bone marrow condition [282]. 
Other leukaemia cells such as chronic lymphocytic leukaemia (CLL) could also come from 
lymphoid tissues of the lymphocytes lineages.  
 Acute myeloid leukaemia (AML) is characterized by a block in differentiation and an 
unregulated proliferation of myeloid progenitor cells [283]. AML are a group of heterogeneous 
haematological malignancies with a similar morphology both in children and mostly in adults 
[284] and affecting nearly 5 in every 100,000 men each year [285]. In view of the occurrence of 
leukaemia’s as a disease, the need to find the way on how treat it remains a big challenge. The 
traditional two-dimensional (2-D) cultures and in vivo animal (murine) models of AML have 
helped to characterize the leukaemic progenitors, defining molecules that regulate leukaemic 
proliferation and differentiation and screening for drugs for efficacy in treating it [264, 285]. 
However, there are still some difficulties which arise that limit the current techniques used in 
the study of AML. First, the long-term primary leukaemic cell growth in 2-D cultures cannot be 
done successfully without the support of exogenous growth factors or stromal cell. Second, 2-D 
culture conditions cannot structurally provide the native haematopoietic microenvironment 
(HM) for human AML cells and can only survive for a few days in culture media with foetal 
calf serum. Third, the animal (murine) models, although superior to 2-D cultures, cannot 
completely replicate the human microenvironment due to the physiological differences between 
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mice and human and also require extensive animal facilities and expertise for use [286, 287]. To 
overcome these challenges, an in vitro 3-D biomimicry of the human haematopoietic 
microenvironment is developed for the study of AML [288].  
 The culturing process of HSCs has been traditionally done in a 2-D culture system developed 
by Dexter in tissue culture flasks/plates [289]. However, HSCs cannot be cultivated in vitro 
without the addition of the growth factors which usually need high concentrations of cytokines 
(in the range of ng/ml) [290]. The drawbacks of this 2-D culture system is that it is too 
expensive, it develops early maturation of the HSCs that could limit its self-renewal capability 
and do not correspond to those found naturally in the BM, in the range of pg/ml [291]. Hence, 
the culture of BM haematopoietic cells in 3-D has been investigated as an alternative since it 
provides a more physiologically accurate microenvironment. Since then, several 3-D cultures 
system have been developed using hematopoietic cells including the use of encapsulated or 
cultured on hydrogel matrices [292], tantalum coated biomaterial [290], porous biomatrix 
CellFoamTM [293], macroporous microspheres [294, 295] or synthetic polymers [292]. Although 
these scaffolds may resemble some elements of the BM architecture and facilitate cell-cell and 
cell-matrix interactions, these methods involve the addition of cytokine cocktails to the culture, 
resulting in unwanted differentiation [7]. Only one study has successfully developed a long-term 
3-D culture system that resembled 3-D niches of bone marrow microenvironment fabricated 
from synthetic polymers (PU and PLGA) using cord blood MNCs without the use of exogenous 
growth factors [7]. These cultures provide a different microenvironment from that of the 2-D 
flask cultures and can be used as a model for in vitro haematopoiesis.  
 
8.2 Aim and Hypothesis 
 
 As the BM microenvironment in vivo is distributed in a 3-D space and plays a critical role in 
hematopoiesis, maintaining stem cell potential and controlling proliferation and differentiation, 
it has some factors (i.e., growth factors) that in absence or presence may result in one outcome 
or another. The identification of these situations although still unclear it could help elucidate 
these questions. As a result, it was hypothesised that by recreating the 3-D bone marrow 
biomimicry, the human primary AML MNCs would, when seeded onto the scaffolds, secrete 
their own ECM proteins and the cells would start proliferating in the artificial scaffolds without 
the need of adding exogenous cytokines and truly recreating the natural in vivo environment. 
For this chapter a 3-D culture system that could expand human primary AML MNCs without 
the addition of exogenous cytokines by mimicking the BM microenvironment was developed. 
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8.3 Approach of Study 
 
 We have previously shown that 3-D scaffolds made of either poly(3-hydroxybutyric acid-co-
3-hydroxyvaleric acid) (PHBV) and poly(3-hydroxybutyric acid) (PHB) were able to sustain 
long-term cultures of leukaemic cell lines (Chapter 7). We have now extended our evaluation of 
these scaffolds to a long-term culture and expansion of unselected human primary acute 
myeloid leukaemia blood MNCs as summarized in Table 8.1. In order to enhance this BM 
biomimicry, we coated PHBV with an extracellular matrix (ECM) protein, with an ideal 
concentration of collagen type I (62.5 µg/ml) that can provide strong mechanical contact 
between the scaffold material and the cells (Chapter 7). 
 
Table 8.1: Human primary acute myeloid leukaemia (AML) main properties. 
 
Cell Properties Patient 1 Patient 2 Patient 3 
Source of material Peripheral blood  Peripheral blood Aspirated bone marrow 
Type  Secondary Secondary  Relapsed-Secondary 
Volume of MNCs supernatant ∼7 ml ∼10 ml ∼9 ml 
Cell number/vial (10 ml blood) 16.86 × 106 cells 21.32 × 106 cells 1.29 × 106 cells 
Culture medium 70% IMDM + 30% FBS + 1% PS 
Cultivation routine Renew media every 2 to 3 days 
 
8.4 Results 
 
 A polymeric scaffold with different conditions: Unmodified (control) and protein-coated 
PHBV were tested and seeded with AML blood MNCs. The aim was to derive a cytokine-free 
3-D culture system by recreating the 3-D porous structure of the BM. Additionally, when the 
cells are seeded onto the scaffolds, they would secrete their own ECM proteins and start 
proliferating in the artificial scaffolds without the need of adding exogenous cytokines and truly 
recreating the natural in vivo environment. Previous studies on PHAs particularly PHB and 
PHBV scaffolds seeded with CLL cell lines suggested that protein coating of the polymer could 
improve its performance. The same technique applied before was used here but human primary 
AML blood MNCs in vitro was used instead. PHBV was coated with collagen type I, using an 
ideal concentration of 62.5 µg/ml to add a mechanical strength between the cell and the material 
surface. The effect of protein coating of PHBV was investigated and compared with the 
uncoated scaffolds (control). 
 
8.4.1 AML Blood MNCs Proliferation 
 
 Twenty-four hours after primary human AML MNCs of 2 different patients were seeded into 
the scaffolds, the seeding efficiency was in the range of 46% to 82% (Patient 1: 51.21 ± 5.43% 
(control PHBV), 62.50 ± 11.45% (protein-coated PHBV). Patient 2: 60.52 ± 10.56% (control 
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PHBV), 71.30 ± 10.48% (protein-coated PHBV)), with no significant difference between them, 
indicating that majority of the cells remained in situ within the scaffolds (Figure 8.1). 
Furthermore, the seeding efficiency of the examined scaffolds when seeded with AML blood 
MNCs was observed to have the same trend when seeded with AML (Chapter 5) and CLL cell 
lines (Chapter 7) as to indicate a nature-like behaviour of non-anchorage cell types which 
produced low cell attachment when seeded on biomaterials.  
 
 
Figure 8.1: Cell seeding efficiency of the unmodified and ECM-coated scaffolds seeded with 
AML blood MNCs. The cultures were performed in parallel on 2 separate occasions, each in 
duplicate. 
 
 Cellular proliferation was evaluated over a period of 28 days without the addition of 
exogenous cytokines. All scaffolds supported the proliferation of primary human AML MNCs 
in long-term culture (Figure 8.2) and was best in the PHBV scaffolds coated with collagen, 
peaking at day 14 (Figure 8.2a and b; p < 0.05). Cells cultivated on the unmodified PHBV 
(control) were seen to peak 1 week later (day 21) with lower levels but similar growth kinetics 
of patient 1 and 2 respectively. Viability of primary leukaemic cells extracted from the scaffolds 
was assessed at day 0, 7, 14, 21 and 28 (Figure 8.3a and b). Cells cultivated in and supported by 
the protein-coated 3-D PHBV scaffolds had the best viability (86.47 ± 2.8% (patient 1); 73.24 ± 
1.7% (patient 2)) compared with that supported by the unmodified PHBV scaffolds (55.21 ± 
2.2% (patient 1); 45.87 ± 1.6% (patient 2); p < 0.05) at the end of the 28 day cytokine-free 
culture. In contrast, AML MNCs (patient 3) in 2-D culture did not survive beyond 5 days 
without the addition of cytokines. Together, the viability and proliferation data indicated that 
viable cells derived from primary human AML MNCs could be supported and expanded long-
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term in cytokine-free conditions, best in collagen-coated PHBV scaffolds in vitro. We next 
characterized the cell-scaffold construct morphologically. 
 
 
 
 
 
 
Figure 8.2: Primary human AML cell support and proliferation on 3-D scaffolds. MNCs from 
blood samples of 2 different patients with AML (labelled as patient 1 (a) and patient 2 (b)) were 
cultured on scaffolds for a period of 28 days in the absence of cytokines. Cellular proliferation 
was assessed by standard MTS assay. From day 7, cellular proliferation was best in PHBV 
scaffolds coated with collagen type I, highest at day 14 prior to termination of all cultures. 
Results are plotted after normalization with control scaffolds (scaffolds without cells at the same 
time point of culture). *p < 0.05 compared within culture day. For all panels, results are means 
± sd, n = 2 replicates per experiment, N = 2 separate experiments. 
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Figure 8.3: Viability of primary human AML MNCs cultured in unmodified and protein-coated 
PHBV scaffolds during a period of 28 days in the absence of cytokines. Three different patients 
were utilized: (a) Patient 1 (3-D culture) and 3 (2-D culture) and (b) Patient 2 (3-D culture). The 
cells were 100% viable when seeded and decreased over time to day 28. In contrast, standard 2-
D 24-well plate cultures of AML MNCs (patient 3: sample aspirated from the bone marrow) 
were non-viable by day 5. *p < 0.05, comparison between groups. For all panels, results are 
means ± sd, n = 2 replicates per experiment, N = 2 separate experiments (MTS assay) and N = 3 
separate experiments (viability).  
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8.4.2 3-D Microenvironment 
 
 Characterization of the 3-D scaffolds and cell morphology was done using SEM for cell 
distribution and surface topography after 0, 14 and 28 days of cell culture in the scaffold. 
Scaffolds were sectioned in the outer and central regions of the rectangular cube. The SEM 
micrographs (Figure 8.4) demonstrate how over a period of 28 days on both unmodified and 
protein-coated PHBV scaffolds; the cells migrated into the pores establishing themselves in 
“niche-like” areas. Cellular density in the pores increased with time and by day 28, the walls of 
the scaffolds were covered by cells. When SEM of the cell-seeded unmodified (control) and 
protein-coated PHBV scaffolds were compared, the cells adhered better when seeded onto 
protein-coated PHBV scaffolds. The cells adhered closely to each other indicating that there was 
a good cell-cell and cell-matrix interaction on the protein-coated PHBV scaffolds apart from the 
formation of fibres-like structure which could possibly be the ECM proteins secreted by the 
cells.  
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Figure 8.4: Scaffold topography and morphology of AML MNCs by SEM over 28 days of 
cytokine-free culture. At day 0, MNCs are seen nestling into the pore surfaces. The enucleated 
red blood cells (indicated by arrows) contaminating the MNCs fraction is visible in the two 
scaffolds tested, together with the rest of the MNCs seeded. By day 14, MNCs have expanded in 
number and start to cover the walls of the pores within all scaffolds. Growth of a small colony 
of cells within the middle section of the scaffold is observed in the protein-coated PHBV 
condition from day 14 to day 28. 
 
8.5 Discussion  
 
 We have developed an in vitro 3-D culture system that expands functional leukaemia cells 
without the addition of exogenous cytokines. By studying 2-D and 3-D growths and comparing 
the results, it was discovered that the 3-D structure facilitated the in vitro expansion of AML 
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blood MNCs without any external support. For the last 10 years, researchers have been able to 
expand a long-term leukaemia MNCs in vitro without the addition of exogenous cytokines 
[285]. Prior to this success, there has been a lack of a consistent cell culture system for growing 
leukaemic cells since the use of traditional two-dimensional (2-D) cultures which cannot 
support long-term primary leukaemic cell growth without exogenous growth factors or stromal 
cell support and structurally provide the native haematopoietic microenvironment (HM) for 
human leukaemic cell [6]. Hence, a long-term leukaemia 3-D in vitro cell culture system by 
mimicking the 3-D abnormal or malignant bone marrow (BM) niches is needed for 
characterizing the leukaemic progenitors, defining molecules that regulate leukaemic 
proliferation and differentiation and screening potential chemotherapeutic agents.  
 Highly porous scaffolds were fabricated from PHBV and provided an ideal system for three-
dimensional human AML blood MNCs culture; these 3-D systems composed of an ECM 
protein and a surface treated 3-D scaffold. In previous studies (Chapter 6), the role of two 
proteins: collagen and fibronectin using different concentrations was studied and it was 
concluded that the combination of PHBV coated with 62.5 µg/ml was best to support the 3-D 
growth of the CLL cells studied. As the AML and CLL cell lines have been cultured 
successfully by using variety of synthetic polymers (e.g., PU, PLA, PLLA, PLGA, etc.), it was 
hypothesized that other classes of polymeric materials (e.g., PHB and PHBV) could also be 
used to make a porous 3-D scaffold and ultimately expand these leukaemic cells for a long-term 
growth (up to 4 weeks). The use of this material for making 3-D bone marrow biomimicry 
scaffold to culture human AML blood MNCs in vitro was a novel approach to observe a long-
term proliferation without the addition of expensive growth factors. Until now, these polymeric 
materials (PHB and PHBV) have not been used for the study of leukaemia and most of the 3-D 
structure made from these polymers was in thin films with the thickness of less than 1 mm (if no 
inorganic salts and porous preform porogen involved). The polymer chosen in this study was 
selected due to the high-quality results obtained in the previous studies for biomedical 
applications on top of being biocompatible and FDA approved [9, 23]. In this study, protein-
coated PHBV showed a higher number of metabolically active cells than the unmodified PHBV 
(control) when seeded with AML blood MNCs. These results can be compared to the ones 
obtained previously when using AML and CLL cell lines where protein-coated PHBV overall 
had also showed better results. This could be explained by the superiority of the ECM protein 
(e.g., collagen type I) which affects cellular adhesion, viability, ingrowth and distribution on the 
protein-coated PHBV scaffolds [7]. 
 Also hydrophobicity had an effect in the differences in metabolically active cells (MTS) 
between the unmodified and surface-treated plus protein-coated PHBV scaffolds. This is due to 
the fact that hydrophilic surface favourably influenced the cells during the initial stage of 
contact and later for cells spreading, proliferation and differentiation [120, 259, 274, 278]. The 
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cells adhere and grow better on hydrophilic scaffolds than on hydrophobic surfaces; thus it is 
expected that the surface-treated plus protein-coated PHBV scaffold seeded with AML blood 
MNCs showed higher number of metabolically active cells than the unmodified PHBV. 
Furthermore, it can be explained by a large amount of polar groups on the surface (such as -OH, 
-COO-) which could provide many sites for collagen adsorption by polar interaction and 
hydrogen bonding [278]. Hence, the sufficient amount of the adsorbed protein on the surface 
has in fact provided a proper microenvironment for AML blood MNCs culture. Although there 
were no differences between the seeding efficiency of the collagen coated and unmodified 
PHBV scaffolds when using PHBV coated with collagen type I; the collagen seemed to 
accelerate cell growth faster than the unmodified scaffolds and also of any other ECM proteins. 
 Cellular expansion was measured using the MTS assay where the results proved cellular 
expansion in the form of increased absorbance. It can be appreciated that the first few days in 
culture the cells expand quickly on the protein-coated scaffolds and they commenced a rapid 
expansion peaking at day 14. Whilst the unmodified scaffolds seems to expand quite slowly for 
the first 7 days until it peaked at day 21. The above mentioned phenomenon was possibly due to 
the time required for the microenvironment to be established (factors that affected the 
establishment: surface hydrophilicity/hydrophobicity and ECM surface coating) and the 
production of self-sustaining growth factors. Although cytokines were not directly measured in 
this study, in the absence of exogenous cytokines added to the cultures, AML blood MNCs 
would not have been viable or expanded if cytokines were not produced by cells within the 
microenvironment in situ, including potentially stromal cells [7]. On the other hand, the 
corroboration of the MTS assay absorbance values with the DNA quantification which related 
to cell number was not executed due to the difficulty of extracting the cells from the scaffold as 
reported from the previous study [7]. It was observed that the longer the culture lasted the more 
difficult it became to extract the seeded cells. The usage of certain agents only (e.g., proteinase-
K or collagenase) might not be enough to release the adhering cells on the protein-coated 
material surface. A combination of physical means such as shaking, agitation and centrifugation 
coupled with enzymatic agents for protein digestion would probably help to harvest more cells. 
The MTS assay for the cell extracted scaffolds (manually extraction) and centrifuged at 1000 
rpm for 5 min showed that there was a changed of the growth media into dark-purplish colour 
after 3 h of incubation (data not shown) to indicate the availability of the remaining cells inside 
the scaffolds. For that reason only the MTS assay results were used to confirm the hypothesis 
that AML blood MNCs were expanded in vitro without the addition of cytokines. Viability 
variance between the unmodified and protein-coated PHBV could be explained by the surface 
hydrophilicity/hydrophobicity and ECM surface coating although both type of the scaffolds 
have the same physical properties (Chapter 6: Table 6.4).  
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 The expansion in number is linked with the production of stromal cells and growth factors. 
Using the scanning electron micrographs taken, it can be supposed that there was a stroma 
formation (Figure 8.4: PHBV with collagen at day 14 and day 28) and growth factor secretion 
as the cells would not be able to expand in numbers if there were not. On top of that, the SEM 
pictures showed an increasing number of cells in the pores that populate the scaffold as time 
progresses. However, due to the structural integrity problem of the PHBV scaffolds, the 
Haematoxylin & Eosin (H & E) immunostaining was unable to carry out for comparing the data 
with the scanning electron micrographs. This is to prove that there was collagen secretion apart 
from the one present in the coated scaffolds. A flexible and sponge-like PHBV scaffold is 
essentially required so that during all the rigorous steps for the preparation of the H & E 
immunostaining, the scaffolds are not destroyed and ruptured into pieces.  
 Overall, there are several important aspects that need to be taken into serious contemplation. 
First, the requirement of the scaffolds to be flexible, sponge-like and robust for further analysis 
is essential so that the microenvironmental structure is not destroyed during the handling 
process. Second, the method improvement of the extraction/detachment of the cells from the 
scaffolds in order to obtain the highest amount of cells. Apart from the suggestion of the 
improvement of the fabrication process and cell extraction procedures, other aspects of 
expanding the studies using this 3-D culture system to the next levels are still ongoing such as 
the possibility of a serum-free culture, determining the microenvironmental niches supported by 
the scaffolds and responsiveness of cells within the niches to external signals. 
 
8.6 Conclusions  
 
 In summary, we have achieved successful long-term culture and expansion of AML blood 
MNCs without the addition of exogenous cytokines using a 3-D scaffold fabricated with PHBV 
and coated with collagen type I. This 3-D bone marrow biomimicry can be used for diagnosis or 
prognosis (predicting the likely outcome of an illness) of the abnormal hematopoiesis in a 
relevant in vitro system and has the potential to be applied to drug discovery platforms and 
expansion protocols for cellular therapies and transplantation. 
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CHAPTER 9 Overall Conclusions and Future Work 
 
9.1 Overall Conclusions 
 
 The main goal of this study was to develop an in vitro 3-D long-term culture of the human 
primary AML blood mononuclear cells without the addition of exogenous cytokines. In order to 
do so, microbial biosynthetic polymers were fabricated, characterized, optimized and selected. 
Overall conclusions as a result of the efforts toward this goal are summarized in the following 
sections. 
 
9.1.1 Summary of Contributions 
 
9.1.1.1 Fabrication of Porous 3-D Scaffolds 
 
 To produce a porous 3-D scaffold with an improved thickness greater than 1 mm (in relative 
to the conventionally made PHA matrices) from this type of microbial biosynthetic polymer 
(e.g., PHB and PHBV) was a big challenged. Most of the scaffolds fabricated from these 
polymers were not in the porous 3-D structure. The applicability and reproducibility of the 
breakthrough technique to fabricate the porous 3-D scaffold was demonstrated on PHB and 
PHBV, manufactured using the solvent-casting particulate-leaching (SCPL) process. Several 
factors have been identified in the successful of fabricating the porous 3-D scaffolds: (1) 
Identification of an ideal polymer concentration. (2) Controlling the rapid phase separation of 
the polymeric solution due to the rapid solvent evaporation. This has been demonstrated by 
keeping the polymer solution plus porogen cast inside a small orifice of lyophilization flask and 
put it inside a fume cupboard with constant velocity air suction. This is to avoid any 
development of thin films on top of the scaffold (etching effect). (3) The usage of cold 
deionized water (DIW) during the salt leaching process avoids fast surface erosion. Fast salt 
leaching processes will facilitate internal structural damage. As the whole structure of the dried 
cast was randomly compacted, a few parts of it might not be compacted properly during the 
drying process. These loose sections might contain large big chunks of agglomerated salt 
particles that were packed together tightly. Contacts with hot water for instance, will cause the 
water to rapidly diffuse through the loose sections due to the expansion of the pores wall (the 
polymer becomes rubber-like condition) and rip off a large chunk of the compacted cast which 
will eventually leave a big hole on the scaffolds. Although the process was considered time 
consuming (it could take up to 2 days), the final structural formation of the porous 3-D scaffolds 
was indeed promising for tissue engineering applications. The porous 3-D scaffolds were 
characterized using conventional characterization techniques prior to the 3-D cell culture work 
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and have demonstrated high porosity, acceptable range of pore diameters and relatively good 
interconnectivity (the results can be viewed in Appendix D).  
 
9.1.1.2 Development of 3-D Biomimicry Culture System 
 
 It was an ideal prospect to mimic the highly porous structure of the spongy cancellous bone 
and its composition (e.g., soft marrow tissue containing HSCs and non-HSCs) in order to 
overcome the problem of culturing AML cells in vitro. It seemed that by using a three 
dimensional configuration that resembled the in vivo bone marrow, the same microenvironment 
was developed. Hence, the 3-D model culture system has been a successful approach. The 
leukaemic cells (e.g., CLL and AML cell lines) can be expanded for long periods of time (up to 
6 weeks). They were all investigated in their natural environment without the addition of 
external growth factors. To validate the three dimensional model, the human primary AML 
blood mononuclear cells was cultivated on the optimized porous 3-D scaffolds. The in vitro 
expansion of human AML blood mononuclear cells represented a possibility to be applied to 
drug discovery platforms and expansion protocols for cellular therapies. The hypothesis was 
that by providing a 3-D environment in the form of a scaffold, it will facilitate the expansion of 
the cells in its native state (the same that it was previously assumed for the CLL and AML cell 
lines). The hypothesis was proven and the cells expanded without the addition of cytokines 
although further studies about the differentiation pattern of the cells are still required and need 
further investigation. 
 Initially, the research was commenced by choosing two types of polymeric scaffolds (e.g. the 
PHB and PHBV) which were produced in our laboratory using the solvent-casting particulate-
leaching (SCPL) process. Both of the polymeric scaffolds were initially tested with the AML 
cell line to observe the cells response on the material without adjusting its native surface 
chemistry and physical properties. As the cells seemed to be irresponsive, the surface 
modifications were employed. The surface of the scaffolds was treated with NaOH and rf-O2 
plasma and the selection of the most suitable surface-treated scaffolds for the CLL cell line 
expansion was carried out. Afterwards, the polymeric scaffolds were coated with two very 
important and common ECM proteins: collagen type I and fibronectin. The cell seeding of the 
protein coated scaffolds showed an enhanced affinity in comparison with the uncoated and 
untreated scaffolds. Protein was incorporated using the vacuum-immersion method to produce 
homogenous surface protein coating and it resulted in better cell spreading and proliferation. 
Although the seeding efficiency of certain cell lines was higher when using the uncoated 
scaffolds, overall and after the long term studies, the protein-coated scaffolds did improve 
cellular expansion by peaking as early as week 2 to week 3 as compared to the uncoated and 
untreated scaffolds which peaked at week 4 to week 5.  
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 Overall, it can be concluded that the scaffold that supported leukaemic cell growth in vitro at 
its best was the scaffold made from PHBV and coated with 62.5 µg/ml of collagen type I. 
Nevertheless even though collagen coating aided cellular expansion further investigations are 
required about different and more efficient methods of coating. Protein absorption should also 
be quantified and the design of a perfusion system where the collagen could be circulated 
efficiently through the sample should be examined as well. 
 
9.1.2 Future Work 
 
9.1.2.1Fabrication of Porous Scaffolds with Optimal Pore Size and Interconnectivity 
 
 Pore diameters, interconnectivity and porosity are important design criteria for the 
fabrication of polymeric 3-D porous scaffolds. They are important parameters to consider 
during the fabrication technique as different cells can attach and spread on a broad range of pore 
sizes. In addition, good interconnectivity would facilitate the delivery of nutrient, oxygen and 
metabolites which are beneficial to the proliferation of cells. It was reported that pore size 
should be close to 20 µm for the ingrowth of hepatocytes, 20 to 150 µm for skin regeneration 
and in the range of 200 to 400 µm for bone regeneration [296]. Various microcellular and 
porous scaffolds morphologies is achievable by adjusting the parameters during the solvent-
casting particulate-leaching (SCPL) process. The shape and the size of the porogen play a vital 
effect on the porosity. Meanwhile, the usage of pressure (compression) during the scaffolds 
moulding affect the pore interconnectivity. It was reported that the sphere shape with face-to-
face contact coupled with the compression pressure can in fact be used to control of the pore 
size and interconnectivity of the scaffold (the higher the pressure, the bigger the pore 
interconnectivity) [202]. Considering such design parameters, the pore diameter and 
interconnectivity of the scaffold could be adjusted to satisfy the various cell growths for tissue 
engineering prior to the surface treatment and to verify whether pore size and interconnectivity 
really matters.  
 
9.1.2.2 Adsorption of Collagen Type I to Polymer Surfaces 
 
 To allow better uptake of collagen during exposure of the polymeric scaffolds to the collagen 
solution, a perfusion system is recommended so that the homogeneous closed system where the 
collagen solution could be circulated throughout the sample can be created. The present method 
involved with many steps just to make sure that the porous structure are not blocked by the 
protein. An alternative approach to expose the polymeric scaffolds to collagen solution would 
be the incorporation of collagen in the polymer solution prior to the SCPL process.  
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9.1.2.3 The Amount of Protein Adsorbed 
 
 There have been many studies focused on protein coating of polymeric surfaces to improve 
cellular affinity and collagen type I has been the molecule mostly used in these cases. The 
problem of measuring protein adsorption still remains uncertain. It is believed that there are 
several interactions needed in order for the protein to be adsorbed onto the solid surface and that 
the polymeric scaffold surface chemistry affects the adsorption of the proteins; furthermore the 
amount of protein adsorbed by the scaffold correlates with the number of surface attached cells. 
A recent technique using Atomic Force Microscopy (AFM) has been employed based on the 
analysis of AFM height histogram obtained from height images to quantify the additional 
thickness added to the disks height (bare surface) during protein adsorption [297, 298].  
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APPENDIX A 
 
NaCl Conductivity Standard Curve  
 
Figure A.1: Relationship between conductivity of sodium chloride (Sigma-Aldrich) solution 
with respect to its different concentration (mg/ml). Conductivity of deionized water was 2.73 
µS/cm. It was a linear correlation between conductivity (mS/cm) and the concentration of 
sodium chloride (mg/ml); Y = 2.8475x + 8.5027; r2 = 0:9999 (n = 3) 
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APPENDIX B 
 
Morphology of Dried Porous 3-D Scaffolds after Salt-Leaching Process 
  
  
 
  
 
Figure B.1: Morphology of the polymeric porous 3-D scaffolds in a cylindrical shape prepared 
using the solvent-casting particulate-leaching (SCPL) technique. They were later cut in cuboids 
with an approximate size of 5 mm × 10 mm × 10 mm: (a) Aerial view of the PHB 4% (w/v) 
porous 3-D scaffold; (b) Side view of the PHB 4% (w/v) porous 3-D scaffold with the thickness 
of 5.25 ± 0.36 mm; (c) Aerial view of the PHBV 4% (w/v) porous 3-D scaffold; (d) Side view 
of the PHBV 4% (w/v) porous 3-D scaffold with the thickness of 4.40 ± 0.52 mm. d: thickness.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) (b) 
(c) (d) 
PHBV 4% (w/v) 
Thickness (d) = 4.40 ± 0.52 mm 
PHB 4% (w/v) 
Thickness (d) = 5.25 ± 0.36 mm 
d 
d 
PHB (4%, w/v) 
Diameter (φ) = 82.20 ± 0.15 mm 
 
PHBV (4%, w/v) 
Diameter (φ) = 84.0 ± 0.24 mm 
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APPENDIX C 
 
Wettibility of Polymeric Porous 3-D Scaffolds 
 
Figure C.1 compares the PHB and PHBV (4%, w/v) porous 3-D scaffolds for their absorbability 
(wettibility) in cell culture medium (IMDM). When the PHBV was put into the cell growth 
media, the scaffold was submerged within 105 min. However, PHB was submerged with faster 
absorbability rate than PHBV (within 60 min) owing to the less hydrophobic character than 
PHBV. The fast wetting and sinking of a scaffold into cell culture medium are highly desirable 
for tissue engineering applications because the cells can be directly seeded and cultured in 
scaffolds without any prewetting treatments (e.g., ethanol) which could induce structural 
deformation [162]. 
 
 
 
 
 
 
 
 
 
(a) Submerging but not sinking 
 
 
 
 
 
 
(b)  Submerging but not sinking 
 
Figure C.1: Photographs showing the submerging of (a) PHBV (4%, w/v) porous 3-D scaffold 
and (b) PHB (4%, w/v) porous 3-D scaffold into the cell culture growth media (IMDM) as a 
function of time. 
 
 
 
 
 
 
 
 
                               1 min                   30 mins                45 mins                 60 mins 
PHB 
Cell growth media 
                        1 min                  30 mins              60 mins              105 mins 
PHBV 
Cell growth media 
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APPENDIX D 
 
Pore Interconnectivity Observation Through Colour Staining 
 
1) Chemical for staining: Alirazin Red S (Sigma-AldrichTM) was dissolved in deionized water 
(DIW) with the concentration of 0.4% (w/v).  
 
2) Instrument for optical microscopic imaging: Dino-Lite AM-311s USB Microscope 10x - 
200x + LED. 
 
3) Software: Image Analyzer 1.33 MeeSoftTM (grayscale mapping exposure). 
 
4) Method: A simple experiment was performed to observe the pores interconnectivity in which 
the polymeric porous 3-D scaffolds were soaked in the color staining solution of Alirazin Red S 
(0.4% w/v) by means of the normal soaking (without pressure) and forced entry (under vacuum 
pressure of 2 mbar) for 60 min to 105 min and 5 min respectively. After the soaking, the sample 
was dried, sectioned and pictured prior to the image analysis by mean of inverted colour 
mapping exposure. Pores with red colour apparently had been accessible, either directly or via 
neighboring pores. 
 
5) Results:  
 
(a) Visible observation  
 
Methods Visible observation of porous 3-D scaffolds[a] 
PHB (4%, w/v) PHBV (4%, w/v)  
Normal soaking  Mild colour stained with 
one big unstained spot 
Mild colour stained with 
scattered unstained spots 
Forced entry (2 mbar) Colour stained almost 
homogeneously 
Colour stained almost 
homogeneously 
    [a] Visible observation on the vertical cross-section of the porous 3-D scaffolds.  
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Figure D.1: Photographs showing the vertical cross section of polymeric porous 3-D scaffolds 
stained by using the Alirazin Red S (Sigma-AldrichTM). Two different methods were conducted 
which are by means of the normal soaking (without pressure) and forced entry (under vacuum 
pressure of 2 mbar for 5 min).  
 
 
 
 
 
 
 
 
 
 
(a) 
Control 
Normal Soaking 
Forced Entry 
1/2 
2/2 3/4 4/4 
1/4 2/4 
1/2 
2/2 
PHB 
(b) 
Control Normal Soaking Forced Entry 
1/4 2/4 
3/4 
4/4 
1/2 
2/2 
1/2 
2/2 
PHBV 
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[a] % Interconnectivity was calculated based on the TOTAL AREAS UNDER THE CURVE of grayscale 
mapping exposure histogram. [b] Optical microscopic images were taken by using Dino-Lite AM-311s 
USB Microscope 10x to 200x. *p < 0.05 as compared with PHB (n = 4). 
           
% Interconnectivity = ∑ Areas under the curve (black coloured area)/[∑ Areas under the curve 
(black coloured area) + Areas under the curve (white coloured area)] × 100%. 
 
Figure D.2: Microscopic images (10x and 20x magnification) demonstrating the vertical cross 
section of polymeric porous 3-D scaffolds stained by using the Alirazin Red S (Sigma-
AldrichTM).  
 
 
 
 
 
 
Methods/parameter PHB (4%, w/v) porous 3-D 
scaffolds [b] 
PHBV (4%, w/v) porous 3-D 
scaffolds [b] 
Normal soaking 
(soaking period: ∼60 min 
to 105 min) 
 
 
 
Interconnectivity (%)[a] 70.12 ± 3.54 74.28 ± 1.52* 
Control (unstained 3-D 
scaffolds) 
  
 
Forced entry (vacuum 
pressure of 2 mbar, 5 min) 
 
 
 
Interconnectivity (%)[a] 78.00 ± 0.41 85.82 ± 0.56* 
10x 10x 
10x 10x 
20x 20x 
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APPENDIX E 
 
Example Calculation of Surface Roughness Ratio (r) Based on the Wenzel’s Theory  
 
Table E.1: Surface roughness ratio (r) of polymeric porous 3-D scaffolds. 
 
Physical properties Polymeric porous 3-D scaffolds 
PHB (4%, w/v) PHBV (4%, w/v) 
Surface roughness ratio, r 1.41 ± 0.02 1.62 ± 0.03* 
BET surface area, As, m2/g 0.70 ± 0.02 0.82 ± 0.03* 
*(p < 0.05) - Results were considered statistically significant (n = 4) as compared with PHB.  
 
 
 
 
Assumptions:  
1. The weight of porous 3-D scaffolds in a cylindrical shape measured is the same amount of polymer 
used in the SCPL process = 2.4 g = 4% (w/v) PHB and PHBV. 
2. The efficacy of SCPL = 100%. 
3. There is no loss of polymer materials during the fabrication and leaching process. 
 
PHB 
1. Diameter of porous 3-D scaffold measured by Vernier caliper = 8.22 cm. 
2. So, radius = 4.11 cm. 
3. Thickness = 0.55 cm. 
4. The geometric surface area of 3-D scaffold (cylindrical shape) = 2(pi)(4.11cm)2 + 
2(pi)(4.11)(0.55cm) = 106 cm2 + 14.20 cm2 = 171.40 cm2 = 120.20 cm2  = 1.20 m2 
5. BET surface area (result is given by the instrument) = Specific surface area (m2/g). 
6. PHB BET surface area = 0.7029 m2/g × 2.4 g (weight of porous 3-D scaffold) = 1.69 m2 
7. Roughness factor (r) = True surface area of porous 3-D scaffolds/Geometric surface area of porous   
3-D scaffolds = 1.69 m2/1.20 m2 = 1.41 
 
PHBV 
1. Diameter of porous 3-D scaffold measured by Vernier caliper = 8.40 cm. 
2. So, radius = 4.20 cm. 
3. Thickness = 0.44 cm. 
4. The geometric surface area of porous 3-D scaffold (cylindrical shape) = 2(pi)(4.20cm)2 + 
2(pi)(4.20)(0.44cm) = 110.83 cm2 + 11.61 cm2 = 122.44 cm2 = 1.22 m2 
5. PHBV BET surface area = 0.8192 m2/g × 2.4 g (weight of porous 3-D scaffold) = 1.97 m2 
6. Roughness factor (r) = True surface area of porous 3-D scaffolds/Geometric surface area of porous   
3-D scaffolds = 1.97 m2/1.22 m2 = 1.62 
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APPENDIX F 
 
1. Surface Thermodynamics (Surface Free Energy on the Thin Film)  
 
Method: The Fowkes equation is chosen as the equation of state (EOS). In this case, the adhesion energy 
at SL interfaces/work of adhesion at SL interfaces/total energy change of separating liquid & solid 
adhesion (Eadh) is a sum of two partial contributions, each of which is expressed as the geometric mean 
polar of two adhesion parameters, γL and γs, the first of which characterizes the "adhesive power" of the 
liquid and the second is the "adhesive power" of the solid. The surface energy of the solvent-cast thin film 
was determined by the contact angles of two types of reference liquids (H2O and CH2I2). The material 
surface free energy (γs) was calculated based on the equations as shown below: 
 
Eadh = WSL = γL(1 + cos θ) = 2[(γdLγdS)½ + (γpLγpS)½]  → (Dupree, Young and Fowkes equation) 
 
 γs = γps + γds → (Surface free energy) 
 
Table F.1: Adhesion parameters for the test liquids [164]. 
 
Test liquid γL (mN/m) = γdL + γpL γdL (mN/m) γpL (mN/m) 
Water (H2O) 72.8 21.8 51.0 
Di-iodomethane (CH2I2) 50.8 50.8 0 
 
Results:   
 
CH2I2 = (50.8)(1+cos42.80) = 2[(50.8 × γds)½ + (0 × γps) ½], (50.8)(1.73) = (14.24)(γds)½ 
87.88/14.24 = (γds)½, γds = (6.17)2 = 38.08 mN/m 
 
H2O = (72.8)(1+cos67.80) = 2[(21.8 × γds)½ + (51.0 × γps) ½] = (72.8)(1.38) = 2[(21.8)(38.08)½] + 2[(51.0 
× γps) ½], 100 = 57.62 + [(14.28)(γps)½], 100 - 57.62 = [(14.28)(γps)½], 42.38/14.28 = (γps)½ 
γps = (2.97)2 = 8.81 mN/m 
 
∴ SFE of PHB (γs = γps + γds) = 8.81 + 38.08 = 46.89 mN/m   
 
Sample θH2O (deg.) θCH2I2 (deg.) Dispersive comp. (γds) Polar comp. (γps) SFE (γs = γps  + γds) 
Thin films (4% w/v) 
PHB 67.80 ± 1.2 42.80 ± 0.5 38.08 ± 0.2 mN/m 8.81 ± 1.3 mN/m 46.89 ± 1.0 mN/m 
 
SFE at the SL interface based on the Young equation = (γSL) = 46.89 - (72.8)cos(67.80) =  19.38 mN/m  
 
Dupree equation (work of adhesive at interfacial) - Eadh = WSL = γL + γS - γLS = 72.8 + 46.89 - 19.39 = +100.30 mN/m 
OR Eadh = WSL = γL(1 + cos θ) = 72.8(1 + cos67.80) = +100.30 mN/m. ([+] represent a non-spontaneous process is 
occurred (the liquid water beads up. No spreading occurred). An external energy (e.g., surface treatment) is needed to 
overcome the strong water intermolecular cohesive forces so that the water can spread on the polymer surface). 
 
Work of cohesion of water [WLL = ∆G = 2γL] if they are separated into 2 sections of liquid which form 2 new surface 
area = 2(72.8 mN/m) = 145.8 mN/m. 
 
Spreading coefficient (water over a thin film) = SH20/thin film = WSL - WLL = 100.30 - 145.8 = -45.50 mN/m ([-] 
spreading coefficient means water will not spread over a thin film surface). 
 
Sample θH2O (deg.) Interfacial (γSL) Work of adhesive (WSL) (SH20/thin film) = WSL - WLL) 
Thin films (4% w/v) 
PHB 67.80 ± 1.2 19.38 ± 0.6 mN/m +100.30 ± 1.1 mN/m -45.50 ± 1.3 mN/m 
 
If WSL > WLL → The work of adhesive at SL interface (e.g., hydrogen bonding [polar component], dipole-dipole 
[dispersive component] and Van der Waal [dispersive component]) is strong enough to overcome the work of 
cohesive of water to promote spreading on the solid surface.  
If WSL < WLL → No wetting occurred.  
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Discussion: According to Blanco et al. [6], POLYMERIC MATERIAL which is hydrophobic and POSSESSES 
HIGH IN INTERFACIAL FREE ENERGY IN AQUEOUS SOLUTION tends to unfavourably influence cells and 
tissues during the initial stages of cell-biomaterial. However, not all polymer materials have high interfacial free 
energy (γSL). As for PHB/PHBV, the surface free energy at solid surface is much higher than at the interface (γS > 
γSL). That is why we observed that the AML and CLL cell lines had a fairly good attachment on both polymeric 
surfaces (Chapter 5 and 6). The hydrophilic surface condition has more than 100 mN/m or at least more than the 
water surface tension 72.8 mN/m (γS  > γSL - SFE@solid is always higher than SFE@SL). As for the hydrophobic 
surface (<100 mN/m), the condition could be γS  > γSL or γS  < γSL. If the case of γS  > γSL (as observed on PHB & 
PHBV), the surface is still considered to have the ability to be wet by the liquid (e.g., water) because the SFE@solid 
is higher than SFE@SL. In fact, this will affect the adsorption of ECM proteins whereby the proteins will rearrange 
its molecular structure to adsorb onto the hydrophobic surface. The protein structure will again rearrange to allow the 
exposed RGD peptides (biosignaling templates) for cell attachment via ligand-receptor interactions. BUT if γS  < γSL 
(as observed on the other highly hydrophobic synthetic polymers (e.g., PS, PE, PMMA, PLA, etc.)), the problem will 
start to occur during the initial contact of polymeric surface with the serum-supplemented aqueous media where only 
small surface area will be spread by the aqueous cell media. This will give only a small area and amount of proteins 
to adsorb onto the surface and eventually make the cell to unfavourably attach to the surface due to the low 
availability of biosignaling compounds. γS  = γSG (solid-gas interface). 
 
2. Cassie-Bexter Contact Angle Corrections for the Heterogeneous Wetting on the Porous 
3-D Scaffolds 
 
Surface physico-chemistry  Polymeric porous 3-D scaffolds Control (Thin films)[a][b][c] 
PHB (4%, w/v) PHBV (4%, w/v) PHB (4%, w/v) PHBV (4%, w/v) 
Surface roughness ratio, r 1.41 ± 0.02 1.62 ± 0.03 N/A N/A 
Fraction of fluid contact area, f [f] 0.52 ± 0.04 0.34 ± 0.02 N/A N/A 
Contact angle, θapparent (deg.) 65.79 ± 1.3 67.55 ± 1.1 66.80 ± 0.2 79.24 ± 0.4 
True contact angle, θporous (deg.)[d][e] 93.95 ± 0.8 117.20 ± 1.8 N/A N/A 
[a] Fabricated by using the solvent casting. [b] Equilibrium contact angle of solvent-cast thin films on polypropylene 
sheet (n = 10). [c] Contact angle of polypropylene (PP) sheet without PHB and PHBV coating = 92.43 ± 0.3o [d] 
Cassie-Baxter regime for the heterogeneous wetting: cosθporous = [rf.f.cosθapparent] + f - 1 (roughness ratio of the wet 
area, rf was assumed to be as an average roughness ratio, r of polymeric porous 3-D scaffolds). [e] Initial true contact 
angle of the redistilled water droplet resting on the porous 3-D scaffolds (n = 10). [f] Fraction of fluid area in contact 
with the material surface, f = 1 - fair. A planar water droplet area is assumed to be in a circle shape with a diameter of 
∼400 µm (DSA software). All pores inside the droplet targeted area were assumed to be in a circle shape where the 
total area of pores which contained air can be calculated (fair is calculated by selecting random pore areas from the 
SEM (n = 3)). 
 
Calculations:  
PHB: cosθporous = rf.f.cosθapparent + f - 1 = cos93.95 = [(1.41)(0.52)(cosθ)] + 0.52 - 1 
 -0.07 = [0.733cosθ] - 0.48, -0.07 + 0.48 = [0.733cosθ], cosθ = 0.41, θ = cos-1[0.41] = 65.79o 
 
PHBV: cosθporous = rf.f.cosθapparent + f - 1 = cos117.20 = [(1.62)(0.34)(cosθ)] + 0.34 - 1 
 -0.45 = [0.55cosθ] - 0.66, -0.45 + 0.66 = [0.55cosθ], cosθ = 0.38, θ = cos-1[0.38] = 67.55o 
 
Discussion: A heterogeneous wetting condition of Cassie-Baxter regime was selected in describing the wetting 
condition of the porous material and predicting the corrected apparent contact angle. Both polymeric porous 3-D 
scaffolds were observed to amplify the theoretical/corrected apparent water contact angle (θapparent) ranging from 
approximately 28o to 49o (θporous - θapparent). These theoretical/corrected apparent water contact angles (θapparent) were 
considered close enough to the solvent-cast thin films (p > 0.05: applicable only for PHB) to indicate that the Cassie-
Baxter regime was quite relevant in explaining the highly observed surface hydrophobicity. In fact, both polymeric 
porous 3-D scaffolds and the corresponding thin films were considered as hydrophobic materials as they have a high 
degree of water contact angle of more than 65o. Thus, the highly observed surface hydrophobicity of the polymeric 
porous 3-D scaffolds in comparison with that of solvent-cast thin films (in accordance with the Cassie-Baxter regime) 
was probably due to the surface heterogeneity (e.g., availability of the surface roughness which could lead to 
hysteresis), air trapped inside the pore grooves (enhances the hydrophobicity because the drop is then partially sitting 
on air) and contaminants of salt on the rough surfaces (which could lead to a decrease of solid-gas (γS) surface 
energy). 
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APPENDIX G 
 
Optimized Parameters Obtained From the Optimization Processes 
 
Table G.1: Optimized parameters obtained from the optimization processes to enhance cell-
biomaterial adhesion and interactions. 
 
(1) Structural optimization  
Polymer concentration  4 % (w/v) - Homogeneous polymer solution. Fixed parameters: 
Temperature, pressure and volume. Independent variables: Time, 
concentration and type of polymers. Dependent variable: 
Homogeneity of the solution (visual assessment) 
Thickness of the 3-D 
scaffolds 
4 mm to 5 mm (recommended dimension of the porous 3-D 
scaffolds to be put inside the 24-well cell culture plate: ∼10 mm 
× ∼10 mm × ∼5 mm). Fixed parameters: Salt weight fraction, % 
w/w, temperature, pressure and volume. Independent variables: 
Polymer concentrations and type of polymers. Dependent 
variable: Thickness 
(2) Physico-chemical optimization via surface treatment 
Mode of treatment Wet chemical method: 0.6M NaOH. Fixed parameters: 
Temperature, pressure, volume, scaffolds dimension and time. 
Independent variables: Type of polymers and NaOH 
concentrations. Dependent variables: Structural integrity (visual 
assessment), wetting (contact angles) and weight loss  
Post optimization outcome: 
Structural morphology  
1) Good structural integrity 
2) More void developed with good interconnected open pores 
3) Weight loss less than 5% (w/w) 
Post optimization outcome: 
Surface chemistry  
A significant decrease of hydrophobic properties. Fully wetting 
condition (contact angle less than 25o) occurred for all polymers. 
Both polymers exhibited well in cellular attachment and 
proliferation 
(3) Cell-biomaterial adhesion and interaction optimization via biological surface coating  
ECM protein concentration Fixed parameters: Polymer concentration, thickness, type of 
surface treatment, scaffolds dimension and cell seeding density. 
Independent variables: Protein concentrations, type of polymers, 
culture time and type of cells. Dependent variable: Absorbance 
(490 nm). REMARKS: On balance, both PHBV and PHB 
coated with collagen type I at a concentration of 62.5 µg/ml have 
the ability to sustain the growth of all CLL cell lines tested in 
vitro well, although each cell line preferentially grew with 
different concentrations of collagen and fibronectin at different 
phases of the cultures 
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APPENDIX H 
 
Comprehensive Comparison of Both Polymers and Criterion of Choosing PHBV-Collagen 
as a Biomaterial 
 
Table H.1: Comprehensive comparison of both polymers and criterion of choosing PHBV-
collagen as a biomaterial to study the biology and treatment of primary leukaemia in an in vitro 
biomimicry. 
 
Criterion PHB 4% (w/v) PHBV 4% (w/v) 
Fabrication process 
(Drying of polymer cast) 
Rapid phase separation produced 
detachable thin films 
No detachable thin films 
occurred 
Fabrication process 
(Salt-leaching process) 
Easily to detach whilst handling 
the wet scaffold 
Stable structure whilst 
handling 
Porosity  82% 93% (extra void spaces) 
Weight loss after surface 
treatment (0.6M NaOH) 
5.28% (w/w): Easily to rupture 
whilst handling the wet scaffold 
3.26% (w/w): Rigid wet 
scaffold structure 
In vitro degradation in 
cell growth media 
Both polymeric scaffolds have the tendency to produce acidic 
degradation between week 4 to week 5 onwards 
Cellular growth response 
from other leukaemic 
cell types (AML: HL-60) 
(Refer to Chapter 5, 
Section 5.4.11) 
Slow cellular growth for the 
untreated scaffolds until week 2 
Better cellular growth until 
week 2 for the untreated 
scaffolds. This is due to the 
highly porous nature of 
PHBV 3-D scaffolds which 
have provided extra 
surfaces onto which the 
cells can growth adequately 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
